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ACD	  	   Allergic	  contact	  dermatitis	  
AIM2	  	   Absent	  in	  melanoma	  2	  
AKR1	  	   Aldo-­‐keto	  reductase	  family	  1	  member	  
AOP	  	   Aderse	  outcome	  pathway	  
AP-­‐1	  	   Activator	  protein	  1	  
APC	  	   Antigen	  presenting	  cells	  
ASC	  	   Apoptosis-­‐associated	  speck-­‐like	  protein	  containing	  
a	  CARD	  domain	  
ATP	  	   Adenosine	  triphosphate	  
CARD	  	   Caspase-­‐recruitment	  domain	  
CD[number]	  	   Cluster	  of	  differentiation	  [number]	  
DAMPs	  	   Damage-­‐associated	  molecular	  patterns	  
DNCB	  	   2,4-­‐dinitrochlorobenzene	  
DPI	  	   Diphenyleneiodonium	  
DPRA	  	   Direct	  Peptide	  Reactivity	  Assay	  
EDTA	   Ethylenediaminetetraacetic	  acid	  
ELISA	  	   Enzyme-­‐linked	  immunosorbent	  assay	  
GPMT	  	   Guinea	  Pig	  Maximization	  Test	  
GSH	  	   Glutathione	  
GSSG	  	   Glutathione	  disulfide	  
h-­‐CLAT	  	   THP-­‐1	  cell	  line	  activation	  assay	  
HClPt	  	   Ammonium	  hexachloroplatinate	  
HMGB1	  	   High	  mobility	  group	  binding	  protein	  1	  
HMOX-­‐1	   Heme	  oxygenase	  (decycling)	  1	  
Hsp	  	   Heat	  shock	  protein	  
ICAM-­‐1	  	   Intracellular	  adhesion	  molecule	  1	  
IFN-­‐ϒ	  	   Interferon	  ϒ	  
IL-­‐[number]	  	   Interleukine	  [number]	  
IRAK	  	   Interleukin-­‐1	  receptor-­‐associated	  kinase	  
KCs	  	   Keratinocytes	  
Keap1	  	   Kelch-­‐like	  ECH-­‐associated	  protein	  1	  
LCs	  	   Langerhans	  cells	  
LLNA	  	   Local	  Lymph	  Node	  Assay	  
LPS	  	   Lipopolysaccharides	  
LRR	  	   Leucine	  repeated	  domain	  
MAPK	  	   Mitogen-­‐activated	  protein	  kinase	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MDI	  	   Diphenylmethane	  diisocyanates	  
MHC	  	   Major	  Hystocapompatibility	  complex	  
MyD88	  	   Myeloid	  differentiation	  primary	  response	  gene	  (88)	  
NADPH	  	   Nicotinamide	  adenine	  dinucleotide	  phosphate	  
NATCH	  	   Nucelotide-­‐binding	  oligomerization	  domain	  
NFkB	  	   Nuclear	  factor	  kappa-­‐light-­‐chain-­‐enhancer	  of	  
activated	  B	  cells)	  
NK	  	   Natural	  killer	  
NLRP3	  	   Nod	  like	  receptor	  P3	  
NOX	  	   NADPH	  oxidase	  
Nrf2	  	   Nuclear	  factor	  (erythroid-­‐derived	  2)-­‐like	  2	  
OECD	  	   Organisation	  for	  Economic	  Co-­‐operation	  and	  
Development	  
P2X7R	  	   Purinergic	  receptor	  2X7	  
PABA	  	   4-­‐aminobenzoic	  acid	  
PAMPs	  	   Pathogen-­‐associated	  molecular	  patterns	  
PI3K	  	   Phosphatidylinositol-­‐4,5-­‐bisphosphate	  3-­‐kinase	  
PMSF	  	   Phenylmethanesulfonylfluoride	  
PPD	  	   ρ-­‐phenylenediamine	  
PPRs	  	   Pattern	  recognition	  receptors	  
PYD	  	   Pyrin	  domain	  
RAGE	  	   Receptor	  for	  advance	  glycation	  end	  products	  
REACH	  	   Registration,	  Evaluation,	  Authorization	  and	  
Restriction	  of	  Chemicals	  substances	  
ROS	  	   Reaactive	  oxigen	  species	  
SDS	  	   Sodium	  lauryl	  sulphate	  
TG	  	   Test	  guideline	  
TGF-­‐α/β	  	   Transforming	  growth	  factor	  
TIR	  	   Toll/IL-­‐1	  receptor	  domain	  
TLR4	  	   Toll-­‐like	  receptor	  4	  
TMA	  	   Trimellitic	  anhydride	  
TMTD	  	   Tetramethylthiuram	  disulfite	  
TNF-­‐α	  	   Tumor	  Necrosis	  Factor	  α	  
TNFR1	  and	  2	  	   TNF	  receptor	  1	  and	  2	  
TRAF	  	   TNF	  receptor	  associated	  factors	  
TRX	  	   Thioredoxin	  
TXNIP	  	   Thioredoxin	  interacting	  protein	  
TXNIP	  	   Thioredoxin-­‐interacting	  protein	  
UVA/UVB	  	   Ultraviolet	  A/B	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Abstract	  
Allergic	   contact	   dermatitis	   (ACD)	   is	   an	   important	   occupational	   and	   environmental	   disease	  
caused	  by	  topical	  exposure	  to	  low	  molecular	  weight	  chemical	  allergens.	  The	  development	  of	  
ACD	  requires	  the	  activation	  of	  innate	  immune	  cells,	  such	  as	  keratinocytes	  (KC),	  necessary	  for	  
the	  maturation	  and	  the	  migration	  of	  dendritic	  cells	  (DC),	  which	  in	  turn	  are	  required	  for	  the	  
activation	   of	   specific	   T	   cells.	   Human	  KC	   constitutively	   express	   several	   cytokines,	   including	  
pro	  IL-­‐1	  alpha,	  pro	  IL-­‐1	  beta	  and	  pro	  IL-­‐18.	  In	  vivo	  it	  has	  been	  demonstrated	  that	  IL-­‐18	  plays	  
a	   key	   proximal	   role	   in	   the	   induction	   of	   allergic	   contact	   sensitization,	   favoring	   Th-­‐1	   type	  
immune	  response	  by	  enhancing	  the	  secretion	  of	  pro-­‐inflammatory	  mediators	  such	  as	  TNF-­‐α,	  
IL-­‐8	  and	  IFN-­‐γ	  (Shornick	  et	  al.,	  1996;	  Wang	  et	  al.,	  1999,	  Cumberbatch	  et	  al.,	  2001).	  
Toxicologists	   have	   the	   responsibility	   of	   identifying	   and	   characterizing	   the	   skin	   and	  
respiratory	   allergenic	   potential	   of	   chemicals,	   and	   estimating	   the	   risk	   they	   pose	   to	   human	  
health.	  Growing	  political	  and	  practical	  resistance	  to	  toxicity	  testing	  in	  animals	  has	  driven	  the	  
development	  of	  animal-­‐free	  methods	  for	  screening	  and	  prioritization	  of	  toxicants,	  including	  
those	  causing	  allergic	  hypersensitivity.	  	  
The	   purpose	   of	   this	   thesis	   was	   to	   develop	   an	   alternative	   in	   vitro	   test	   based	   on	   the	  
keratinocytes	   and	   IL-­‐18	   to	   characterize	   the	   allergenic	   potential	   of	   low	   molecular	   weight	  
chemicals,	   and	   to	   understand	   the	   molecular	   mechanism(s)	   underlying	   chemical	   allergen-­‐
induced	  IL-­‐18	  production.	  In	  addition	  to	  human	  keratinocytes	  cell	   lines	  (NCTC2544,	  HaCaT,	  
HPKII),	   commercially	   available	   reconstituted	  human	  epidermis	   3D-­‐epidermal	  models	  were	  
also	  used	  as	  experimental	  model.	  Due	  to	  their	  anatomical	   location	  and	  critical	   role	   in	  skin	  
inflammatory	  and	  immunological	  reactions,	  the	  use	  of	  the	  KC	  and	  skin	  organotypic	  culture	  
as	   a	   simplified	   in	   vitro	  model	   to	   evaluate	   the	   potential	   toxicity	   of	   chemicals	   destined	   for	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epicutaneous	  application	   is	  amply	   justified.	  To	  perform	  these	  studies	  22	  contact	  allergens,	  
12	   photoallergens/photoirritant	   compounds,	   3	   respiratory	   allergens	   and	   9	   irritants	  
chemicals	  were	  used.	  The	  choice	  of	  chemicals	  was	  dictated	  by	  the	  SENS-­‐IT-­‐IV	  programme	  as	  
relevant	   and	   representative	   of	   the	   ‘universe’ 	   of	   irritants,	   respiratory	   and	   contact	  
allergens.	   Phototoxic	   chemicals	   were	   selected	   based	   on	   compounds	   used	   in	   similar	  
published	  studies	  and	  reported	  to	  cause	  phototoxicity.	  
Results	   obtained	   indicate	   that	   the	   NCTC2544	   IL-­‐18	   assay	   is	   able	   to	   discriminate	   contact	  
allergens	   and	   photoallergens	   from	   irritants/photoirritants	   and	   respiratory	   allergens.	  
Important	   factors	   including	   compound	   solubility,	   chemical	   reactivity	   and	   metabolic	  
activation,	   which	   may	   mask	   the	   potential	   allergenicity	   of	   some	   chemicals,	   must	   be	  
considered	   in	   the	   development	   of	   in	   vitro	   tests.	   Submerged	   cell	   culture	   may	   be	  
unfavourable	   for	  many	   of	   the	   respiratory	   sensitizers,	   due	   to	   chemical	   instability;	   for	   this	  
reason	   we	   have	   tested	   IL-­‐18	   production	   also	   in	   reconstituted	   human	   epidermis,	   which	  
allows	  application	  in	  organic	  solvent,	  i.e.	  acetone:	  olive	  oil.	  The	  lack	  of	  metabolic	  activation	  
may	   be	   a	   relevant	   problem	   in	   case	   of	   proaptens.	   However,	   NCTC	   2544	   cells	   posses	   both	  
phase	  I	  and	  II	  metabolic	  activation	  capacity	  (Gelardi	  et	  al.,	  2001),	  and	  positive	  results	  were	  
indeed	  obtained	  with	  the	  proaptens	  tested	  (eugenol	  and	  cinnamic	  alcohol).	  A	  sensitivity	  of	  
87%,	  specificity	  of	  95%	  and	  an	  accuracy	  of	  90%	  was	  obtained	  (Corsini	  et	  al.,	  2009;	  Galbiati	  et	  
al.,	  2011). 	  
In	  addition	  to	  being	  able	  to	  determine	  whether	  or	  not	  a	  chemical	  is	  a	  sensitizer	  (labelling)	  it	  
is	  also	  equally	  important	  to	  determine	  the	  potency	  of	  a	  sensitizer	  (classification)	  in	  order	  to	  
identify	   a	   maximum	   safe	   concentration	   for	   human	   exposure	   (risk	   assessment). The	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combination	  of	  the	  epidermal	  equivalent	  potency	  assay	  with	  the	  release	  of	  IL-­‐18	  lead	  to	  the	  
development	  of	  an	  in	  vitro	  model	  able	  to	  identify	  contact	  allergens	  and	  rank	  them	  according	  
to	  their	  potency.	  	  	  
One	  other	  objective	  of	  this	  thesis	  was	  to	  study	  the	  signal	  transduction	  pathways	  involved	  in	  
PPD,	   DNCB	   and	   citral-­‐induced	   IL-­‐18.	   For	   such	   purpose	   several	   inhibitors	   were	   used.	   To	  
investigate	   the	   intracellular	   source	   of	   ROS,	   specific	   inhibitors	   of	   the	   three	   main	   cellular	  
sources	   of	   ROS,	   namely	   DPI,	   a	   NADPH	   synthetase	   inhibitor;	   rotenone,	   a	   mitochondrial	  
electron	   transport	   inhibitor;	   allopurinol,	   a	   xanthine	   oxidase	   inhibitor,	   were	   used.	   Z-­‐VAD-­‐
FMK,	   a	   cell-­‐permeant	  pan	   caspase	   inhibitor,	   that	   irreversible	  binds	   to	   the	   catalytic	   site	  of	  
caspases,	   and	   a	   neutralizing	   anti-­‐TLR4	   antibody	   were	   used	   to	   investigate	   the	   role	   of	   the	  
inflammasome	  and	  TLR4.	  Glycirrizic	  acid,	  a	  direct	   inhibitor	  of	  HMGB1	  protein,	  was	  used	  to	  
establish	   the	   role	  of	  HMGB1	  as	  possible	  DAMP	  associated	  with	  allergen-­‐induced	   IL-­‐18.	  To	  
specifically	   investigate	   the	   signal	   transduction	   pathway	   involved	   in	   PPD-­‐induced	   IL-­‐18	  
production	  selective	  inhibitors	  were	  used:	  GF109203X	  to	  inhibit	  PKC,	  PDTC	  and	  Bay	  11-­‐70-­‐
85	  to	  inhibit	  NF-­‐κB,	  and	  SB203580,	  as	  p38	  MAPK	  inhibitor.	  	  
The	  results	  obtained	  during	  this	  three	  year	  of	  research	  activity	  have	  clearly	  shown	  that	  the	  
in	   vitro	   methods	   based	   on	   NCTC2544	   and	   IL-­‐18	   production	   are	   able	   to	   discriminate	  
contact/photocontact	   allergens	   from	   irritants/photoirritants	   and	   respiratory	   allergens.	  
Furthermore,	  the	  combined	  use	  of	  the	  epidermis	   in	  vitro	  model	  with	  the	  IL-­‐18	  production,	  
beside	  the	  ability	  to	  identify	  sensitising	  compounds,	  is	  able	  to	  rank	  them	  according	  to	  their	  
potency.	   With	   respect	   to	   the	   molecular	   mechanisms	   behind	   skin	   sensitization	   I	   could	  
demonstrate	   that	   different	   intracellular	   sources	   of	   ROS	   are	   triggered	   by	   different	   contact	  
allergens.	   Allergens-­‐induced	   IL-­‐18	   production	   is	   dependent	   upon	   NF-­‐κB	   and	   p38	   MAPK	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activation	   and	   TLR4	   and	   inflammasome	   activation.	   Among	   the	   DAMPs,	   the	   evolutionarily	  
conserved	  non-­‐hystone	  chromatin-­‐binding	  protein	  HMGB1	  is	  released	  into	  the	  extracellular	  
space	   following	   exposure	   to	   contact	   allergens,	   resulting	   in	   TLR4	   activation	   and	   IL-­‐18	  
neosynthesis.	  
	  
Even	   if	   more	   studies	   are	   necessary	   to	   elucidate	   the	   mechanisms	   that	   are	   involved	   in	  
chemical	  allergens-­‐induced	  oxidative	  stress,	  the	  signalling	  pathways	  activated	  and	  their	  role	  
in	   contact	   allergy,	   data	   clearly	   indicated	   a	   pivotal	   role	   of	   ROS	   in	   chemical	   allergy.	  
Consequently,	  the	  redox	  state	  of	  the	  cell	  becomes	  imbalanced,	  with	  the	  activation	  of	  several	  
pathways,	   including	   MAPK,	   such	   as	   SAPK/JNK,	   ERK1/2	   and	   p38,	   NF-­‐κB,	   Akt/ASK1	   or	  
Keap1/Nrf2	   pathways,	   resulting	   in	   a	   inflammatory	   and	   cytotoxic	   response	   with	   the	  
production	   of	   costimulatory	   molecules,	   cytokines,	   chemokines,	   and	   phase	   1	   detoxifying	  
enzymes.	  
	  
On	  the	  basis	  of	  the	  results	  obtained,	  the	  following	  scenario	  could	  be	   imagined	  (see	  Figure	  
below):	  chemical	  sensitisers	  can	  induce	  oxidative	  stress	  owing	  to	  their	  elecrophilicity,	  which	  
in	  turn	  activates	  the	  inflammasome	  and	  HMGB1	  release	  (and	  possible	  other	  DAMPs),	  which	  
can	  activate	  TLR4.	  Activation	  of	  TLR4	  will	  results	   in	  NF-­‐κB	  and	  p38	  MAPK	  activation	  and	  in	  
the	  neosynthesis	  of	  IL-­‐18.	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1.1 	  Allergic	  contact	  dermatitis	  	  
	  
Chemical	  allergy	  describes	  adverse	  health	  effects,	  resulting	  from	  the	  stimulation	  of	  specific	  
immune	  response	  by	  chemicals.	  The	  two	  most	  frequent	  manifestations	  of	  chemical-­‐induced	  
allergy	   are	   contact	   hypersensitivity	   and	   respiratory	   sensitization,	   both	   of	   which	   can	   have	  
serious	  impact	  on	  the	  quality	  of	  life,	  and	  represent	  a	  common	  occupational	  health	  problem	  
(Wahlberg,	  1996).	  
	  
Irritant	  and	  allergic	  contact	  dermatitis	  (ACD)	  is	  undesired	  side	  effects	  in	  the	  development	  of	  
drugs	   and	   cosmetics	   as	   well	   as	   after	   contact	   with	   environmental	   or	   industrial	   chemicals.	  
Whereas	  irritant	  contact	  dermatitis	  is	  a	  skin	  inflammation	  induced	  by	  primary	  contact	  with	  
chemicals,	  and	  is	  though	  not	  to	  be	  mediated	  by	  lymphocytes,	  ACD	  represents	  a	  lymphocyte-­‐
mediated	   delayed	   type	   hypersensitivity	   reaction,	  which	   requires	   previous	   sensitization	   by	  
the	   same	  chemicals	   (Basketter	  et	  al.,	   2008;	  Nosbaum	  et	  al.,	   2009).	  Because	   such	   reaction	  
represents	   a	   true	   allergy,	   only	  minute	   quantities	   of	   chemical	   are	   necessary	   to	   elicit	   overt	  
reactions.	   This	   is	   distinct	   from	   irritant	   contact	   dermatitis,	   in	   which	   the	   intensity	   of	   the	  
reaction	   is	  proportional	   to	  the	  dose	  applied.	  An	  estimated	  20%	  of	  all	  contact	  dermatitis	   is	  
allergic	   (1).	   In	   industrialized	   countries,	   ACD	   is	   the	   most	   frequent	   manifestation	   of	  
immunotoxicity,	  with	  large	  socio-­‐economic	  consequences	  (Thyssen	  et	  al.,	  2007).	  Five	  to	  ten	  
	   12	  
percent	  of	  all	  occupational	  skin	  disease	  is	  estimated	  to	  result	  from	  skin	  allergy.	  In	  addition,	  
several	  chemicals	  may	  also	  cause	  respiratory	  sensitization.	  The	  exact	  relation	  between	  skin	  
and	   respiratory	   sensitization	   is	   not	   clear	   and	   is	   already	   for	   some	   years	   under	   scientific	  
debate	   (McFadde	   et	   al.,	   2011).	   In	   general,	   low	  molecular-­‐weight	   chemicals	   (haptens)	   are	  
responsible	   for	   causing	   ACD.	   Most	   are	   less	   than	   1000	   Daltons	   and	   are	   electrophilic	   or	  
hydrophilic.	   Some	   of	   these	   molecules	   are	   not	   inherently	   allergenic	   and	   must	   undergo	  
metabolic	  transformation	  before	  participating	  in	  an	  allergic	  response.	  Because	  the	  skin	  has	  
substantial	   metabolic	   capabilities,	   including	   many	   phase	   I	   and	   phase	   II	   enzymes,	   such	  
biotransformation	  may	  occur	  in	  the	  skin	  at	  the	  site	  of	  contact	  with	  the	  chemical.	  Haptens,	  
which	  are	  not	  intrinsically	  allergenic,	  must	  penetrate	  the	  stratum	  corneum	  and	  form	  a	  link	  
with	  epidermal	  carrier	  proteins	  to	  form	  a	  complete	  allergen.	  They	  penetrate	  the	  epidermis	  
and	  conjugate,	  most	  often	  covalently,	  to	  body	  proteins.	  The	  sensitizing	  potential	  of	  hapten	  
cannot	   be	   reliable	   be	   predicted	   from	   its	   chemicals	   structure,	   although	   there	   is	   some	  
correlation	   with	   the	   number	   of	   haptens	   attached	   to	   the	   carrier	   and	   the	   ability	   of	   the	  
molecule	  to	  penetrate	  the	  skin.	  Also,	  certain	  contact	  allergens	  have	  unsatured	  carbon	  bonds	  
and	  are	  easily	  oxidized.	  Some	  haptens,	  such	  as	  DNCB,	  sensitize	  nearly	  all	  individuals	  and	  can	  
be	  used	  to	  assess	  cell-­‐mediated	  immunity.	  
	  
Contact	   dermatitis	   may	   occur	   upon	   exposure	   to	   any	   of	   the	   thousands	   of	   allergens	   that	  
people	  are	  potentially	  exposed	  to	  in	  the	  course	  of	  a	  day	  (Table	  1).	  Contact	  hypersensitivity	  
can	  occur	  as	  a	  result	  of	  exposure	  to	  a	  wide	  variety	  of	  chemical	  and	  certain	  drugs	  (Nethercott	  
and	  Holness,	  1989),	  cosmetics	  (De	  Groot	  et	  al.,	  1988;	  Remaut,	  1992;	  Andersen,	  1993),	  and	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various	   metals	   including	   nickel	   (Picardo	   et	   al.,	   1990)	   and	   chromium	   (Nethercott	   and	  
Holness,	  1989).	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig.1	  –	  Allergic	  Contact	  Dermatitis	  [1]	  
	  
The	  causes	  of	  ACD	  are	  ubiquitous	  in	  the	  materials	  that	  come	  into	  contact	  with	  human	  skin.	  
There	   are,	   however,	   several	   allergens,	   such	   as	   nickel,	   chromium,	   cobalt,	   and	   some	   food	  
flavourings,	  that	  occur	  with	  great	  frequency.	  When	  an	  individual	  has	  a	  contact	  sensitivity	  to	  
an	   agent,	   that	   is	   systematically	   administered	   (orally),	   a	   generalized	   skin	   eruption	   with	  
associated	   symptoms	   such	   headache,	   malaise,	   and	   arthralgia	   may	   occur	   (Fig.1).	   Less	  
dramatic	   eruptions	   may	   include	   flaring	   of	   a	   previous	   contact	   dermatitis	   to	   the	   same	  
substance,	  vesicular	  hand	  eruptions,	  and	  an	  eczematous	  eruption	  in	  flexus	  areas.	  Systemic	  
contact	   dermatitis	  may	   produce	   a	   delayed	   type	   hypersensitivity	   reaction	   or	   deposition	   of	  
immunoglobulin’s	   and	   complement	   components	   in	   the	   skin.	   Such	   deposits	   are	   potent	  
inducers	   of	   a	   secondary	   inflammatory	   response	   and	   are	   responsible	   for	   the	   initial	  
pathophysiology	  of	  many	  blistering	  and	  connective	  tissue	  disease	  of	  the	  skin.	  
Cross-­‐reactions	  between	  chemicals	  may	  occur	  if	  they	  share	  functional	  groups	  critical	  to	  the	  
formation	  of	   complete	   allergens	   (hapten	  plus	   carrier	   protein).	   These	   reactions	  may	   cause	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difficulties	   in	   controlling	   contact	   dermatitis	   because	   avoidance	   of	   known	   allergens	   and	  
potentially	  cross-­‐reacting	  substances	  is	  necessary	  for	  improvement.	  Proper	  diagnosis	  can	  be	  
hampered	   by	   concomitant	   sensitization	   to	   two	   chemicals	   in	   the	   same	   product	   or	  
simultaneous	  sensitization	  to	  two	  chemicals	  in	  different	  products	  (Table	  2).	  	  
	  
A	   contact	   hypersensitivity	   reaction	   occurs	   in	   two	   stages:	   sensitization	   or	   induction	   and	  
elicitation.	  Sensitization	  takes	  10-­‐14	  days	  in	  humans.	  Once	  absorbed,	  the	  hapten	  combines	  
with	   a	   protein	   and	   is	   internalized	   by	   epidermal	   Langerhans	   cells	   (LCs),	   which	   leave	   the	  
epidermis	   and	   migrate	   as	   veiled	   cells,	   afferent	   lymphatic’s,	   to	   the	   paracortical	   areas	   of	  
regional	   lymph	   nodes.	   Here	   they	   present	   processed	   haptens-­‐protein	   conjugates	   (in	  
association	  with	  MHC	  class	   II	  molecules)	   to	  CD4+	   lymphocytes,	  producing	  a	  population	  of	  
memory	  CD4+	  T	  cells.	  
The	   application	   of	   an	   allergen	   generally	   causes	   a	   modest	   decrease	   in	   Langerhans	   cell	  
number	   in	   the	  epidermis	  within	  hours	  of	  application.	  Antigen	  presentation	  by	  Langerhans	  
cell	  then	  occurs	  in	  skin	  and	  lymph	  nodes.	  Degranulation	  and	  cytokine	  release	  by	  mast	  cells	  
and	  epithelial	  cells	   follows	  soon	  after	  contact	  with	  an	  allergen.	  TNF-­‐α	  and	   IL-­‐1	   from	  many	  
cell	   types,	   and	   from	   macrophages	   in	   particular,	   are	   potent	   inducers	   of	   endothelial	   cell	  
adhesion	   molecules.	   These	   locally	   released	   cytokines	   produce	   a	   gradient	   signal	   for	  
movement	  of	  mononuclear	  cells	  towards	  the	  dermo-­‐epidermal	  junction	  and	  epidermis.	  The	  
earliest	   histological	   change,	   seen	   after	   4-­‐8	   hours,	   is	   the	   appearance	  of	  mononuclear	   cells	  
around	  annex	  and	  blood	  vessel,	  with	  subsequent	  epidermal	  infiltration.	  The	  number	  of	  cells	  
infiltrating	  the	  epidermis	  and	  dermis	  peaks	  at	  48-­‐72	  hours.	  Most	  infiltrating	  lymphocytes	  are	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CD4+,	  with	   few	  CD8+.	   Less	   than	   1%	  of	   infiltrating	   cells	   are	   of	   a	   single	   clonal	   lineage.	   The	  
main	  mechanism	  for	  T-­‐cell	  recruitment	  is	  antigen	  independent.	  
	  
Both	   skin	   resident	   cells,	   such	   as	   keratinocytes	   (KCs),	   LCs	   and	  mast	   cells,	   and	   immigrating	  
leucocytes,	   including	   T	   lymphocytes	   and	  natural	   killer	   cells,	   actively	   participate	   in	   contact	  
allergy	  	  (Cavani	  et	  al.,	  2007).	  	  
Contact	   hypersensitivity	   is	   primarily	   an	   epidermal	   reaction	   (Fig.2),	   and	   the	   dendritic	  
Langerhans	  cell,	  located	  in	  the	  suprabasal	  epidermis,	  is	  the	  principle	  antigen-­‐presenting	  cell	  
(APC)	  involved.	  Langerhans	  cells	  are	  derived	  from	  bone	  marrow	  and	  express	  CD1,	  MHC	  class	  
II	  antigens	  and	  surface	  receptor	  for	  Fc	  and	  complement.	  
	  
KCs	  provide	   the	   structural	   integrity	  of	   the	  epidermis	  and	  have	  a	   central	   role	   in	  epidermal	  
immunology.	  They	  may	  express	  MHC	  class	  II	  molecules	  and	  ICAM-­‐1	  in	  the	  cell	  membrane.	  
They	  also	  can	  release	  cytokines	   including	   IL-­‐1,	   IL-­‐3,	   IL-­‐6,	   IL-­‐8,	   IL-­‐18,	  GM-­‐CSF,	  TNF-­‐α,	  TGF-­‐α	  
and	  TGF-­‐β.	  Some	  of	  these	  cytokines	  can	  activate	  Langerhans	  cells,	  co-­‐stimulate	  proliferative	  
responses	  and	  recruit	  mast	  cells,	  and	  induce	  the	  secretion	  of	  immunosuppressive	  cytokines	  
such	  as	  IL-­‐10	  and	  TGF-­‐β,	  which	  dampen	  the	  immune	  response	  and	  induce	  clonal	  anergy	  in	  
Th1	  cells.	  KC	  can	  be	  activated	  by	  a	  number	  of	  stimuli,	  including	  allergens	  and	  irritants.	  Some	  
antigens,	  such	  as	  urushiol	  in	  poison	  ivy,	  may	  directly	  induce	  TNF-­‐α	  and	  IL-­‐8.	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Fig.2	  –	  Players	  of	  ACD	  [2]	  
	  
KCs	  have	  a	  key	  role	  in	  skin	  sensitization,	  as	  they	  provide	  the	  essential	  danger	  signal,	  they	  are	  
involved	  in	  the	  protein	  haptenation	  process,	  and	  supply	  enzymes	  that	  are	  necessary	  for	  the	  
metabolic	  activation	  of	  prohaptens	  (Hennen	  et	  l.,	  2011;	  Kim	  and	  Choi,	  2010).	  KCs	  play	  a	  role	  
in	  all	  phases	  of	  ACD.	  They	  respond	  to	  allergens	  by	  producing	  a	  range	  of	  pro-­‐inflammatory	  
cytokines,	  which	  are	  important	  for	  dendritic	  cells	  maturation	  and	  migration	  to	  the	  draining	  
lymph	  node,	  where	  the	  activation	  of	  the	  specific	  immune	  response	  take	  place	  (Vandebriel	  et	  
al.,	  2005;	  Gober	  and	  Gaspari,	  2008).	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Chemical	   respiratory	   allergy,	   although	   less	   common	   than	   allergic	   contact	   dermatitis,	   is	   of	  
considerable	   significance,	   not	   only	   because	   asthma	   resulting	   from	   sensitization	   can	   be	  
severe,	   but	   at	   times	   it	   can	   also	   be	   fatal.	   A	   variety	   of	   chemicals	   have	   been	   implicated	   as	  
causing	   occupational	   respiratory	   allergy.	   Among	   these	   are	   diisocyanates,	   acid	   anhydrides,	  
some	   reactive	   dyes,	   certain	   chlorinated	   platinum	   salts,	   glutaraldehyde,	   chloramine-­‐T,	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Table	  1	  –	  Common	  contact	  allergens	  [1a]	  
Source	   Common	  Allergens	  
























Plants	  and	  trees	   Abietic	  acid	  





















Leather	   Formaldehyde	  
Glutaraldehyde	  
Potassium	  dichromate	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Table	  2	  –	  common	  cross-­‐reacting	  chemicals	  [1a]	  
Chemical	   Cross-­‐reactor	  
Abietic	  acid	  
p-­‐aminobenzoic	  acid	  
Balsam	  of	  Peru	  
Bisphenol	  A	  
Pine	  resin	  
p-­‐aminosalicylic	  acid,	  sulphonamide	  
pine	  resin,	  cinnamates,	  benzoates	  



















Resorcinol,	  cresols,	  hydroquinone	  
Parabens,	  p-­‐aminobenzoic	  acid	  
Hydroquinone	  monobenzyl	  eter	  





1.1.1 Adverse	  outcome	  pathway	  (AOP)	  
An	  adverse	  outcome	  pathway	  (AOP)	  is	  the	  sequence	  of	  events	  from	  the	  chemical	  structure	  
of	  a	  target	  chemical	  or	  group	  of	  similar	  chemicals	  through	  the	  molecular	  initiating	  event	  to	  
an	  in	  vivo	  outcome	  of	  interest.	  Each	  AOP	  represents	  the	  existing	  knowledge	  concerning	  the	  
linkage	  between	  a	  molecular	  initiating	  event,	  intermediate	  events	  and	  an	  adverse	  outcome	  
at	  the	  individual	  or	  population	  level.	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Knowledge	  of	   the	  AOP	  for	  skin	  sensitization	  has	  evolved	  rapidly	  over	  the	  past	  decade	  and	  
four	  events	  that	  are	  recognised	  as	  key	  ones,	  have	  been	  identified	  (Fig.	  3):	  
1. The	  first	  key	  event	   is	   the	   interaction	  of	  the	  chemical	  with	  skin	  protein.	  Specifically,	  
the	  target	  chemical	  or	  its	  metabolite	  or	  abiotic	  transformation	  product	  of	  the	  target	  
chemical	  covalently	  binds	  to	  cysteine	  and/or	  lysine	  residues	  of	  skin	  proteins;	  
2. The	   second	   key	   event	   takes	   place	   in	   the	   keratinocytes.	   It	   includes	   inflammatory	  
responses	   as	   well	   as	   gene	   expression	   associated	   with	   specific	   cell	   signalling	  
pathways;	  
3. The	  third	  key	  event	  is	  the	  activation	  of	  dendritic	  cells,	  which	  is	  typically	  assessed	  by	  
expression	  of	  specific	  cell	  surface	  markers	  and	  release	  of	  chemokines	  and	  cytokines.	  
4. The	  final	  key	  event	   is	  the	  specific	  T-­‐cell	  clonal	  expansion,	  which	   is	  measured	   in	  the	  
murine	  LLNA.	  
Following	  a	  brief	  description	  of	  each	  key	  steps	  is	  reported.	  
	  
	  
Fig.	  3	  –	  Flow	  diagram	  of	  the	  pathways	  associated	  with	  skin	  sensitization	  [3]	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Chemical	  reactivity	  
One	   of	   the	   key	   molecular	   events	   in	   chemical-­‐induced	   skin	   sensitisation	   is	   protein	  
haptenation	   (the	   chemical	   modification	   of	   self-­‐skin	   proteins).	   Chemical	   allergens	   are	  
reactive	   exogenous	   compounds	   able	   to	   chemically	   modify	   skin	   proteins	   making	   them	  
immunogenic	   and	   thus	   able	   to	   trigger	   a	   specific	   T-­‐cell	   mediated	   immune	   response.	  
Sensitizing	  chemicals	  have	  been	  divided	  according	  to	  their	  suspected	  reaction	  mechanisms	  
(Divkovic	  et	  al.,	  2005;	  Aptula	  et	  al.,	  2005).	  Many	  compounds	  are	  not	  allergenic	  themselves	  
but	  are	  activated	  before	  skin	  contact	  (prehaptens),	   i.e.	  via	  air	  oxidation,	  or	   in	  the	  skin,	   i.e.	  
metabolically	  (prohaptens),	  to	  form	  skin	  sensitisers	  (Karlberg	  et	  al.,	  2008).	  
The	  skin	  can	  best	  be	  described	  as	  a	  nucleophilic	  environment,	  rich	  in	  water	  and	  nucleophilic	  
functional	   groups	   present	   in	   proteins,	   i.e.	   susceptible	   amino	   acids	   include	   tyrosine,	  
tryptophan,	  histidine,	   lysine,	  methionine,	  and	  cysteine.	  The	  majority	  of	   contact	   sensitisers	  
are	  electrophiles	   (Divkovic	  et	   al.,	   2005,	  Karlberg	  et	   al.,	   2008	  and	  Natsch	  et	   al.,	   2012).	   Five	  
types	  of	  reactions	  have	  been	  recognized,	  including,	  SN2	  reactions,	  SNAr	  reactions,	  Schiff	  base	  
formations,	   Michael	   type	   additions,	   and	   acylation	   reactions.	   The	   possibility	   of	   a	   radical	  
mechanism	  involved	  in	  antigen	  formation	  has	  also	  been	  proposed.	  Hydroperoxides,	  formed	  
by	   air	   oxidation	   of	   many	   commonly	   used	   chemicals,	   have	   been	   shown	   to	   be	   strongly	  
sensitisers.	   Most	   organic	   compounds,	   including	   turpentine,	   fragrance	   terpenes	   (i.e.	  
limonene,	   linalool,	   geraniol),	   can	   undergo	   autoxidation,	   forming	   hydroperoxyde	   (ROOH).	  
They	   are	   known	   to	   easily	   form	   radicals	   by	   cleavage	  of	   the	   labile	  O–O	  bond,	   the	   resulting	  
radical	  may	  either	  bind	  directly	  with	  proteins	  or	  rearrange	  to	  an	  epoxide	  to	  form	  a	  hapten–
carrier	  complex	  (electrophilic	  haptens).	  A	  third	  type	  of	  contact	  allergens	  are	  metal	  ions,	  i.e.	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Ni,	  Cr,	  and	  Co,	  which	  form	  stable	  coordination	  complexes	  with	  proteins,	  then	  recognized	  as	  
nonself.	  
Binding	   to	   the	   thiol	   group	   of	   cysteine	   is	   the	   one	   most	   often	   associated	   with	   sensitisers	  
(Divkovic	  et	  al.,	  2005),	  which	  may	  lead	  to	  glutathione	  depletion	  and	  oxidative	  stress,	  tissue	  
damage	  and	  increased	  inflammation.	  
On	   the	   basis	   of	   this	   mechanistic	   understanding,	   the	   relationship	   between	   reactivity	   of	  
molecules	  toward	  proteins	  and	  their	  sensitisation	  potential	  has	  attracted	  increased	  interest	  
and	  was	  used	   to	  develop	  experimental	   assay	   to	  predict	   the	   skin	   sensitisation	  potential	   of	  
chemicals	  to	  replace	  in	  vivo	  animal	  tests	  (Gerberick	  et	  al.,	  2008).	  
	  
A	  role	  of	  KC	  
KC	  form	  an	  interface	  between	  the	  body	  and	  the	  environment,	  they	  are	  important	  guardians	  
for	   the	   detection	   of	   danger	   signals	   and	   the	   consecutive	   initiation	   of	   an	   inflammatory	  
response.	  KC	  play	  a	  role	  in	  all	  phases	  of	  allergic	  contact	  dermatitis,	  from	  the	  early	  initiation	  
phase	  with	  the	  elaboration	  of	  inflammatory	  cytokines,	  that	  plays	  a	  role	  in	  Langerhans	  cells	  
(LC)	  migration,	   and	   T-­‐cell	   trafficking,	   through	   the	   height	   of	   the	   inflammatory	   phase	   with	  
direct	   interactions	   with	   epidermotrophic	   T-­‐cells,	   through	   the	   resolution	   phase	   of	   allergic	  
contact	   dermatitis	   with	   the	   production	   of	   anti-­‐inflammatory	   cytokines	   and	   tolerogenic	  
antigen	  presentation	  to	  effector	  T-­‐cells	  (Gober	  and	  Gaspari,	  2008).	  KC	  sense	  haptens,	  and	  in	  
turn	  initiate	  a	  program	  of	  enhances	  or	  de	  novo	  expression	  of	  inflammatory	  molecules	  which	  
are	   important	   for	   dendritic	   cells	   maturation	   and	   migration	   to	   the	   draining	   lymph	   node,	  
where	   the	   activation	   of	   the	   specific	   immune	   response	   take	   place.	   Among	   the	   cytokines	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produced	  by	  KC,	  IL-­‐18	  is	  of	  particular	  interest	  as	  it	  is	  a	  potent	  inducer	  of	  IFN-­‐γ	  by	  activated	  T	  
cells	  (Okamura	  et	  al.,	  1995).	  This	  cytokine	  has	  been	  shown	  to	  play	  a	  key	  proximal	  role	  in	  the	  
induction	   of	   allergic	   contact	   sensitisation	   and	   to	   favor	   Th-­‐1	   type	   immune	   response	   by	  
enhancing	   the	   secretion	   of	   pro-­‐inflammatory	   mediators	   such	   as	   TNF-­‐α,	   IL-­‐18	   and	   IFN-­‐γ	  
(Okamura	   et	   al.,	   1995,	   Cumberbatch	   et	   al.,	   2001	  and	  Antonopoulos	   et	   al.,	   2008).	   Human	  
keratinocytes	  constitutively	  express	   IL-­‐18	  mRNA	  and	  protein	  (Naik	  et	  al.,	  1999),	  and	  works	  
published	   by	   Naik	   et	   al.,	   1999	  and	  Van	   Och	   et	   al.,	   2005	   showed	   the	   induction	   of	   IL-­‐18	  
following	  exposure	  to	  contact	  sensitisers.	  
Recently,	   there	   have	   been	   several	   reports	   supporting	   the	   participation	   of	   ROS	   in	   the	  
pathogenesis	  of	  contact	  dermatitis	  (reviewed	  by	  Corsini	  et	  al.,	  2013).	  Oxidative	  stress	  may	  
be	   the	   starter	   point,	   as	   it	   leads	   to	   the	   activation	   of	   transcription	   factors	   and	   signalling	  
pathways,	   including	   NF-­‐κB	   and	   p38	   MAPK,	   which	   leads	   to	   the	   release	   of	   cytokines	   and	  
chemokines	  (Gloire	  et	  al.,	  2006;	  Kim	  and	  Choi,	  2010).	  Reactive	  oxygen	  species	  plays	  also	  an	  
important	  role	  in	  the	  activation	  of	  the	  NLRP3/NALP3	  inflammasome	  (Martinon	  et	  al.,	  2010;	  
Cumberbatch	   et	   al.,	   2001),	   which	   is	   required	   to	   direct	   the	   proteolytic	   maturation	   of	  
inflammatory	   cytokines	   such	   as	   IL-­‐1β	   and	   IL-­‐18	   (Martinon,	   2010).	   The	   ability	   of	   contact	  
sensitisers	  to	  induce	  the	  oxidative	  stress	  pathway	  in	  keratinocytes	  (Natsch	  and	  Emter,	  2007)	  
has	  been	  recently	  confirmed	  by	  Vandebriel	  et	  al.	  (2010).	  
	  
The	  role	  of	  dendritic	  cells	  
In	   the	   induction	  of	   contact	   sensitisation,	  DC	   represents	   the	  most	   important	   initiators	   and	  
regulators	  of	  contact	  allergy.	  Within	  the	  skin,	  there	  are	  at	  least	  two	  distinct	  subsets	  of	  DC,	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LC,	  localized	  in	  the	  epidermis,	  and	  dermal	  DC	  (dDC).	  LC	  are	  the	  only	  DC	  subset	  to	  reside	  in	  
the	   epidermis	   and,	   were	   once	   considered	   to	   be	   wholly	   responsible	   for	   presentation	   of	  
chemical	   allergen	   to	   T-­‐cells.	   Recently,	   some	   studies	   have	   challenged	   this	   belief,	   with	   the	  
suggestion	   that	   also	   other	   subsets	   may	   contribute	   to	   induction	   and	   regulation	   of	   skin	  
sensitisation	  (Ainscough	  et	  al.,	  2012).	  
In	   order	   to	   activate	   a	   specific	   immune	   response,	   DC	   must	   migrate	   through	   the	   dermis,	  
towards	  the	  lymph	  nodes.	  The	  cytokines	  tumor	  necrosis	  factor-­‐α,	   interleukin-­‐1β	  and	  IL-­‐18,	  
produced	   by	   KC	   and	   DC	   following	   DAMPs	   generation	   in	   the	   skin	   microenvironment,	   are	  
particularly	   important.	  All	   this	   is	   integral	   to	   the	  process	  of	  DC	  mobilization,	  migration	  and	  
functional	  maturation.	  	  
In	  DC,	  Mizuashi	  et	  al.	  (2005)	  showed	  that	  all	  the	  sensitisers	  tested	  (Ni,	  formaldehyde,	  DNCB,	  
MnCl2	  and	  thimerosal),	  but	  none	  of	  the	  non	  sensitisers	  reduced	  the	  GSH/GSSG	  ratio,	  which	  
was	   accompanied	   by	   p38	   MAPK	   activation.	   The	   antioxidant	   N-­‐acetyl-­‐L-­‐cysteine,	   which	  
suppressed	  the	  reduction	  of	  the	  GSH/GSSG	  ratio,	  abrogated	  p38	  MAPK	  activation	  and	  CD86	  
expression,	  a	  common	  marker	  of	  DC	  maturation,	  induced	  by	  chemical	  sensitisers.	  
Chemical-­‐induced	  oxidation	  of	  the	  cell	  surface	  thiols	  appears	  to	  be	  one	  of	  the	  triggers	  of	  DC	  
maturation,	  resulting	  in	  intracellular	  redox	  imbalance	  (Suzuki	  et	  al.,	  2009	  and	  Kagatani	  et	  al.,	  
2010).	  Interestingly,	  in	  human	  DC,	  ROS	  were	  produced	  by	  both	  contact	  allergens	  DNCB	  and	  
thimerosal	   and	   the	   irritant	   benzalkonium	   chloride,	   and	   were	   both	   decreased	   by	   pre-­‐
treatment	   with	   N-­‐acetyl-­‐L-­‐cysteine.	   However,	   only	   DNCB	   up-­‐regulated	   CD86	   and	   HLA-­‐DR	  
molecules	   and	   induced	   protein	   carbonylation,	   suggesting	   the	   DNCB-­‐induced	   ROS	   are	  
somehow	  different	  from	  those	  produced	  by	  irritant	  (Byamba	  et	  al.,	  2010).	  The	  same	  Authors	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demonstrated	  that	  DNCB	  induced	  ROS	  were	  reduced	  by	  diphenylene	  iodonium	  (DPI),	  while	  
benzalkonium	  chloride-­‐induced	  ROS	  were	  slightly	  decrease	  by	  N-­‐monomethyl-­‐L-­‐arginine	  (a	  
nitric	  oxide	  synthase	   inhibitor),	   suggesting	  a	  different	  cellular	  source	  of	  ROS.	   In	  particular,	  
results	  suggest	  that	  irritant-­‐induced	  ROS	  may	  consist	  of	  nitric	  oxides	  or	  peroxynitrite,	  while	  
contact	  allergen-­‐induced	  ROS	  may	  consist	  of	  hydrogen	  peroxide	  or	  superoxide,	  derived	  from	  
the	   NOX2	   pathway	   (Byamba	   et	   al.,	   2010).	   However,	   the	   involvement	   of	  mitochondria	   as	  
source	   of	   ROS	   cannot	   be	   ruled	   out,	   as	   the	   inhibitor	   used	   DPI	   not	   only	   inhibits	   NADPH	  
oxidase,	  but	  also	  potently	  inhibits	  mitochondrial	  ROS	  production	  (Li	  and	  Trush,	  1998).	  
Proteins	  that	  are	  reversibly	  modulated	  by	  ROS	  are	  of	  high	  interest.	   In	  this	  context,	  protein	  
kinases	   and	  phosphatases,	  which	   act	   coordinately	   in	   the	   regulation	  of	   signal	   transduction	  
through	   the	   phosphorylation	   and	   dephosphorylation	   of	   target	   proteins,	   have	   been	  
described	  to	  be	  key	  elements	   in	  ROS-­‐mediated	  signaling	  events.	  The	  major	  mechanism	  by	  
which	   these	   proteins	   may	   be	  modified	   by	   oxidation	   involves	   the	   presence	   of	   key	   redox-­‐
sensitive	   cysteine	   residues.	   The	   protein	   kinase	   C	   (PKC)	   family	   is	   composed	   of	   10	  
serine/threonine	  protein	  kinases	  that	  are	  involved	  in	  a	  variety	  of	  pathways	  that	  regulate	  cell	  
growth,	   differentiation,	   apoptosis,	   transformation	   and	   tumorigenicity.	   Most	   cells	   express	  
more	   than	   one	   isoform,	   and	   each	   type	   of	   PKC	   mediates	   different	   cellular	   events.	   PKC	  
isoforms	   are	  differentially	   distributed	  not	  only	  with	   respect	   to	   tissue	  but	   also	   in	   terms	  of	  
subcellular	   localization,	   suggesting	   that	   each	   isoform	   could	   have	   specific	   functions.	   PKC	  
isoforms	   differ	   in	   their	   structure,	   cofactor	   requirement	   and	   substrate	   specificity.	   The	  
members	  of	   the	  PKC	   family	  have	  been	  divided	   into	   three	  major	  groups:	   the	  classical	  PKCs	  
(cPKCs),	  including	  the	  α,	  βI,	  βII,	  and	  γ	  isoforms;	  the	  novel	  PKCs	  (nPKCs),	  including	  the	  θ,	  η,	  ε,	  
δ	   isoforms;	   and	   the	   atypical	   PKCs	   (aPKCs),	   including	   the	   ζ	   and	   ι/λ	   isoforms.	   PKC	   isoforms	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have	   been	   shown	   to	   contain	   a	   unique	   structural	   feature	   that	   is	   susceptible	   to	   oxidative	  
modification	   (Cosentino-­‐Gomes	   et	   al.,	   2012).	   In	   particular,	   two	   pairs	   of	   zinc	   fingers	   are	  
found	  within	  the	  regulatory	  domain	  (sites	  of	  diacylglycerol	  and	  phorbol	  ester	  binding).	  Each	  
zinc	   finger	   is	   composed	   of	   six	   cysteine	   residues	   and	   two	   zinc	   atoms.	   The	   high	   levels	   of	  
cysteine	  residues	  render	  the	  regulatory	  domain	  susceptible	  to	  redox	  regulation	  (Giorgi	  et	  al.,	  
2010	  and	  Gopalakrishna	   and	   Jaken,	   2000).	   Oxidative	   stress	   destroys	   the	   zinc	   finger	  
conformation,	  and	  the	  autoinhibition	  is	  relieved,	  resulting	  in	  a	  PKC	  form	  that	  is	  catalytically	  
active	   in	   the	   absence	   of	   Ca2+	   or	   phospholipids.	   Currently,	   evidence	   supports	   the	   direct	  
activation	   of	   different	   PKC	   isoforms	   by	   ROS	   generation	   (Gopalakrishna	   and	   Jaken,	  
2000	  and	  DelCarlo	  and	  Loeser,	  2006).	  In	  the	  context	  of	  skin	  sensitisation,	  however,	  PKC	  is	  of	  
particular	  interest,	  as	  it	  has	  been	  demonstrated	  almost	  20	  years	  ago	  by	  Halliday	  and	  Lucas.	  
(1993)	   to	  be	  required	   for	  LC	  migration,	  and	  that	  within	   the	  epidermis,	   the	   isoform	  beta	   is	  
exclusively	  expressed	   in	   LCs,	   and	   its	  downregulation	   impaired	   LC	   function	  with	   respect	   to	  
contact	  hypersensitivity	  (Goodell	  et	  al.,	  1996).	  Furthermore,	  not	  only	  ROS	  can	  activate	  PKC,	  
but	  PKC	  also	  has	  been	  shown	  to	  promote	  the	  production	  of	  endogenous	  ROS.	  The	  β	  isoform	  
of	  PKC	  induces	  ROS	  generation	  through	  mitochondrial	  damage	  (Pinton	  et	  al.,	  2007).	  PKCβ	  is	  
responsible	   for	   the	   activation/phosphorylation	   of	   the	   mitochondrial	   p66shc	   protein,	  
resulting	  in	  ROS	  generation	  (Migliaccio	  et	  al.,	  1999).	  In	  myeloid	  leukemia	  cells,	  ROS	  are	  not	  
necessary	  for	  the	  translocation	  of	  PKCβII	  from	  the	  cytosol	  to	  the	  cell	  membrane.	  However,	  
PKCβII	   was	   shown	   to	   be	   essential	   for	   ROS	   production	   induced	   by	   the	   PKC	   activator	   TPA	  
(Datta	   et	   al.,	   2000).	   Also	   other	   PKC	   isoforms,	   including	   PKCα,	   PKCε	   and	   PKCζ,	   have	   been	  
involved	   in	  mitochondrial	   ROS	   production	   in	   different	   experimental	  models	   (Wang	   et	   al.,	  
2006	  and	  Agudo-­‐López	  et	  al.,	  2011).	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Primary	  cells	  (i.e.	  CD34+	  derived	  dendritic	  cells,	  monocyte	  derived	  dendritic	  cells)	  as	  well	  as	  
dendritic	   cell-­‐like	   cell	   lines	   ((i.e.	  THP-­‐1,	   U-­‐937,	   MUTZ-­‐3,	   KG-­‐1,	   HL-­‐60,	   and	   K562)	  have	  
been	  extensively	  described	   along	  with	   biomarkers	   such	   as	   cell	   surface	  markers,	   cytokines,	  
chemokines	   and	   kinases	   and	   nicely	   reviewed	   by	   Dos	   Santos	   et	   al.,	   (2009).	   There	   are	  
currently	   two	   different	   sources	   of	   DC	   for	   assay	   development.	   These	   are	   DC	  derived	   from	  
fresh	  blood	  cell	  precursors	  and	  DC-­‐like	  cell	  lines.	  Whereas	  DC	  derived	  from	  fresh	  blood	  cell	  
precursors	  are	  more	  physiologically	  relevant	  than	  DC-­‐like	  cell	  lines,	  their	  implementation	  is	  
limited	  by	  i)	  the	  logistics	  involved	  in	  supplying	  fresh	  blood	  to	  the	  cell	  culture	  lab,	  ii)	  ethical	  
issues	   and	   iii)	   donor	   variation.	   Cell	   lines	   have	   the	   potential	   to	   provide	  large	   amounts	   of	  
readily	  available	  DC-­‐like	  cells	  without	  donor	  variation	  (dos	  Santos	  et	  al.,	  2009).	  
The	   following	   five	   assays	   use	   primary	   cells	   or	   cell	   lines	   as	   surrogates	   for	   dermal	   DC.	  
Expression	  of	  markers	  which	  are	  considered	  prerequisites	  for	  the	  migration	  of	  dermal	  DC	  to	  
the	   adjacent	   lymph	  nodes	   (key	   event	   3	   in	   the	   skin	   sensitisation	  AOP)	   such	   as	   cell-­‐surface	  
CD54	   and/or	   CD86	   or	   transcription	   of	   chemokine	   receptor	   (CCR)2	   are	   used	   as	  
measurements	  of	  cell	  activation.	  
1. Human	  cell	  line	  activation	  test	  (h-­‐CLAT,	  developed	  by	  Kao	  and	  Shiseido).	  The	  h-­‐CLAT	  
assay	   uses	   THP-­‐1	   cells	   (a	   human	  monocytic	   leukemia	   cell	   line)	   as	   a	   surrogate	   for	  
dermal	   DC.	   Relative	   fluorescence	   intensity	   (RFI)	   compared	   to	   vehicle-­‐only	   treated	  
control	  cells	  is	  used	  as	  an	  indicator	  of	  CD86	  and	  CD54	  induction.	  	  The	  h-­‐CLAT	  method	  
has	   been	  evaluated	   in	   a	   European	   Union	   Reference	   Laboratory	   for	   Alternatives	   to	  
Animal	   Testing	   (EURL	   ECVAM)-­‐coordinated	   validation	   study	   and	   subsequent	  
independent	  peer	  review	  by	  the	  EURL	  ECVAM	  Scientific	  Advisory	  Committee	  (ESAC)	  
and	  was	  considered	  scientifically	  valid	  to	  be	  used	  as	  part	  of	  an	  IATA	  to	  support	  the	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discrimination	   between	  sensitisers	   and	   non-­‐sensitisers	   for	   the	   purpose	   of	   hazard	  
classification	  and	  labelling	  (OECD	  GUIDELINE	  FOR	  THE	  TESTING	  OF	  CHEMICALS,	  July	  
2014).	  
2. Myeloid	  U937	  skin	  sensitisation	  test	  (MUSST,	  L´Oreal).	  The	  MUSST	  assay,	  which	  uses	  
the	  U937	  cell	  line	  (a	  human	  histiocytic	  leukemia	  cell	  line),	  is	  designed	  to	  evaluate	  the	  
capacity	   of	   a	   substance	   to	   induce	   dendritic	   cell	   activation.	   To	   achieve	   this,	   CD86	  
expression	  is	  assessed	  by	  flow	  cytometry.	  A	  substance	  inducing	  an	  increase	  in	  CD86	  
protein	  expression	  of	  P150%	  is	  considered	  to	  be	  a	  sensitiser.	  	  
3. Modified	  myeloid	  U937	   skin	   sensitisation	   test	   (mMUSST,	   BASF).	   The	  mMUSST	   also	  
uses	   the	   U937	   cell	   line	   measuring	   CD86	   by	   flow	   cytometry.	   A	   test	   substance	   is	  
predicted	   to	   have	   a	   dendritic	   cell	   line	   activating	   potential	   when	   CD86	   induction	  
exceeds	  the	  threshold	  of	  1.2	  with	  respect	  to	  vehicle	  treated	  cells.	  
4. Peripheral	   blood	   monocyte-­‐derived	   dendritic	   cell	   assay	   (PBMDC,	   Beiersdorf).	   In	  
contrast	   to	   the	   above	   cell	   line-­‐based	   assays,	   the	   PBMDC	   assay	   uses	   human	  
peripheral	  blood	  monocyte-­‐derived	  dendritic	  cells	  isolated	  from	  the	  fresh	  buffy	  coats	  
of	   five	  different	  donors.	   CD1a	  negative/CD14	  positive	  monocytes	   are	   selected	   and	  
differentiated.	  CD86	  expression	  is	  determined	  by	  flow	  cytometry.	  If	  a	  test	  substance	  
induces	  on	  average	  P20%	   increase	   in	  CD86-­‐positive	   cells	   compared	   to	  non-­‐treated	  
cells	  it	  is	  considered	  as	  a	  skin	  sensitiser.	  
5. VITOSENS	   (VITO).	   The	   VITOSENS	   assay	   uses	   differentiated	   CD34+	   progenitor	   cells	  
derived	  from	  human	  cord	  blood	  as	  surrogate	  for	  DC.	  The	  response	  to	  test	  substance	  
exposure	  is	  evaluated	  by	  comparing	  the	  fold	  change	  in	  the	  expression	  of	  CCR2	  (C–C	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chemokine	   receptor	   type	  2)	  and	   the	   transcription	   factor	  cAMP	  responsive	  element	  
modulator	  (CREM)]	  compared	  to	  solvent-­‐exposed	  cells	  (Hooyberghs	  et	  al.,	  2008).	  	  
It	   can	  be	   concluded	   that	  whilst	  DC	  cell	  based	  assays	   look	  very	  promising	   (e.g.:	  U-­‐937	  and	  
THP-­‐1	  assays	  using	  CD86	  as	  biomarker)	  these	  assays	  will	  most	  probably	  not	  be	  suitable	  as	  a	  
stand	   alone	   assay	   to	   distinguish	   a	   potential	   sensitizer	   from	   a	   non-­‐sensitizer	   to	   the	   same	  
level	  of	  accuracy	  and	  reliability	  as	  the	  LLNA	  (dos	  Santos	  et	  al.,	  2009).	  
	  
T	  cell	  activation	  
T-­‐cells	   are	   typically	   affected	  by	   protein-­‐hapten	   complexes	   presented	  by	  dendritic	   cells	   on	  
MHC	   molecules.	   Molecular	   understanding	   of	   this	   process	   has	   improved	   in	   recent	   years	  
(Martin	   et	   al,	   2010).	   Briefly,	   MHC	  molecules	   are	   membrane	   proteins,	   which	   present	   the	  
small	   peptide	  antigens	  placed	   in	   a	   “groove”	  of	   the	  MHC	  molecules	  during	   its	   intracellular	  
synthesis	  and	  transport	  to	  the	  cell	  surface.	  In	  the	  context	  of	  the	  MHC	  molecular	  on	  the	  cell	  
surface,	  the	  small	  peptide	  antigen	  is	  recognized	  via	  the	  T-­‐cell	  receptors	  as	  a	  self	  or	  non-­‐self.	  
If	   this	   peptide	   antigen	   is	   recognised	   via	   the	   T-­‐cell	   hapten	   complex,	   the	   T-­‐cell	   will,	   be	  
activated	   to	   form	   a	   memory	   T-­‐cell,	   which	   subsequently	   proliferates.	   If	   reactivated	   upon	  
hapten	  presentation	  by	  skin	  DCs	  cells,	  these	  memory	  T-­‐cell	  will	  induce	  ACD	  (Vocanson	  et	  al.,	  
2009).	  
Recognizing	   the	   importance	  of	   the	  process	  of	   antigen	  presentation	   (i.e.	   T-­‐cell	   priming),	   in	  
vitro	  T-­‐cell	  priming	  assays	  have	  been	  developed	  (Martin	  et	  al.,	  2010).	  While	  first	  generation	  
assays	   could	   only	   detect	   strong	   or	   extreme	   sensitisers,	   more	   recent	   development	   using	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normal	   human	   peripheral	   blood	   depleted	   of	   regulatory	   cells	   that	   normally	   prevent	   the	  
sensitisation	   phase,	   increased	   the	   probability	   of	   the	   detection	   of	   T-­‐	   cell	   proliferation	  
(Vocanson	   et	   al.,	   2008).	   A	   related	   approach	   is	   based	   on	   the	   hypothesis	   that	   there	   is	   a	  
correlation	   between	   the	   potency	   of	   contact	   allergens	   and	   T-­‐cell	   frequency	   and	   T-­‐cell	  
receptor	   repertoire	   (Kotturi	   et	   al.,	   2008).	   It	   is	   plausible	   that	   sensitisation	   potency	   may	  
correlate	  with	   the	  size	  of	   the	  contact	  allergen-­‐specific	  effector	  and	   regulatory	  T-­‐cell	  pools	  
and	   their	   diversity,	   and	   this	   could	   form	   the	   basis	   of	   a	   new	   generation	   of	   in	   vitro	   T-­‐cell	  
priming	  assays.	  	  
Perhaps	  the	  most	  interesting	  finding	  about	  lymphoid	  tissue,	  as	  related	  to	  the	  sensitisation	  is	  
the	   selectivity	   of	   cytokine	   secretion.	   Hopkins	   et	   al.	   (2005),	   building	   on	   earlier	   work	   of	  
Dearman	   and	   co-­‐	   workers,	   reported	   that	   lymphoid	   tissue	   of	   mice	   exposed	   to	   classic	  
electrophiles	   with	   conjugate	   proteins	   via	   nucleophilic	   substitution	   as	   halo-­‐nitro-­‐aromatic	  
compounds	   (i.e.	   1-­‐chloro-­‐2,4-­‐dinitrobenzene	   and	   1-­‐fluoro-­‐	   2,4-­‐dinitrobenzene)	   expresses	  
high	   levels	   of	   the	   Th1	   cytokine	   IFN-­‐γ	   and	   low	   levels	   of	   the	   Th2	   cytokines	   IL-­‐5	   and	   IL-­‐10.	  
Conversely,	   lymphoid	   tissue	   for	   mice	   exposed	   to	   2,4-­‐dinitrobenzene	   sulphonyl	   chloride,	  
which	   conjugates	   with	   proteins	   via	   nucleophilic	   substitution	   as	   a	   sulphonyl	   halides,	   the	  
acylating	   agent	   trimellitic	   anhydride,	   or	   fluorescein	   isothiocyanate,	  which	   conjugates	  with	  
proteins	  via	  nucleophilic	  addition	  to	  the	  carbon	  atom	  of	  the	  isothiocyanate	  (-­‐N=C=S)	  moiety,	  
express	  high	   levels	  of	   the	  Th2	  cytokines	   IL-­‐5	  and	   IL-­‐10	  and	   low	   levels	  of	   the	  Th1	  cytokine	  
IFN-­‐γ	   (Hopkins	   et	   al.,	   2005).	   Based	   on	   differential	   binding	   to	   cellular	   and	   serum	   proteins	  
Hopkins	   et	   al.	   (2005)	   showed	   that	   chemicals	   that	   stimulate	   a	   Th1	   cytokine	   response	  bind	  
selectively	  to	  cellular	  proteins,	  while	  chemicals	  that	  stimulate	  a	  Th2	  cytokine	  response	  bind	  
selectively	   to	   serum	   proteins.	   While	   it	   would	   be	   tempting	   to	   say	   electrophiles	   which	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preferentially	   bind	   to	   cysteine	   express	   a	   Th1	   cytokine	   profile	   and	   electrophiles	   which	  
preferentially	  bind	  to	  lysine	  express	  a	  Th2	  cytokine	  profile,	  it	  is	  most	  likely	  not	  that	  simple.	  	  
Given	  the	  complexity	  of	  ACD,	  a	  single	  alternative	  method	  cannot	  replace	  the	  LLNA,	  but	  it	  is	  
necessary	   to	   combine	  methods	   through	   an	   integrated	   testing	   strategy	   (ITS).	   To	   ensure	   a	  
mechanistic	  basis	  and	  cover	  the	  complexity,	  multiple	  methods	  should	  be	   integrated	   into	  a	  
ITS.	   But	   the	   strategy	   most	   suitable	   for	   regulatory	   decision-­‐making	   still	   remains	   to	   be	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1.2 	  Photoallergy	  
	  
In	   the	   course	   of	   life,	   the	   skin	   is	   exposed	   to	   radiation	   that	   spans	   the	   electromagnetic	  
spectrum,	   including	   ultraviolet	   (UV),	   visible,	   and	   infrared	   radiation	   from	   the	   sun,	   artificial	  
light	   sources,	   and	   heat	   sources.	   In	   general,	   the	   solar	   radiation	   reaching	   the	   earth	   that	   is	  
most	  capable	  of	  inducing	  skin	  changes	  extends	  from	  290	  nm	  to	  700	  nm,	  the	  UV	  and	  visible	  
spectra.	  Wavelengths	  on	   the	  extremes	  of	   this	   range	  are	  either	  significantly	   filtered	  by	   the	  
earth’s	  atmosphere	  or	  insufficiently	  energetic	  to	  cause	  cutaneous	  pathology.	  The	  absorption	  
of	   light	   is	   deeper,	  more	   vital	   structures	   of	   the	   skin	   are	   dependent	   on	   a	   variety	   of	   optical	  
parameters	   that	   differ	   from	   region	   to	   region	   on	   the	   body.	   Melanin	   is	   a	   significant	  
chromophore	  in	  the	  skin	  because	  it	  is	  capable	  of	  absorbing	  a	  broad	  range	  of	  radiation	  from	  
UVB	   through	   the	   visible	   spectrum.	   Other	   chromophores	   in	   the	   skin	   are	   amino	   acids	   and	  
their	  breakdown	  products,	  such	  as	  tryptophan	  and	  urocanic	  acid,	  which	  are	  able	  to	  absorb	  
light	   in	  the	  UVB	  range.	  Biologically,	  the	  most	  significant	  chromophore	  is	  DNA,	  because	  the	  
resultant	  damage	  from	  the	  radiation	  may	  have	  lasting	  effects	  on	  the	  structure	  and	  function	  
of	  the	  tissue.	  
	  
Described	  as	  abnormal	  sensitivity	  to	  UV	  and	  visible	  light,	  photosensitivity	  may	  results	  from	  
endogenous	   or	   exogenous	   factors.	   Illustrating	   the	   former,	   a	   variety	   of	   genetic	   diseases	  
impair	   the	  cells	  ability	   to	   repair	  UV	   light-­‐induced	  damage.	  The	  autoimmune	  disease	   lupus	  
erithematosus	   also	   features	   abnormal	   sensitivity	   to	   UV	   light.	   In	   hereditary	   or	   chemically	  
induced	  porphyria,	  enzyme	  abnormalities	  disrupt	  the	  biosynthetic	  pathways	  producing	  eme,	  
leading	  to	  accumulation	  of	  porphyrin	  precursors	  or	  derivate	  throughout	  the	  body,	  including	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the	  skin.	  These	  compounds	   in	  general	  fluoresce	  when	  exposed	  to	  UV	  light	  of	  400-­‐410	  nm,	  
and	  in	  this	  exited	  state	  they	  interact	  with	  cellular	  macromolecules	  or	  with	  molecular	  oxygen	  
to	  generate	  toxic	  free	  radicals.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Fig.4	  -­‐	  Wavelength	  and	  skin	  [4]	  
	  
	  
Phototoxic	   reactions	   from	   exogenous	   chemicals	   may	   be	   produced	   by	   systemic	   or	   topical	  
administration	  or	  exposure.	   In	  acute	  reactions,	   the	  skin	  may	  appear	  red	  and	  blister	  within	  
minutes	   to	   hours	   after	   UV	   light	   exposure	   and	   resemble	   bad	   sunburn.	   Chronic	   phototoxic	  
responses	  may	   result	   in	   hyperpigmentation	   and	   thickening	   of	   the	   affected	   areas.	   UVA	   is	  
most	  commonly	  responsible;	  however,	  UVB	  may	  occasionally	  be	  implicated.	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Not	  photodynamic	  mechanisms	  have	  been	  implicated	  in	  the	  pathogenesis	  of	  phototoxicity,	  
psoralen	  being	  the	  prime	  examples.	  Upon	  entering	  the	  cell,	  psoralen	  intercalate	  with	  DNA	  in	  
a	  non-­‐photodependent	  manner.	  Subsequent	  excitation	  with	  UVA	  provokes	  a	  photochemical	  
reaction	   that	   ultimately	   results	   in	   a	   covalently	   linked	   cycloadduct	   between	   psoralen	   and	  
pyrimidine	   bases.	   This	   substantially	   inhibits	   DNA	   synthesis	   and	   repair,	   resulting	   in	   clinical	  
phototoxicity	  reactions.	  Psoralens	  may	  be	  found	  in	  sufficiently	  high	  concentrations	  in	  plants	  
that	   contact	  with	   their	   fruit	  and	   leaves	   in	   the	  presence	  of	   sunlight	   can	  cause	  a	   significant	  
blistering	  eruption	  called	  phytophotodermatitis.	  
	  
Photoallergy	   represent	   a	   true	   type	   IV	   delayed	   hypersensitivity	   reaction.	   Hence,	   while	  
phototoxic	   reactions	   can	   occur	   with	   the	   first	   exposure	   to	   the	   offending	   chemical,	  
photoallergy	   requires	   prior	   sensitization.	   Induction	   and	   subsequent	   elicitation	   of	   reaction	  
may	   results	   from	   topical	   or	   systemic	   exposure	   to	   the	   agent.	   If	   topical,	   the	   reactions	   are	  
termed	   photocontact	   dermatitis,	   while	   systemic	   exposures	   are	   termed	   systemic	  
photoallergy.	  In	  most	  situations,	  systemic	  photoallergy	  is	  the	  result	  of	  the	  administration	  of	  
medications.	   Generally,	   the	   mechanisms	   of	   photocontact	   dermatitis	   and	   of	   systemic	  
photoallergy	  are	  the	  same	  as	  those	  described	  for	  the	  ACD,	   in	  the	  context	  of	  photocontact	  
dermatitis;	  however,	  UV	  light	  is	  necessary	  to	  convert	  a	  potential	  photosensitizing	  chemical	  
into	  a	  hapten	  that	  elicits	  an	  allergic	  response.	  
	  
Safety	  evaluation	  of	   ingredients	  is	  an	  important	  part	  of	  the	  development	  of	  cosmetics	  and	  
drugs.	   Phototoxicity,	   photoirritation	   and	   photoallergy	   are	   health	   hazard	   arising	   from	  
exposure	  of	  skin	  to	  normally	  harmless	  levels	  of	  light	  in	  the	  presence	  of	  radiation-­‐absorbing	  
	   35	  
compounds.	   The	   growing	   use	   of	   cosmetics	   in	   combination	   with	   relative	   high-­‐UV	   light	  
exposure	  potentiates	  this	  problem.	  Photoactivation	  and	  binding	  of	  photoactive	  compounds	  
to	  proteins	   is	   a	   known	  prerequisite	   for	   the	   formation	  of	   immunogenic	  photoantigens	  and	  
the	   induction	   of	   photoallergy.	   Ultraviolet	   A	   (UVA)	   is	   the	   action	   spectrum	   of	   this	  
photoderivatization,	   as	  protein	  an	   cells	   are	  photocoulped	  with	  photohaptenic	   compounds	  
by	  irradiation	  with	  UVA	  but	  not	  UVB	  (Tokura	  et	  al.,	  200;	  2005).	  Photochemotoxic	  reactions	  
may	   be	   a	   phototoxic	   or	   photoallergic	   in	   nature.	   Acute	   phototoxic	   reactions	   are	   generally	  
characterized	  by	  erythema	  and	  oedema	  followed	  by	  hyperpigmentation	  and	  desquamation.	  
Chronic	  repeated	  injury	  of	  this	  type	  may	  result	  in	  fragility,	  blistering	  and	  milia	  formation	  or	  
even	  actinic	  keratosis	  and	  skin	  cancers.	  The	  photochemical	  mechanisms	  involved	  may	  differ.	  
They	  include	  photoaddition	  of	  the	  chemical	  to	  biological	  targets	  such	  as	  DNA,	  the	  formation	  
of	  toxic	  products	  due	  to	  the	  absorption	  of	  light	  by	  the	  phototoxic	  molecule,	  the	  generation	  
of	  reactive	  oxygen	  species	  or	  free	  radicals	  (Epstein	  and	  Wintroub,	  1985).	  	  
	  
Phototoxic	  reactions	  are	  significantly	  more	  common	  than	  photoallergic	  reactions	  and	  mostly	  
resemble	   to	   exaggerated	   sunburns.	   Photoallergic	   reactions	   appear	   only	   in	   minority	   of	  
individuals	  and	  resemble	  ACD	  on	  sun-­‐exposed	  areas,	  although	  sometimes	  may	  extend	  into	  
covered	   areas.	   Generally,	   the	   physics	   examination	   and	   a	   positive	   patient’s	   history	   of	  
photosensitivity	   reactions	   on	   substances	   are	   of	   great	   importance	   for	   the	   diagnosis.	  
Photocontact	  AD	  is	  one	  of	  the	  undesirable	  adverse	  effect	  produced	  by	  chemicals	  and	  drugs	  
in	  our	  environment	   (Yamamoto	  and	  Tokura,	  2003),	   it	   is	  a	  delayed	   type	   IV	  hypersensitivity	  
reaction	  seen	  when	  exogenous	  agent	  comes	   into	  contact	  with	   the	  skin	   in	   the	  presence	  of	  
UV.	  Various	  chemicals	  have	  been	  reported	  to	  cause	  photocontact	  dermatitis.	  The	  physical	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manifestation	  of	  this	  increased	  photosensitivity	  will	  depend	  on	  the	  specific	  photosensitisers;	  
some	   will	   reduce	   the	   threshold	   to	   sunburn	   while	   others	   may	   induce	   a	   photoallergy	   in	  
susceptible	   individuals	   (Maverakis	   et	   al.,	   2010).	   Historically,	   the	   use	   of	   halogenated	  
salicyanilide	   and	   related	   compounds,	   especially	   3,	   3’,	   4’,	   5-­‐tetrachlorosalicylanilide	   and	  
bithionol,	   resulted	   in	   a	   large	   number	   of	   patients	   with	   this	   skin	   disease.	   More	   recent	  
causative	  agents	  include	  cosmetics	  or	  sunscreen	  products	  such	  as	  6-­‐methylcoumarine,	  musk	  
ambrette,	   benzophenone.	   Likewise,	   there	   have	   been	   various	   culprit	   drugs	   to	   evoke	  
photosensitivity,	   including	  chlorpromazine,	  promethazine,	  quinolones,	  such	  as	  sparfloxacin	  
and	  enoxacin,	  piroxicum,	  afloqualone	  and	  non-­‐steroidal	  anti-­‐inflammatory	  drugs	  (Kurita	  et	  
al.,	  2007).	  
	  
Assessments	  of	  phototoxic	  properties	  of	   ingredients	  have	  generally	  been	  performed	  using	  
animal	  test	  including	  Guinea	  pigs,	  rabbits,	  rats	  and	  mice	  (Maurer	  et	  al.,	  1980;	  Jordan,	  1982;	  
Gerberick	  and	  Ryan,	  1990;	  Ulrich	  et	  al.,	  1998).	  For	  phototoxicity	  testing,	  the	  in	  vitro	  3T3	  NRU	  
phototoxicity	  test	  has	  been	  adopted	  as	  an	  alternative	  to	  in	  vivo	  phototoxicity	  test	  (OECD	  no.	  
432).	  In	  vitro	  replacement	  for	  the	  in	  vivo	  photoallergy	  test	  have	  also	  been	  sought	  (Tokura,	  
2000;	  Lovell	  and	  Jones,	  2000;	  Barratt	  et	  al.,	  2000;	  Neumann	  et	  al.,	  2005;	  Onoue	  and	  Tsuda,	  
2005;	  Kurita	  et	  al.,	  2007;	  Hoya	  et	  al.,	  2009;	  Karschuk	  et	  al.,	  2010),	  but	  to	  date	  no	  accepted	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1.3 	  Keratinocytes	  and	  IL-­‐18	  
KC	  form	  an	  interface	  between	  the	  body	  and	  the	  environment,	  they	  are	  important	  guardians	  
for	   the	   detection	   of	   danger	   signals	   and	   the	   consecutive	   initiation	   of	   an	   inflammatory	  
response.	  KC	  play	  a	  role	  in	  all	  phases	  of	  allergic	  contact	  dermatitis,	  from	  the	  early	  initiation	  
phase	  with	  the	  elaboration	  of	  inflammatory	  cytokines,	  that	  plays	  a	  role	  in	  Langerhans	  cells	  
(LC)	  migration,	   and	   T-­‐cell	   trafficking,	   through	   the	   height	   of	   the	   inflammatory	   phase	   with	  
direct	   interactions	   with	   epidermotrophic	   T-­‐cells,	   through	   the	   resolution	   phase	   of	   allergic	  
contact	   dermatitis	   with	   the	   production	   of	   anti-­‐inflammatory	   cytokines	   and	   tolerogenic	  
antigen	  presentation	  to	  effector	  T-­‐cells	  (Gober	  and	  Gaspari,	  2008).	  KC	  sense	  haptens,	  and	  in	  
turn	   initiate	   a	   program	   of	   enhances	   or	   de	   novo	   expression	   of	   inflammatory	   molecules	  
representing	   the	   starting	   point	   of	   primary	   inflammation.	   KC	   mount	   immune	   responses	  
through	  the	  secretion	  of	  a	  variety	  of	  inflammatory	  cytokines,	  soluble	  proteins	  and	  ROS.	  KC	  
play	  a	  role	  in	  all	  phase	  of	  allergic	  dermatitis.	  	  
Mehrotra	   et	   al.	   (2005)	   were	   the	   first	   to	   demonstrate	   that	   both	   contact	   allergens	   and	  
irritants	   can	   induce	   ROS	   and	   nitrogen	   species	   in	   the	   human	   keratinocyte	   cell	   line	   A431.	  
More	  recently,	  Kim	  et	  al.	   (2012)	  demonstrated	  in	  HaCaT	  cells	  that	  both	  the	  allergen	  DNCB	  
and	   the	   irritant	   benzalkonium	   chloride	   can	   generate	   ROS	   in	   a	   time-­‐	   and	   dose-­‐dependent	  
manner,	  however,	  only	  DNCB	   induced	  a	  ROS-­‐dependent	  protein	  carbonylation,	   suggesting	  
that	  the	  characteristic	  of	  ROS	  generated	   in	  response	  to	  chemicals	  might	  differ.	  Changes	   in	  
ROS	  levels	  were	  detected	  after	  treatment	  for	  30	  min.	  Interestingly,	  not	  all	  allergens	  tested	  
induced	  ROS	  production	  as	   assessed	  by	  DCFH,	  nickel	   and	  hydroquinone	   failed,	   suggesting	  
that	   cellular	   oxidative	   stress	   after	   contact	   with	   chemicals	   might	   depend	   on	   the	   specific	  
nature	  of	  the	  chemicals	  themselves.	  Further	  studies	  are	  necessary	  to	  verify	  oxidative	  stress-­‐
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dependent	  or	  oxidative	  stress-­‐independent	  mechanisms	  in	  chemicals-­‐induced	  KC	  activation	  
and	  to	  establish	  its	  role	  in	  contact	  allergy.	  
	  
As	  previous	  mentioned,	  human	  KCs	  constituvely	  express	  several	  cytokines,	  including	  pro-­‐IL-­‐
1α,	   pro-­‐IL-­‐1β,	   and	   pro-­‐IL-­‐18.	   The	   IL-­‐1	   family	   is	   a	   group	   of	   cytokines	   involved	   in	   local	   and	  
systemic	   inflammatory	   reactions.	   IL-­‐1	   induces	   acute-­‐phase	   proteins,	   cytokines,	   and	  
adhesion	  molecules.	  	  Among	  the	  cytokines	  produced	  by	  KC,	  IL-­‐18	  is	  of	  particular	  interest	  as	  
it	  is	  a	  potent	  inducer	  of	  IFN-­‐γ	  by	  activated	  T	  cells	  (Okamura	  et	  al.,	  1995).	  This	  cytokine	  has	  
been	  shown	  to	  play	  a	  key	  proximal	  role	  in	  the	  induction	  of	  allergic	  contact	  sensitisation	  and	  
to	   favor	   Th-­‐1	   type	   immune	   response	   by	   enhancing	   the	   secretion	   of	   pro-­‐inflammatory	  
mediators	   such	   as	   TNF-­‐α,	   IL-­‐18	   and	   IFN-­‐γ	   (Okamura	   et	   al.,	   1995,	   Cumberbatch	   et	   al.,	  
2001	  and	  Antonopoulos	   et	   al.,	   2008).	   Human	   keratinocytes	   constitutively	   express	   IL-­‐18	  
mRNA	  and	  protein	  (Naik	  et	  al.,	  1999),	  and	  works	  published	  by	  Naik	  et	  al.,	  1999	  and	  Van	  Och	  
et	  al.,	   2005	   showed	   the	   induction	  of	   IL-­‐18	   following	  exposure	   to	   contact	   sensitisers.	   IL-­‐12	  
and	   IL-­‐18	   play	   important	   roles	   in	   the	   development	   of	   T	   helper	   type	   I	   (Th1)	   cells	   and	   are	  
synergistic	  in	  the	  induction	  of	  IFN-­‐γ	  by	  T-­‐cells	  (Okamura	  et	  al.,	  1995).	  IL-­‐18	  has	  an	  important	  
role	  in	  Th-­‐1	  type	  immune	  response	  enhancing	  the	  secretion	  of	  proinflammatory	  mediators	  
such	   as	   TNF-­‐α,	   IL-­‐8,	   and	   IFN-­‐γ	   and	   also	   in	   the	   induction	   of	   allergic	   contact	   sensitization	  
(Shornick	  et	  al.,	  1996;	  Wang	  et	  al.,	  1999).	  	  
	  
As	  shown	  in	  Figure	  5,	  IL-­‐1β	  and	  IL-­‐18	  are	  synthesized	  as	  preforms,	  which	  require	  proteolytic	  
maturation	   by	   cysteine	   protease	   caspase-­‐1,	   which	   must	   first	   be	   activated	   by	   the	  
inflammasome	  (He	  et	  al.,	  2012;	  Lu	  et	  al.,	  2012).	  The	  inflammasome	  is	  a	  complex	  consisting	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of	  receptor	  linked	  to	  inactive	  procaspase-­‐1	  by	  an	  intermediate	  apoptosis-­‐associated	  speck-­‐
like	  protein	   containing	  a	   caspase	  activation	  and	   recruitment	  domain	   (Menzel	  et	   al.,	   2011;	  
Menu	   and	   Vince,	   2011;	   Tschopp	   and	   Schroder,	   2010).	   IL-­‐1	   and	   the	   inflammasome	   are	  
involved	  in	  sensing	  contact	  sensitisers	  and	  triggering	  an	  innate	  immune	  response	  to	  these,	  
which	   subsequently	   has	   a	   role	   in	   triggering	   the	   adaptive	   immune	   response	   to	   contact	  
sensitisers	  in	  the	  skin	  (Sutterwala	  et	  al.,	  2006;	  Watanabe	  et	  al.,	  2007).	  
IL-­‐18	  plays	  a	  key	  proximal	  role	  in	  the	  induction	  of	  ACD	  (Cumberbatch	  et	  al.,	  2001).	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1.4 	  Signal	   transduction	   pathways	   involved	   in	   the	   activation	   of	   the	  
inflammasome	  and	  IL-­‐18	  production	  
	  
A	  wide	  range	  of	  proinflammatory	  stimuli,	  including	  pathogen-­‐associated	  molecular	  patterns	  
(PAMPs)	  and	  endogenous	  damage-­‐associated	  molecular	  patterns	  (DAMPs)	  (Contassot	  et	  al.,	  
2012),	  activate	  the	  NLRP3	  inflammasome.	  Among	  DAMPs,	  the	  evolutionarily	  conserved	  non-­‐
histone	   chromatin-­‐binding	   protein	   HMGB1	   is	   released	   into	   the	   extracellular	   space	   during	  
infection	   or	   injury	   by	   activated	   immune	   cells	   and	   damaged	   cells.	   HMGB1	   functions	   as	   a	  
proinflammatory	   mediator,	   it	   is	   a	   Toll-­‐like	   receptor	   4	   (TLR4)-­‐agonist,	   and	   it	   contributes	  
importantly	   to	   the	   pathogenesis	   of	   inflammatory	   diseases	   (Lu	   et	   al.,	   2013).	   As	   all	   NLRP3	  
activators	  induced	  the	  generation	  of	  ROS,	  it	  has	  been	  reported	  that	  ROS	  production	  triggers	  
NLRP	  inflammasome	  activation	  (Tshopp	  and	  Schroder,	  2010).	  Generation	  of	  ROS	  induces	  the	  
dissociation	  of	   thioredoxin	   from	   thioredoxin-­‐interacting	  protein.	   Then	   the	   latter	   is	   able	   to	  
bind	   NLRP3,	   which	   induced	   inflammasome	   activation	   (Zhou	   et	   al.,	   2010).	   The	   imbalance	  
between	   the	   formation	   of	   ROS	   and	   the	   ability	   to	   detoxify	   these	   oxidizing	   radicals	   can	  
produce	   a	   cellular	   state	   known	   as	   oxidative	   stress	   (Valko	   et	   al.,	   2007).	   It	   is	   the	   skin	  
microenvironment	   that	   provides	   the	   DAMPs,	   including	   ROS,	   uric	   acid,	   hyaluronic	   acid	  
fragments,	   HMGB-­‐1,	   and	   adenosine	   triphosphate,	   that	   are	   required	   for	   the	   activation	   of	  
pattern	  recognition	  receptors	  (PRRs)	  and	  full	  activation	  of	  DC.	  	  
	  
1.4.1 NLRP3	  
The	   inflammasome	   is	  a	  cytosolic	  molecular	  complex	   that	  once	  activated	  has	  an	  enzymatic	  
activity	   mediated	   by	   the	   recruitment	   and	   activation	   of	   caspase-­‐1.	   The	   maintenance	   of	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homeostasis	   is	  a	  primary	   function	  of	   the	   innate	   immune	  system,	  achieved	   in	  part	   through	  
immune	  surveillance	  by	  PRRs,	  such	  as	  TLRs	  and	  NLRs,	  predominantly	  expressed	  by	  cells	  of	  
the	  myeloid	  lineage	  (Sutterwala	  et	  al.,	  2014).	  	  
	  
	  Fig	  6.	  	  –	  Inflammasomes	  [5]	  
	  
The	   cytosolic	   NLR	   family	   of	   PRRs	   functions	   to	   sense	   and	   respond	   to	   threats	   in	   the	  
intracellular	  compartment	  (Fig.	  6).	  NLR	  members	  are	  classified	  based	  on	  their	  shared	  three-­‐
domain	   structural	   homology.	   The	  N-­‐terminal	   effector	   domain	   can	   include	   a	   pyrin	   domain	  
(PYD),	  a	  caspase-­‐recruitment	  domain	  (CARD),	  or	  a	  baculovirus	   inhibitory	  repeated	  domain,	  
and	   is	   the	   basis	   by	   which	   NLRs	   may	   be	   further	   subcategorized.	   The	   central	   nucleotide-­‐
binding	  oligomerization	  domain	  (NATCH)	  is	  a	  common	  feature	  of	  all	  NLR	  proteins,	  followed	  
by	  a	  leucine	  repeated	  domain	  (LRR)	  at	  the	  C-­‐terminus	  (Ting	  et	  al.,	  2008).	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NLRP1,	  NLRP3	  and	  NLRC4,	  along	  with	  the	  pyrin	  and	  HIN	  domain-­‐containing	  (PYHIN)	  family	  
member	   AIM2,	   can	   be	   induced	   to	   associate	   with	   other	   proteins	   in	   large	   multimeric	  
complexes	  termed	  inflammasomes.	  
	  
Consisting	  of	  an	  NLR	  or	  PYHIN,	  in	  some	  cases	  the	  adaptor	  protein	  ASC	  (apoptosis-­‐associated	  
speck-­‐like	   protein	   containing	   a	   CARD	   domain),	   and	   the	   cysteine	   protease	   procaspase-­‐1,	  
inflammasome	  formation	  ultimately	  results	  in	  the	  autocatalysis	  and	  activation	  of	  caspase-­‐1	  
(Martinon	  et	  al.,	  2002;	  Hornung	  and	  Latz,	  2010).	  Once	  enzymatically	  active,	  caspase-­‐1	  can	  
go	   on	   to	   process	   the	   cytokines	   pro-­‐IL-­‐1β	   and	   pro-­‐IL-­‐18	   into	   their	  mature	   secreted	   forms.	  
These	   proinflammatory	   cytokines	   initiate	   an	   inflammatory	   cascade	   that	   leads	   to	   the	  
recruitment	  of	  innate	  immune	  cells	  and	  can	  also	  determine	  the	  character	  of	  the	  subsequent	  
adaptative	  immune	  response	  (Dinarello,	  2009).	  
	  
The	   NLRP3	   inflammasome	   is	   the	   most	   extensively	   investigated	   of	   the	   inflammasome	  
identified.	  The	  NLRP3	  protein	  was	   first	   identified	  due	   to	  gain-­‐of-­‐function	  mutations	   in	   the	  
encoding	  gene	  that	  are	  associated	  with	  the	  autoinflammatory	  cryopyrin	  associated	  periodic	  
syndromes	   (Hoffman	   et	   al.,	   2001;	   Aksentijevich	   et	   al.,	   2002).	   In	   addition	   to	   the	   central	  
NATCH	   and	   C-­‐terminal	   LRR,	   NLRP3	   is	   characterized	   by	   its	   N-­‐terminal	   PYD,	   which	   allows	  
NLRP3	  to	  recruit	   the	  adaptor	  molecule	  ASC	  through	  PYD-­‐PYD	   interactions,	   thus	   facilitating	  
the	  recruitment	  of	  procaspase-­‐1	  to	  form	  the	  inflammasome	  complex	  (Agostini	  et	  al.,	  2004;	  
Fernandes-­‐Alnemri	  et	  al.,	  2007).	  Activation	  of	  the	  NLRP3	  inflammasome	  can	  be	  achieved	  by	  
a	  wide	   range	   of	   structurally	   dissimilar	   agonists,	   including	   pathogens,	   pore-­‐forming	   toxins,	  
environmental	  irritants,	  and	  endogenous	  DAMPs.	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A	  two	  steps-­‐model	   in	  which	  both	  priming	  and	  activating	  signals	  are	  required	  to	  produce	  a	  
functional	  inflammasome	  is	  generally	  accepted	  (Sutterwala	  et	  al.,	  2014	  	  -­‐	  Fig.7).	  
	  
	  
Fig.	  7	  –	  NLRP3	  priming	  and	  activation	  [7]	  	  
	  
Signal	  1:	  priming	  
The	   initial	   inflammasome	   priming	   step	   upstream	   of	   activation	   affects	   NLRP3	   at	   the	  
transcriptional	   level	   and	   also	   serves	   to	   trigger	   post-­‐translational	   modifications	   of	  
inflammasome	  components	  that	  allow	  for	  oligomerization.	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In	  general,	  priming	  stimuli	  can	  include	  any	  whose	  receptor	  signalling	  results	  in	  the	  activation	  
of	   the	   transcription	   factor	   NF-­‐κB,	   such	   as	   ligand	   for	   IL-­‐1R,	   TLRs,	   NLRs,	   and	   the	   cytokine	  
receptors	  TNFR1	  and	  TNFR2	  (Bauernfeind	  et	  al.,	  2009;	  Fanchi	  et	  al.,	  2009).	  The	  activation	  of	  
NF-­‐κB	  is	  critical	  for	  upregulating	  the	  transcription	  of	  both	  pro-­‐IL-­‐1β	  and	  NLRP3,	  as	  pro-­‐IL-­‐1β	  
is	   not	   constitutively	   expressed	   and	   basal	   levels	   of	   NLRP3	   are	   inadequate	   for	   efficient	  
inflammasome	  formation.	  In	  contrast,	  transcriptional	  modulation	  is	  not	  required	  to	  license	  
the	  inflammasome	  components	  ASC	  and	  procaspase-­‐1	  for	  inflammasome	  activation,	  nor	  the	  
caspase-­‐1	  substrate	  pro	  IL-­‐18,	  as	  there	  are	  found	  at	  adequate	  concentrations	  in	  the	  steady	  
state	  (Schroder	  et	  al.,	  2012).	  Although	  NLRP3	  inflammasome	  activation	  is	  possible	  if	  priming	  
and	  activation	  signals	  are	  provided	  simultaneously,	  the	  kinetics	  and	  extent	  of	  inflammasome	  
activation	  are	  greatly	  enhanced	  with	   increased	  availability	  of	  NLRP3	  and	  pro-­‐IL-­‐1β	  (Latz	  et	  
al.,	  2013;	  Juliana	  et	  al.,	  2012).	  
	  
Signal	  2:	  activation	  
The	  second	  step	  in	  activation	  of	  NLRP3	  inflammasome	  is	  provided	  by	  one	  of	  a	  diverse	  group	  
of	   agonist	   that	   triggers	   the	   specific	   activation	   of	   NLRP3,	   assembly	   of	   the	   inflammasome	  
complex,	  and	  finally	  culminated	  is	  in	  the	  activation	  of	  caspase-­‐1.	  	  
The	   activators	   include	   both	   exogenous	   and	   endogenous	   molecules	   such	   as	   crystalline	  
molecules	   (alum,	   silica,	   asbestos,	   monosodium	   urate)	   that	   require	   phagocytosis	   for	  
activation,	  ATP	  acting	  through	  its	  cell	  surface	  receptor	  P2X7R,	  and	  pore-­‐forming	  toxins	  such	  
as	   nigericin.	   As	   the	   activators	   are	   structurally	   dissimilar	   and	   act	   upon	   the	   cell	   in	   discrete	  
ways,	  it	  has	  been	  suggested	  that	  the	  final	  activation	  signal,	  the	  binding	  of	  a	  ligand	  directly	  to	  
NLRP3,	  must	  occur	  downstream	  from	  these	  unrelated	  upstream	  activators.	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Common	   pathways	   necessary	   for	   NLRP3	   inflammasome	   activation	   include	   cationic	   fluxes	  
both	  to	  and	  from	  extracellular	  spaces,	  a	  well	  as	  from	  within	  the	  cell,	  and,	  additionally,	  the	  
involvement	  of	  discrete	   subcellular	  organelles	   including	   lysosomes,	  mitochondria,	   and	   the	  
endoplasmic	  reticulum	  (Sutterwala	  et	  al.,	  2014).	  
	  
1.4.2 ROS	  
ROS	  are	  free	  reactive	  species	  that	  contain	  the	  oxygen	  atom	  and	  include	  hydrogen	  peroxide	  
(H2O2),	   superoxide	   anion	   (O°2-­‐)	   and	   hydroxyl	   radical	   (OH°).	   These	   molecules	   are	   highly	  
reactive	  due	  to	  the	  presence	  of	  unrepaired	  valence	  shell	  electron.	  ROS	  mainly	  originate	  as	  a	  
by-­‐product	  of	  oxygen	  metabolism	  in	  the	  electron	  transport	  chain	  within	  the	  mitochondria.	  
ROS	  are	  also	  generated	  by	  the	  activity	  of	  cellular	  enzymes	  such	  as	  NADPH	  oxidases,	  xanthine	  
oxidoreductases,	  lypooxigenases	  and	  cyclooxygenase	  (Fig.	  8).	  
Cellular	   production	   of	   ROS	   regulates	   several	   important	   physiological	   responses,	   such	   as	  
oxygen	   sensing,	   angiogenesis,	   control	   of	   vascular	   tone,	   and	   regulation	   of	   cell	   growth,	  
differentiation	   and	   migration.	   While	   ROS	   is	   also	   important	   for	   cell	   signalling	   (redox	  
signalling),	   sustained	   ROS	   production	   can	   cause	   cellular	   damage.	   To	   cope	  wit	   this	   stress,	  
several	   enzyme	   displaying	   anti-­‐oxidant	   activities,	   including	   thioredoxin	   (TRX),	   superoxide	  
dismutase,	   glutathione	   peroxidase	   and	   catalase,	   are	   involved	   in	   neutralizing	   ROS.	   The	  
imbalance	  between	  the	  formation	  of	  ROS	  and	  the	  ability	  to	  detoxify	  these	  oxiding	  radicals	  
can	  produce	  a	  cellular	  state	  known	  as	  oxidative	  stress.	  ROS-­‐mediated	  oxidative	  stress	  plays	  
an	   important	   role	   in	   pathological	   processes	   such	   as	   aging,	   hypertension,	   atherosclerosis,	  
cancer,	  ischemia,	  neurodegenerative	  disease	  and	  diabetes.	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Fig.8	  –	  different	  cellular	  font	  of	  ROS	  
	  
Production	  of	  reactive	  ROS	  is	  crucial	  to	  the	  regulation	  of	  innate	  immune	  responses.	  Beyond	  
its	   antiseptic	   function,	   release	   of	   ROS	   by	   damaged	   tissues	   can	   form	   a	   decreasing	  
concentration	   gradient	   that	   directs	   leukocytes	   recruitment	   at	   the	   site	   of	   tissue	   injury,	  
demonstrating	  that	  ROS	  can	  orchestrate	  inflammatory	  responses	  in	  tissues.	  
Redox	  signalling	  is	  also	  important	  in	  the	  signal	  pathways	  engaged	  by	  various	  inflammatory	  
conditions.	   ROS	   production	   by	   the	   PRR,	   TLR,	   regulates	   activation	   of	   redox-­‐regulated	  
transcription	   factor	   (NF-­‐kB	   and	   AP-­‐1)	   and	   cytokines	   production.	   Recently,	   ROS	   has	   been	  
proposed	   to	   play	   an	   important	   role	   in	   the	   activation	   of	   the	  NLRP3/NALP3	   inflammasome	  
(Martinon	  2010).	  
ROS	  NADPH	  oxidase	  
Mitochondria	  Xanthine	  oxidase	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Evidence	   indicates	   that	   allergic	   and	   inflammatory	   skin	  diseases	  are	  mediated	  by	  oxidative	  
stress	   (Okayama,	  2005;	  Byamba	  et	  al.,	  2010;	  Corsini	  et	  al.,	  2013).	  Proteomic	  and	  genomic	  
analyses	   of	   human	   keratinocytes	   as	   well	   as	   of	   dendritic	   cells	   revealed	   large	   numbers	   of	  
clearly	   sensitiser-­‐specific	   markers,	   with	   several	   interesting	   overlaps.	   Particularly,	   markers	  
relating	   to	   the	   Nrf2-­‐mediated	   oxidative	   response	   and	   oxidative	   stress	   in	   general	   were	  
identified	   repeatedly,	   very	  much	   in	   line	  with	   the	   prominent	   position	   that	   oxidative	   stress	  
holds	  in	  chemical	  sensitisation	  (Ryan	  et	  al.,	  2004;	  Ade	  et	  al.,	  2009;	  Hooyberghs	  et	  al.,	  2008;	  
Johansson	  et	  al.,	  2011;	  Van	  der	  Veen	  et	  al.,	  2013).	  	  
Electrophilicity	   is	   one	   of	   the	   most	   common	   features	   of	   skin	   contact	   sensitisers	   and	   it	   is	  
necessary	   for	   protein	   haptenation.	   The	   Keap1	   [Kelch-­‐like	   ECH-­‐associated	   protein	   1]/Nrf2-­‐
signaling	  pathway	  is	  dedicated	  to	  the	  detection	  of	  electrophilic	  stress	  in	  cells	  leading	  to	  the	  
upregulation	  of	  genes	  involved	  in	  protection	  or	  neutralization	  of	  chemical	  reactive	  species.	  
Several	   Authors	   have	   proposed	   that	   monitoring	   of	   this	   pathway	   may	   provide	   new	  
biomarkers	  (e.g.,	  Nrf2,	  hmox1)	  for	  the	  detection	  of	  the	  sensitisation	  potential	  of	  chemicals	  
both	  in	  KC	  and	  DC	  (Natsch	  and	  Emter,	  2007	  and	  Ade	  et	  al.,	  2009).	  A	  significant	  inhibition	  of	  
the	  expression	  of	  oxidative	  stress	  associated	  genes	  and	  CD86	  expression	  was	  observed	  by	  
preincubated	  with	  N-­‐acetyl	   cysteine,	   a	   glutathione	   precursor	   used	   to	   reinforce	   the	   redox	  
potential	   of	   cells,	   further	   supporting	   the	   role	   of	   oxidative/electrophilic	   stress	   in	   chemical	  
allergen-­‐induced	  DC	  activation.	  Mizuashi	  et	  al.	  (2005)	  showed	  in	  human	  monocyte-­‐derived	  
dendritic	  cells	  that	  chemical	  sensitisers	  induced	  oxidative	  stress	  measuring	  the	  glutathione	  
GSH/GSSG	   ratio,	   as	   a	   redox	   marker.	   These	   authors	   also	   showed	   that	   reduction	   of	   the	  
glutathione	   GSH/GSSG	   ratio	   was	   accompanied	   by	   CD86	   upregulation	   and	   p38	   mitogen-­‐
activated	  protein	  kinase	  (p38	  MAPK)	  activation,	  suggesting	  that	  the	  electrophilic	  properties	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of	  chemical	  sensitisers	  may	  be	  perceived	  by	  DCs	  as	  a	  danger	  signal	  leading	  to	  DC	  maturation	  
(Sasaki	  and	  Aiba,	  2007).	  
	  
1.4.3 NLRP3	  and	  ROS	  
Most	   identified	   NLRP3	   activators	   also	   trigger	   ROS	   production.	   Moreover,	   the	   use	   of	  
antioxidants	   has	   been	   shown	   to	   inhibit	   NLRP3	   inflammasome	   activation,	   suggesting	   that	  
redox	  signalling	  or	  oxidative	  stress	  is	  involved	  in	  NLRP3	  activation.	  
Extracellular	  ATP	   is	  an	   inflammatory	  signal	  that	  has	  been	   implicated	   in	   innate	   immunity	   in	  
both	   plants	   and	   animals.	   In	   mammals,	   extracellular	   ATP	   binds	   to	   P2X7	   receptors	   and	  
activates	  the	  NLRP3	  inflammasome.	  Treatment	  of	  macrophages	  with	  ATP	  results	  in	  the	  rapid	  
production	   of	   ROS	   and	   the	   use	   of	   the	   broad	   spectrum	   NADPH	   oxidase	   inhibitor,	  
diphenyleneiodonium	   (DPI)	   inhibits	   ATP-­‐mediated	   caspase-­‐1	   activation.	   The	   NLRP3	  
activating	   particulate	   elements	   uric	   acid	   crystals,	   alum	   and	   particulate	  metals	   have	   been	  
shown	   to	   induce	   ROS	   production.	   Similarly,	   ROS	   is	   detectable	   quickly	   upon	   exposure	   of	  
macrophages	   to	  silica	  or	  asbestos.	  Other	  NLRP3	  activators,	   such	  as	   the	   toxin	  nigericin,	  UV	  
light	   and	   skin	   sensitisers	   activate	   a	   cellular	   redox	   imbalance	   required	   for	   inflammasome	  
formation.	   ROS	   has	   also	   been	   implicated	   in	   NLRP3	   activation	   by	   the	   malaria	   pathogenic	  
crystal,	  hemozoin,	  the	  influenza	  virus	  and	  yeast	  Candida	  albicans.	  
Various	   pathways	   have	   been	   proposed	   to	   mediate	   ROS	   production	   by	   NLRP3	   activators.	  
Potassium	  efflux	   and	  decrease	   in	   cytosolic	   potassium	   concentration	   are	   the	  most	   sticking	  
features	  associated	  with	  NLRP3	  activators.	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Some	   NLRP3	   activators	   such	   as	   uric	   acid	   crystals,	   alum,	   asbestos	   and	   silica	   are	   large	  
particulate	   elements	   that	   can	   induce	   the	   so-­‐called	   frustrated	   phagocytosis	   at	   the	   cell	  
surface.	   Evidence	   has	   also	   demonstrated	   that	   uric	   acid	   crystals	   can	   be	   phagocytosed.	  
Ultrastructure	   studies	   of	   uric	   acid	   crystals-­‐containing	   phagolysosomes	   show	   a	   disrupted	  
membrane	  and	  possibly	  release	  of	  part	  of	  their	  content	  in	  the	  cytoplasm.	  In	  line	  with	  these	  
observations,	   silica	   crystals	   and	   alum	   trigger	   damage	   and	   rupture	   of	   the	   lysosome.	  
Importantly,	   the	   release	   of	   cathepsin	   B	   by	   damaged	   lysosomes	   has	   been	   proposed	   to	  
mediate	  inflammasome	  activation.	  It	  is	  also	  possible	  that	  lysosomal	  damage	  and	  cathepsin	  B	  
release	   act	   upstream	   of	   ROS	   production.	   In	   line	   with	   this	   model,	   cathepsin	   B	   has	   been	  
shown	  to	  promote	  ROS	  production,	  in	  hepatocytes	  and	  neurons.	  
The	   observation	   that	   NOX	   inhibitors	   such	   as	   DPI	   inhibits	   inflammasome	   activation	   by	  
virtually	   all	   NLRP3	   activators	   identified	   so	   far	   suggests	   that	   NOX	   are	   involved	   in	   ROS	  
production	   Indeed,	   DPI	   inhibits	   caspase-­‐1	   mediated	   IL-­‐18	   activation	   in	   mice	   undergoing	  
physical	   stress.	  NOX	   inhibitors	  may	  have	  additional	   targets.	  DPI	  can	  exert	   inhibitory	  effect	  
on	  mitochondrial	  ROS	  production	   in	  addition	  to	  NOX.	  However,	   in	   line	  with	  the	  possibility	  
that	   NOX	   are	   involved	   in	   inflammasome	   activation,	   extracellular	   ATP	   has	   been	   shown	   to	  
trigger	   translocation	  of	   cytosolic	  NOX	   components	  onto	  membrane-­‐bound	  NOX2,	   forming	  
an	   active	   macromolecular	   complex.	   Indeed,	   NOX2	   deficiency	   impairs	   ATP-­‐mediated	   ROS	  
production	  by	  macrophages,	  suggesting	  that	  NOX2	  may	  be	  involved	  in	  ATP-­‐mediated	  NLRP3	  
activation.	  On	  the	  contrary,	  NOX2-­‐deficient	  macrophages	  have	  no	  defect	  in	  inflammasome	  
activation	  upon	  stimulation	  with	  other	  NLRP3	  agonists	  including,	  uric	  acid	  crystals	  and	  silica	  
while	   knockdown	   of	   p22phox,	   in	   the	   monocytic	   cell	   line	   THP-­‐1	   impairs	   inflammasome	  
activation	  by	   hemozoin,	   silica,	   uric	   acid	   crystal	   and	   asbestos.	   Because	  p22phox	  deficiency	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affects	   several	   NOX,	   it	   is	   possible	   that	   multiple	   NOX	   mediate	   ROS	   production	   to	   trigger	  
NLRP3	  inflammasome	  assembly	  (Fig.	  9).	  
	  
ROS	  production	  by	  H2O2	   activates	   the	   inflammasome;	   furthermore,	   knockdown	  of	   TRX,	   a	  
cellular	   antioxidant	   protein,	   enhances	   IL-­‐1beta	   activation	   by	   silica,	   uric	   acid	   crystals	   and	  
asbestos.	   These	   findings	   suggest	   that	  oxidative	   stress	   could	  be	   sufficient	   to	   trigger	  NLRP3	  
activation.	  	  ROS	  may	  either	  directly	  trigger	  inflammasome	  assembly	  or	  be	  indirectly	  sensed	  
through	   cytoplasmic	   proteins	   that	   modulate	   inflammasome	   activity.	   ATP-­‐mediated	   ROS	  
production	  has	  been	  shown	  to	  stimulate	  the	  PI3K	  pathway,	  and	  pharmacological	  inhibition	  
of	  PI3K	  inhibits	  ATP-­‐mediated	  caspase-­‐1	  activation	  suggesting	  that	  PI3K	  may	  be	  involved	  in	  
inflammasome	  activation	  downstream	  of	  ROS.	  
Recently	   Tshopp	   et	   al.	   (2010)	   identified	   TXNIP/VDUP1	   as	   an	   essential	   protein	   that	   may	  
directly	   activate	   NLRP3	   upon	   oxidative	   stress.	   The	   authors	   suggest,	   in	   resting	   cells,	  
TXNIP/VDUP1	  interacts	  with	  TRX	  and	  is	  therefore	  unable	  to	  activate	  NLRP3.	  Upon	  oxidative	  
stress	  TXNIP/VDUP1	  is	  released	  from	  oxidised	  TRX	  and	  in	  turn	  directly	  binds	  the	  leucine-­‐rich	  
region	   of	   NLRP3	   leading	   to	   inflammasome	   assembly.	   Consistent	   with	   this	   findings,	  
TXNIP/VDUP1-­‐deficient	   macrophages	   treated	   with	   extracellular	   ATP	   or	   uric	   acid	   crystals	  
have	   decreased	   caspase-­‐1	   and	   IL-­‐1beta	   processing.	   This	   finding	   provides	   support	   for	   a	  
model	  in	  which	  TXNIP/VDUP1	  and	  NLRP3	  set	  up	  a	  surveillance	  of	  cellular	  stress,	  preparing	  to	  
drive	  inflammation	  in	  case	  of	  excessive	  stress	  or	  danger	  signals.	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In	  1997,	  a	  human	  homologue	  of	  the	  Drosophila	  Toll	  protein	  was	  described,	  a	  protein	  later	  to	  
be	   designated	   TLR4	   (Fig.	   10).	   Since	   that	   time,	   additional	   human	   and	  murine	   TLR	   proteins	  
have	  been	   identified.	  Mammalian	  TLR	  proteins	  appear	   to	   represent	  a	   conserved	   family	  of	  
innate	  immune	  recognition	  receptors.	  These	  receptors	  are	  coupled	  to	  a	  signalling	  pathway	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that	  is	  conserved	  in	  mammals,	   insects,	  and	  plants,	  resulting	  in	  the	  activation	  of	  genes	  that	  
mediate	  innate	  immune	  defences.	  	  
	  
The	  activation	  of	  specialized	  receptors	  for	  pathogen-­‐associated	  structures	  on	  sentinel	  cells	  
is	  translated	  into	  the	  production	  and	  release	  of	  endogenous	  alarm	  mediators.	  IL-­‐1β,	  TNF-­‐α,	  
IL-­‐12	   and	   IL-­‐18	   are	   rapidly	   released	   by	   these	   cells	   as	   first	   line	   defence.	   Interestingly,	   the	  
receptors	   recognizing	   many	   pathogen-­‐associated	   structure,	   the	   human	   TLRs,	   ands	   the	  
receptors	   for	   the	   endogenous	   pro-­‐inflammatory	   cytokines	   IL-­‐1	   and	   IL-­‐18,	   share	   a	  
cytoplasmic	   motif,	   the	   Toll/IL-­‐1	   receptor	   (TIR)	   domain,	   which	   is	   required	   for	   initiating	  
intracellular	   signalling	   (Martin	   and	   Wesche,	   2002).	   Thus,	   these	   receptors	   are	   not	   only	  
grouped	   into	   one	   family	   because	   of	   the	   sharing	   of	   TIR	   domains	   and	   utilization	   of	   the	  
MyD88/IRAK	  module	   but	   also	   functionally,	   as	   they	   include	   pivotal	   alarm	   receptors	   of	   the	  
innate	   immune	  system.	   It	  needs	  to	  be	  stressed,	  however,	   that	  both	   IL-­‐1	  and	   IL-­‐18	  are	  not	  
just	  mediators	  of	  the	  innate	  immune	  response.	  Both	  cytokines	  are	  centrally	  involved	  in	  the	  
development,	   proliferation	   and	   differentiation	   of	   T	   helper	   cells	   and	   B	   cells.	   Thus,	   they	  
represent	  key	  elements	  at	  the	  interface	  of	  innate	  and	  adaptative	  immune	  responses	  (Martin	  
and	  Wesche,	  2002).	  	  
TLR4	   specifically	   recognizes	   bacterial	   lipopolysaccharide,	   along	   with	   several	   other	  
components	  of	  pathogens	  and	  endogenous	  molecules	  produced	  during	  abnormal	  situations,	  
such	  as	  tissue	  damage.	  Medzhitov	  et	  al.	  (1997)	  showed	  that	  activation	  of	  a	  human	  TLR	  leads	  
to	  activation	  of	  transcription	  factor	  NF-­‐kB	  and	  elements	  of	  innate	  immune	  responses.	  TLR2	  
and	   TLR4	   signalling	   appear	   to	   require	   the	   adapter	   protein	   MyD88,	   the	   kinase	   IRAK,	   and	  
TRAF6.	  MyD88	   is	   a	   35-­‐kDa	   protein	   that	   contains	   three	   functional	   domains.	   It	   contains	   an	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amino-­‐terminal	  death	  domain,	  an	  intermediate	  domain,	  and	  a	  carboxy-­‐terminal	  TIR	  domain,	  
thus	  making	  MyD88	  a	  member	  of	  the	  TLR	  family.	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  
Fig.	  10	  –	  TLR4	  and	  signal	  transduction	  pathways	  [9]	  
	  
Using	   2-­‐hybrid	   analysis,	   MyD88	   was	   shown	   to	   directly	   interact	   with	   TLR4.	   These	   data	  
suggest	   that	  MyD88	   and	   IRAK	   are	   part	   of	   the	   TLR4	   signalling	   complex.	   IRAK	   contains	   an	  
amino-­‐terminal	  death	  domain	  that	  interacts	  with	  MyD88	  (Means	  et	  al.,	  2000).	  
	  
The	   observation	   that	   TLR4-­‐deficient	   cells	   lose	   all	   the	   canonical	   responses	   to	   LPS,	   such	   as	  
expression	   of	   proinflammatory	   cytokines	   and	   IFNs,	   has	   established	   the	   dogma	   that	   TLR4	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accounts	   exclusively	   for	   all	   the	   host	   responses	   to	   LPS.	   Strikingly,	   recent	   studies	   have	  
revealed	  the	  existence	  of	  host	  responses	  to	  LPS	  that	  do	  not	  require	  TLR4	  (Tan	  and	  Kagan,	  
2014)	  
In	   addition	   to	   the	  NLR,	   other	   PAMPs/DAMPs	   receptors	   exist,	   including	   TLRs,	   c-­‐type	   lectin	  
receptors,	   prostanoid	   receptors	   and	   neuropeptide	   receptors	   (Trinchieri	   and	   Sher,	   2007),	  
that	  permit	   recognition	  of	  PAMPs	   that	  derived	   from	  bacteria,	   fungi	  and	  viruses.	  However,	  
these	  TLRs	  are	  equally	  well	  equipped	  to	  recognize	  and	  respond	  to	  DAMPs	  that	  derive	  from	  
the	   traumatic	   changes	   that	   may	   be	   associated	   with	   topical	   exposure	   to	   skin-­‐sensitizing	  
chemicals.	  Among	  the	  endogenous	  TLR	  ligands	  that	  may	  be	  elaborated	  in	  response	  to	  cell	  or	  
tissue	  damage	  are	  fibronectin,	  hyaluronan,	  cathelicidin	  and	  heparin	  sulphate	  (McFadden	  et	  
al.,	  2013).	  
Ligand	   activation	   of	   TLR4	   and	   TLR2	   leads	   to	   increased	   expression	   of	   a	   variety	   of	  
proinflammatory	  cytokines,	  including	  IL-­‐1,	  TNF-­‐α,	  IL-­‐6,	  IL-­‐12,	  IL-­‐18,	  IL-­‐23	  and	  IFN-­‐γ.	  Similarly,	  
expression	  of	   several	  endogenous	   ligands	  of	  TLR4	  has	  been	   recorded	   following	  cutaneous	  
exposure	   to	   contact	   allergens,	   including	   fibronectin,	   Hsp70,	   hyaluronan	   and	   β-­‐defensin	  
(Esser	  et	  al.,	  2011).	  	  
Martin	  et	  al.	  (2008),	  have	  shown	  experimentally	  that	  activation	  of	  TLR4	  and	  TLR2	  is	  essential	  
for	   skin	  sensitization;	   thus,	   it	  would	  appear	   that	  stimulation	  of	  membrane-­‐expressed	  TLRs	  
via	  the	  elaboration	  of	  endogenous	   ligands	   is	  the	  key	  event	  for	  successful	  danger	  signalling	  
by	  contact	  allergen.	  	  
	  
Oxidative	   stress,	   the	   inflammasome	   and	   TLR4	   activation	   are	   strictly	   cross-­‐linked	   and	   they	  
play	  a	  key	  role	  in	  the	  innate	  immune	  and	  stress	  responses.	  TLR4,	  after	  a	  danger	  signal,	  can	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activate	  NF-­‐κB	  and	  MAPK	  pathways,	  inducing	  the	  release	  of	  inflammatory	  cytokines	  such	  as	  
IL-­‐1β	  and	  IL-­‐18.	  Additionally	  TLR4	  has	  the	  ability	  to	  further	  induce	  ROS,	  which	  play	  a	  triple	  
role:	  (1)	  they	  are	  able	  to	  directly	  stimulate	  inflammatory	  and	  cytotoxic	  responses;	  (2)	  they	  
can	   activate	   the	   NF-­‐κB	   and	   MAPK	   pathways;	   and	   (3)	   they	   can	   interact	   with	   the	  
inflammasome	  leading	  to	  IL-­‐1β	  and	  IL-­‐18	  release	  (Galbiati	  et	  al.,	  2014).	  
	  
1.4.5 HMGB-­‐1	  
HMGB1	  is	  a	  ubiquitously	  expressed,	  highly	  conserved	  nuclear	  protein	  that	  plays	   important	  
roles	   in	  chromatin	  organization	  and	  transcriptional	  regulation	  (Bianchi,	  2009).	  HMGB1	  was	  
identified	  in	  1999	  as	  an	  important	  extracellular	  mediator	  of	  inflammation.	  When	  cells	  die	  in	  
a	   non-­‐programmed	  way	   (necrosis),	   they	   release	   HMGB1	   by	   simple	   diffusion;	   in	   contrast,	  
cells	   that	  die	   in	   a	  programmed	  way	   (apoptosis)	   avidly	   retain	  HMGB1	  bound	   to	   chromatin	  
remnants	   even	   after	   eventual	   cell	   lysis	   (Bianchi	   and	   Manfredi,	   2004).	   This	   different	  
behaviour	  between	  necrotic	  and	  apoptotic	  cells	  makes	  HMGB1	  the	  primary	  signal	  of	  tissue	  
damage;	   extracellular	   HMGB1	   promotes	   local	   and	   systemic	   responses	   in	   the	   organism,	  
including	   inflammation	   and	   the	   activation	   of	   innate	   and	   adaptative	   immunity	   (Lotze	   and	  
Tracey,	  2005).	  	  
	  
Activated	  monocytes,	  macrophages,	   neutrophils,	   platelets,	   and	  dendritic	   and	  NK	   cells	   can	  
also	   release	   HMGB1	   in	   the	   extracellular	   space.	   Extracellular	   HMGB1	   activates	   a	   large	  
number	  of	  different	  physiological	  responses	  in	  different	  cell	  types,	  and	  can	  be	  considered	  a	  
cytokine.	   Its	   beneficial	   roles	   include	   the	   promotion	   of	   tissue	   regeneration,	   by	   attracting	  
stem	  cells	  and	  inducing	  them	  to	  proliferate.	  However,	  HMGB1	  plays	  a	  pathogenetic	  role	  in	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severe	  sepsis	  and	  arthritis,	  and	  may	  play	  	  a	  role	  in	  atherosclerosis	  and	  cancer	  (Mollica	  et	  al.,	  
2007).	  
Several	   receptors	   have	   been	   implicated	   in	   HMGB1-­‐mediated	   functions,	   including	   RAGE	  
(receptor	   for	   advance	   glycation	   end	   products)	   and	   TLR2,	   TLR4	   and	   TLR9	   (Schiraldi	   et	   al.,	  
2012).	   Downstream	   signalling	   is	   not	   completely	   understood,	   but	   involves	   Src,	  MAPK,	   and	  
NF-­‐κB	  activation.	  	  It	  is	  currently	  not	  known	  whether	  all	  receptors	  and	  all	  signalling	  pathways	  
are	  required	  for	  the	  different	  responses	  to	  HMGB1;	  recent	  evidence	  suggest	  that	  TLR4	  but	  
not	  RAGE	   is	  required	  for	  cytokine	  release	  (Yang	  et	  al.,	  2010),	  and	  that	  RAGE	   is	   involved	   in	  
cell	  migration.	  HMGB-­‐1-­‐induced	  cell	  migration	  requires	  activation	  of	  both	  the	  canonical	  and	  
non-­‐canonical	  NF-­‐κB	  pathways,	  which	  lead	  to	  the	  transcription	  of	  the	  Cxcl12	  gene	  (Penzo	  et	  
al.,	  2010).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Fig.	  11	  –	  HMGB1	  and	  signal	  transduction	  pathways	  [10]	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1.5 	  Cosmetics	  tests	  and	  Europe	  
	  
In	  addition	  to	  be	  able	  to	  determine	  whether	  or	  not	  a	  chemical	  is	  a	  sensitiser	  (labelling),	  it	  is	  
also	  equally	   important	   to	  determine	   the	  potency	  of	  a	   sensitiser	   (classification)	   in	  order	   to	  
identify	  a	  maximum	  safe	  concentration	  for	  human	  exposure	  (risk	  assessment).	  	  
	  
The	   assessment	   of	   the	   skin	   sensitisation	   potential	   of	   chemicals	   represents	   an	   important	  
component	   of	   the	   safety	   assessment,	   relevant	   in	   the	   context	   of	   several	   EU	   regulations	  
aiming	   at	   the	   protection	   of	   human	   health.	   Predictive	   testing	   to	   identify	   and	   characterize	  
substances	  causing	  skin	  sensitization	  historically	  has	  been	  based	  on	  animal	   tests.	  Officially	  
accepted	   animal	   test	   methods	   for	   skin	   sensitization	   potential	   assessment	   include	   the	  
Buehler	   occluded	   patch	   test	   in	   the	   Guinea	   pig,	   the	   Guinea	   Pig	   Maximization	   Test	   by	  
Magnusson	  &	  Kligman	  (GPMT)	  and	  the	  Mouse	  Local	  Lymph	  Node	  Assay	  (LLNA)	  with	  its	  non-­‐
radioactive	  modifications	  (LLNA-­‐DA	  and	  the	  LLNA-­‐BrdU	  Elisa).	  	  The	  OECD	  Test	  Guideline	  (TG)	  
regulates	  all	  of	  these	  in	  vivo	  methods:	  TG406	  for	  the	  GPMT	  and	  Buehler	  test;	  TG429	  for	  the	  
LLNA;	  TG442A	  and	  442B	  for	  the	  LLNA-­‐DA	  and	  the	  LLNA-­‐BrdU	  Elisa	  respectively.	  Whereas	  the	  
mouse	  LLNA	  measures	  the	  response	  provoked	  during	  the	  induction	  of	  sensitization,	  the	  two	  
Guinea	   pig	   test	   measure	   challenge	   induced	   elicitation	   reactions	   in	   previously	   sensitised	  
animals.	   The	   LLNA	   is	   considered	   a	   reduction	   and	   refinement	   method	   compared	   to	   the	  
traditional	  Guinea	  pig	  tests.	  	  
	  
There	  has	  been	  a	  continuous	  effort	  to	  find	  alternative	  approaches,	  which	  avoid	  testing	  on	  
animals	   wherever	   possible.	   Whenever	   replacement	   is	   not	   possible,	   the	   development	   of	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methods	  that	  use	  fewer	  animals	  or	  cause	  least	  harm	  to	  the	  animals	  is	  supported.	  The	  ‘Three	  
Rs	  Principle’	  (replacement,	  reduction	  and	  refinement	  of	  animal	  use)	  is	  present	  in	  all	  relevant	  
EU	   legislations.	   In	   early	   2003,	   the	   7th	   amendment	   to	   the	   European	   Union’s	   Cosmetics	  
Directive	  (76/768/EEC)	  was	  adopted,	  and	  according	  to	  it	  an	  immediate	  end	  to	  animal	  testing	  
in	  the	  EU	  for	  cosmetic	  products	  and	  a	  complete	  ban	  of	  animal	  testing	  for	  ingredients	  by	  11	  
March	   2009.	   The	   animal	   testing	   ban	   was	   reinforced	   by	   a	   marketing	   ban	   on	   all	   cosmetic	  
ingredients	   or	   products	   tested	   for	   the	   purposes	   of	   the	  Directive	   outside	   the	   EU	   after	   the	  
same	  date.	  Since	  11	  July	  2013	  the	  new	  EU	  Regulation	  1223/2009	  (Cosmetics	  Regulation)	  is	  
in	   force,	   which	   prohibits	   the	   marketing	   of	   cosmetic	   products,	   the	   final	   formulation,	  
ingredients	   or	   combinations	   of	   ingredients,	  which	   have	   been	   tested	   on	   animals,	   and	   also	  
prohibit	  each	  test	  currently,	  carried	  out	  using	  animals.	  	  
Starting	  from	  the	   in	  vivo	  observation	  that	   in	  mouse	  IL-­‐1α	  expression	  by	  KC	  was	  selectively	  
increased	  after	   in	   vivo	   application	  of	   contact	   sensitisers	  but	  not	   tolerogen	  or	   irritant	   (Enk	  
and	  Katz,	  1992),	  similar	  results	  were	  reproduced	  in	  vitro	  using	  the	  murine	  KC	  cell	  line	  HEL30	  
(Corsini	   et	   al.,	   1998).	   Same	   results	   were	   also	   obtained	   by	   Van	   Och	   et	   al	   (2005)	   and,	  
furthermore,	   the	  authors	  observed	   that	   the	   ranking	  of	  potency	  was	  similar	   to	   the	   ranking	  
established	   using	   the	   local	   lymph	   node	   assay.	   Similarly,	   using	   human	   KC	   it	   has	   been	  
demonstrated	  that	  allergens	  but	  not	   irritants	   induced	   IL-­‐12	   (Muller	  et	  al.,	  1994;	  Corsini	  et	  
al.,	  1999).	  Trinitrobenzene	  sulphonic	  acid	   induced	  the	  expression	  of	  CD40	  on	  KC,	  whereas	  
SLS	   did	   not	   (Coutant	   et	   al.,	   1999).	   All	   together	   these	   studies	   indicate	   the	   possibility	   to	  
identify	  contact	  sensitiser	  using	  murine	  or	  human	  KC.	  	  
In	   the	   screening	  of	  new	  chemicals	   for	  human	  use,	   it	   should	  be	   very	   important	  both	   from	  
safety	   and	   economic	   point	   of	   view	   to	   have	   biological	  markers	   to	   discriminate	   allergy	   and	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irritation	  events	  that	  have	  different	  impact	  on	  human	  health	  (Corsini	  and	  Roggen,	  2009;	  dos	  
Santos	  et	  al.,	  2009;	  Galbiati	  et	  al.,	  2010).	  	  
	  
On	  the	  other	  side,	  the	  EU	  Regulation	  on	  chemicals	  and	  their	  safe	  use	  –	  REACH	  (Registration,	  
Evaluation,	  Authorization	  and	  Restriction	  of	  Chemicals	  substances)	  –	  which	  came	  into	  force	  
in	  2007,	  gives	  greater	  responsibility	  to	  industry	  to	  manage	  the	  risks	  from	  chemicals	  and	  to	  
provide	  safety	  information	  on	  the	  substances	  to	  allow	  safe	  handling.	  The	  REACH	  Regulation	  
also	  calls	  for	  the	  progressive	  substitution	  of	  the	  most	  dangerous	  chemicals	  where	  possible.	  
Beside	   the	   ethical	   aspects,	   economic	   considerations	   also	   call	   for	   the	   timely	   development	  
and	   validation	   of	   alternative	   approaches	   with	   the	   use	   of	   cells	   or	   tissues	   derived	   where	  
possible	   from	  humans	   that	   are	   cultured	   under	   controlled	   conditions	   in	   the	   laboratory	   (in	  
vitro	  methods).	  These	  can	  be	  used	  together	  with	  computational	  (in	  silico)	  approaches	  in	  an	  
integrated	  approach	  to	  reduce	  the	  in	  vivo	  animal	  tests.	  
	  
With	   respect	   to	   the	   methods	   which	   have	   been	   validated	   at	   EURL	   ECVAM,	   three	   of	   the	  
essential	   steps	   to	   the	   induction	   of	   skin	   sensitization	   are	   represented:	   the	   direct	   peptide	  
reactivity	   assay	   (DPRA)	   for	   covalent	   binding	   to	   protein;	   the	   Keratinosens™	   assay	   for	  
keratinocyte	  inflammatory	  responses;	  and	  the	  human	  THP-­‐1	  cell	  line	  activation	  test	  (h-­‐CLAT)	  
for	  the	  activation	  of	  dendritic	  cells.	  Concerning	  chemical	  reactivity,	   in	  the	  DPRA,	  generally,	  
non-­‐allergens	  and	  weak	  allergens	  demonstrated	  minimal	  to	  low	  peptide	  reactivity,	  whereas	  
moderate	   to	   extremely	   potent	   allergens	   displayed	   moderate	   to	   high	   peptide	   reactivity.	  
Classifying	  minimal	   to	   low	   reactivity	   as	  non-­‐sensitisers	   and	  moderate	   to	  high	   reactivity	   as	  
sensitisers,	  a	  prediction	  accuracy	  of	  89%	  was	  reported.	  The	  KeratinoSens	  ™	  assay	   is	  based	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on	  a	  luciferase	  reporter	  gene	  under	  the	  control	  of	  an	  anti-­‐oxidant	  response	  element	  of	  the	  
human	   AKR1C2	   gene	   stably	   inserted	   into	   HaCaT	   keratinocytes,	   while	   the	   h-­‐CLAT	   address	  
CD86	  and	  CD54	  upregulation	  in	  THP-­‐1	  cells.	  
As	   emerged	   from	   the	   “January	   2014	   Status	   Report	   for	   ICCR”	   for	   allergic	   contact	  
dermatitis/skin	   sensitization	   validation	   studies	   for	   four	   in	   vitro	   test	   methods	   have	   been	  
finalized.	  The	  ESAC	  peer	  review	  of	  the	  DPRA	  and	  the	  KeratinoSens™	  methods	  were	  finalized	  
and	   a	   EURL	   ECVAM	  Recommendation	   on	   the	  DPRA	   and	   KeratinoSens	  ™	  was	   published	   in	  
2013	  and	  in	  February	  2014,	  respectively.	  The	  ESAC	  peer	  review	  of	  h-­‐CLAT	  is	  on	  going.	  
	  
A	   number	   of	   assays	   for	   the	   in	   vitro	   identification	   of	   contact	   and	   respiratory	   sensitization	  
have	  been	  developed	  within	  the	  integrated	  European	  Framework	  Program	  6	  Project	  SENS-­‐
IT-­‐IV	  .	  	  
The	  aim	  of	  the	  SENS-­‐IT-­‐IV	  EU	  Frame	  Programme	  6	  funded	  integrated	  Project	  (LSHB-­‐CT-­‐2005-­‐
018681)	  was	   to	   develop	   and	  optimize	   an	   integrated	   testing	   strategy	   consisting	   of	   in	   vitro	  
human	  cell	  based	  assays,	  which	  will	  closely	  mimic	  sensitization	  mechanisms	   in	  vivo.	  These	  
assays	   should	   provide	   an	   alternative	   approach	   to	   the	   LLNA.	   In	   vitro	   assays	   for	   risk	  
assessment	   of	   potentially	   sensitizing	   substances	   can,	   once	   formally	   validated	   and	  
implemented	   into	   European	   regulations,	   replace	   the	   LLNA	   (Kimber	   et	   al.,	   1990,	   1991).	   In	  
principle,	  a	  test	  system	  comprised	  of	  KC	  alone	  may	  not	  be	  useful	   in	  establishing	  allergenic	  
potency	   as	   these	   cells	   lack	   antigen-­‐presenting	   capacity.	   However,	   in	   addition	   to	   chemical	  
processing	   LC	   activation	   requires	   the	   binding	   of	   cytokines	   produced	   by	   KC	   as	   a	   result	   of	  
initial	  chemical	  exposure.	  The	  irritant	  capacity	  of	  allergens	  might	  present	  an	  additional	  risk	  
factor	  so	  that	  irritant	  allergens	  may	  be	  stronger	  allergens	  than	  non-­‐irritant	  ones	  (Grabbe	  et	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al.,	  1996).	  In	  that	  case,	  the	  potency	  of	  chemicals	  to	  induce	  cutaneous	  sensitization	  may	  be	  
assessed	  as	  a	  function	  of	  KC	  cytokine	  expression.	  
	  
Given	   the	   complexity	   of	   the	   biological	   mechanisms	   underlying	   the	   acquisition	   of	   skin	  
sensitization	  it	  is	  proposed	  that,	  in	  the	  near	  future,	  no	  single	  non-­‐animal	  test	  method	  will	  be	  
able	   to	   replace	   the	   currently	   used	   regulatory	   animal	   tests,	   instead	   a	   combination	   of	  
methods	  addressing	  key	  mechanisms	  of	  the	  sensitization	  adverse	  outcome	  pathway	  (AOP)	  
will	  be	  needed	  to	  achieve	  full	  replacement.	  
	  
It	   is	  already	  recognised	  that	   information	  produced	  from	  non-­‐animal	  assays	  can	  be	  used	   in	  
regulatory	  decision-­‐making,	  notably	   in	   term	  of	   classifying	  a	   substance	  as	  a	   skin	   sensitiser.	  
The	  evolution	  into	  a	  full	  replacement	  for	  hazard	  identification,	  where	  the	  decision	  is	  not	  to	  
classify,	   requires	   the	   generation	  of	   confidence	   in	   the	   in	   vitro	   alternative,	   the	  existence	  of	  
peer	  reviewed	  publications	  and	  the	  knowledge	  that	  the	  assays	  are	  founded	  on	  key	  elements	  
of	   the	  AOP	   for	   skin	   sensitization.	  At	   this	  moment	   it	   is	  highly	  unlikely	   that	  a	   single	   in	   vitro	  
alternative	  method	  would	   completely	   replace	   the	   current	   animal	   tests.	   A	   combination	   of	  
information	  from	  in	  vitro	  methods	  are	  likely	  to	  be	  necessary	  for	  confident	  replacement	  of	  in	  
vivo	   assays	   for	   the	   identification	   of	   the	   presence	   or	   absence	   of	   skin	   sensitization	   hazard.	  
Furthermore,	  it	  was	  noted	  that	  even	  the	  output	  from	  an	  Integrated	  Testing	  Strategies	  (ITS)	  
would	  best	  be	  placed	  within	  a	  weight	  of	  evidence	  argument	  concerning	  classification.	  
	  
Promising	  progress	  has	  been	  made	  in	  advancing	  alternative	  methods	  to	  animal	  testing	  over	  
the	   last	   years,	   but	   full	   replacement	   is	   not	   yet	   possible.	   The	   European	   Commission	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nevertheless	   believes	   that	   the	  most	   appropriate	  way	   forward	   is	   to	   let	   the	  marketing	   ban	  
enter	  into	  force,	  in	  particular	  by	  ensuring	  a	  coherent	  implementation	  of	  the	  marketing	  ban	  
and	   monitoring	   its	   impacts;	   by	   continuing	   the	   support	   for	   research,	   development	   and	  
validation	  of	  new	  alternative	  methods	  for	  human	  safety	  testing;	  and	  by	  making	  alternative	  
methods	  an	  integral	  part	  of	  the	  Union's	  trade	  agenda	  and	  international	  cooperation.	  
	  
In	  conclusion,	  the	  most	  positive	  view	  of	  timing	  for	  the	  full	  replacement	  of	  animal	  methods	  is	  
another	   7–9	   years	   (2017–2019),	   but	   alternative	   methods	   able	   to	   discriminate	   between	  
sensitisers	   and	   non-­‐sensitisers	   are	   already	   available.	   Therefore,	   it	   is	   clear	   that	   at	   the	  
moment	   the	  more	   realistic	  way	   forward	   to	   fully	   replace	   animal	   testing	   seems	   to	   have	   as	  
more	   as	   possible	   validated	   alternative	   methods	   (in	   vitro,	   in	   silico)	   covering	   the	   different	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Aims	  of	  the	  thesis	  
The	  aims	  of	  this	  thesis	  were:	  
1. To	  develop	  an	  in	  vitro	  test	  based	  on	  the	  use	  of	  keratinocytes	  and	  IL-­‐18	  production	  to	  
identify	  and	  discriminate	  contact	  allergens	  from	  irritants	  and	  respiratory	  allergens;	  
2. To	   develop	   an	   in	   vitro	   test	   to	   discriminate	   photoallergens	   from	   phototoxic	  
compounds;	  
3. To	   develop	   a	   single	   in	   vitro	   test	   for	   identification	   and	   ranking	   potency	   of	   skin	  
sensitizing	   chemicals,	   including	   chemicals	  with	   low	  water	   solubility	   and	   stability	   in	  
water;	  
4. To	   characterize	   the	   molecular	   mechanisms	   underlying	   allergen-­‐induced	   IL-­‐18	  
production	   in	   keratinocytes,	   to	   identify	   the	   cellular	   sources	   of	   reactive	   oxygen	  











	   64	  
Chapter	  2	  
MATERIALS	  AND	  METHODS	  
	  
2.1	  CHEMICALS	  	  
As	  respiratory	  allergens	   the	  following	  chemicals	  were	  used	  diphenylmethane	  diisocyanate	  
(MDI);	   trimellitic	   anhydride	   (TMA);	   ammonium	   hexachloroplatinate	   (HClPt).	   As	   skin	  
sensitisers	   2,4-­‐dinitrochlorobenzene	   (DNCB),	   4-­‐bromobenzylbromide,	   2-­‐
mercaptobenzothiazole,	  cinnamaldehyde,	  cinnamyl	  alcohol,	  eugenol,	  isoeugenol,	  resorcinol,	  
tetramethylthiuram	  disulfite	  (TMTD),	  ρ-­‐phenylenediamine	  (PPD),	  oxazolone,	  formaldehyde,	  
phenyl	  acetaldehyde,	  α-­‐hexylcinnamaldehyde,	  benzocaine,	  citral,	  cobalt	  (II)	  chloride,	  4-­‐nitro	  
benzylbromide,	   glyoxal;	   as	   irritants	   sodium	   lauryl	   sulphate	   (SLS),	   salicylic	   acid,	   lactic	   acid,	  
octanoic	  acid,	  methyl	  salicylate,	  tween	  20,	  chlorobenzene,	  hydroxybenzoic	  acid,	  and	  phenol	  
were	  used.	  Glycerol	  was	  used	  as	  negative	  compound.	  	  
	  As	   photoallergens	   2-­‐ethylhexyl-­‐4-­‐methoxicinnamate,	   6-­‐methylcoumarin,	   avobenzone,	  
benzophenone,	   ketoprofen	   were	   used;	   as	   photoallergens/photoirritants	   4-­‐aminobenzoic	  
acid	   (PABA),	   chlorpromazine	   and	   promethazine	   were	   used;	   as	   photoirritants	   8-­‐
methoxypsoralen,	  acridine,	  ibuprofen,	  retinoic	  acid	  were	  used.	  	  
The	  choice	  of	   chemicals	  was	  dictated	  by	   the	  SENS-­‐IT-­‐IV	  program	   (Newsletter	  number	  02–
2007,	   January,	   26.	   http://www.sens-­‐it-­‐iv.eu/files/newsletter/Sens-­‐it-­‐
iv_Newsletter_08.html).	   Chemicals	   have	   been	   selected	   by	   relevant	   and	   representative	   of	  
the	  ‘universe’	  irritants,	  respiratory	  and	  contact	  allergens.	  All	  reagents	  were	  purchased	  from	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Sigma	   (St	   Louis,	  MO,	  USA)	  at	   the	  highest	  purity	   available.	  Anti-­‐TLR4	  antibody,	   allopurinol,	  
rotenone,	   and	   glycirrizic	   acid	   were	   from	   Sigma	   Aldrich,	   whereas	   Z-­‐VAD-­‐FMK	  
(benzyloxycarbonyl-­‐Val-­‐Ala-­‐Asp	   (OMe)-­‐fluoromethylketone)	   and	   DPI	   were	   obtained	   from	  
Tocris	   (St	   Louis,	   MO).	   MDI,	   TMA,	   DNCB,	   cinnamaldehyde,	   cinnamic	   alcohol,	   resorcinol,	  
TMTD,	   PPD,	   salicylic	   acid,	   lactic	   acid	   and	   phenol	   were	   dissolved	   in	   DMSO	   (final	  
concentration	  of	  DMSO	  in	  culture	  medium	  0.2%),	  while	  HClPt	  and	  SLS	  were	  dissolved	  in	  PBS.	  
Cell	  culture	  media	  and	  all	  supplements	  were	  from	  Sigma.	  
Maximum	   solubility	  was	   determined	   for	   each	   training	   chemical	   separately	   using	   PBS	   and	  
DMSO	  as	  vehicles	  for	  the	  NCTC2544	  IL-­‐18	  assay	  and	  1%	  DMSO	  and	  acetone:olive	  oil	  (AOO,	  
4:1)	  as	  vehicles	  for	  the	  EE-­‐potency	  assay.	  The	  vehicle	  displaying	  the	  highest	  solubility	  upon	  
visual	  inspection	  was	  selected	  as	  the	  vehicle	  to	  be	  used	  for	  that	  particular	  chemical.	  When	  
the	  solubility	  in	  PBS	  was	  equal	  to	  the	  solubility	  in	  DMSO,	  PBS	  was	  used	  as	  a	  vehicle	  for	  the	  
NCTC2544	   IL-­‐18	  assay.	  For	   the	  EE-­‐potency	  assay,	  1%	  DMSO	  was	  used	  when	  solubility	  was	  
equal	  to	  AOO.	  Maximum	  solubility	  tested	  was	  500	  mg/ml.	  The	  highest	  concentration	  tested	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Table	  3	  –	  Tested	  chemicals	  and	  vehicles	  
Chemical	   Category	   Vehicle	  NCTC	   Vehicle	  epiCS	  	  
2-­‐mercaptobenzothiazole	   Contact	  allergen	   DMSO	   AOO	  
4-­‐bromo	  benzylbromide	   Contact	  allergen	   DMSO	   	  
4-­‐nitro	  benzylbromide	   Contact	  allergen	   DMSO	   	  
Benzocaine	   Contact	  allergen	   DMSO	   AOO	  
Cinnamaldehyde	   Contact	  allergen	   DMSO	   AOO	  
Cinnamic	  alcohol	   Contact	  allergen	   DMSO	   	  
Citral	   Contact	  allergen	   DMSO	   AOO	  
Cobalt	  (II)	  chloride	   Contact	  allergen	   DMSO	   DMSO	  
DNCB	   Contact	  allergen	   DMSO	   AOO	  
Eugenol	   Contact	  allergen	   DMSO	   AOO	  
Eugenol	   Contact	  allergen	   DMSO	   	  
Formaldehyde	   Contact	  allergen	   DMSO	   DMSO	  
Glyoxal	   Contact	  allergen	   PBS	   	  
Glyoxal	   Contact	  allergen	   DMSO	   	  
Isoeugenol	   Contact	  allergen	   DMSO	   AOO	  
Isoeugenol	   Contact	  allergen	   DMSO	   	  
Oxazolone	   Contact	  allergen	   DMSO	   AOO	  
Phenyl	  acetaldehyde	   Contact	  allergen	   DMSO	   AOO	  
PPD	   Contact	  allergen	   DMSO	   AOO	  
Resorcinol	   Contact	  allergen	   DMSO	   	  
TMTD	   Contact	  allergen	   DMSO	   	  
α-­‐hexylcinnamaldehyde	   Contact	  allergen	   DMSO	   AOO	  
	  
2-­‐ethylhexyl-­‐4-­‐methoxicinnamate	   Photoallergens	   	   	  
6-­‐methylcoumarin	   Photoallergens	   DMSO	   	  
Avobenzone	   Photoallergens	   DMSO	   	  
Benzophenone	   Photoallergens	   DMSO	   	  
Ketoprofen	   Photoallergens	   DMSO	   	  
	  
4-­‐aminobenzoic	  acid	   Photoallergens/Photoirritants	   DMSO	   	  
Chlorpromazine	   Photoallergens/Photoirritants	   DMSO	   	  
Promethazine	   Photoallergens/Photoirritants	   DMSO	   	  
	  
HClPt	   Respiratory	  allergens	   PBS	   	  
MDI	   Respiratory	  allergens	   PBS	   	  
TMA	  	   Respiratory	  allergens	   PBS	   	  
	  
Chlorobenzene	   Irritants	   	   AOO	  
Hydroxybenzoic	  acid	   Irritants	   	   AOO	  
Lactic	  acid	   Irritants	   PBS	   AOO	  
Methyl	  salicylate	   Irritants	   	   AOO	  
Octanoic	  acid	   Irritants	   DMSO	   AOO	  
Phenol	   Irritants	   DMSO	   DMSO	  
Salicylic	  acid	   Irritants	   PBS	   AOO	  
SDS	   Irritants	   PBS	   DMSO	  
Tween	  	  20	   Irritants	   	   AOO	  
	  
8-­‐methoxipsoralen	   Photoirritants	   DMSO	   	  
Acridine	   Photoirritants	   DMSO	   	  
Ibuprofen	   Photoirritants	   DMSO	   	  
Retinoic	  acid	   Photoirritants	   DMSO	   	  
	  
Glycerol	   Non-­‐irritant	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2.2	  CELL	  CULTURE	  
2.2.1	  Human	  keratinocyte	  NCTC2544	  cells	  	  
This	  test	  is	  used	  to	  evaluate	  the	  capacity	  of	  a	  compound	  to	  induce	  skin	  sensitization	  in	  vivo.	  
The	   NCTC2544	   IL-­‐18	   assay	   is	   based	   on	   the	   dose-­‐dependent	   specific	   increase	   of	   IL-­‐18	  
production	  by	  these	  cells	  upon	  exposure	  to	  skin-­‐sensitizing	  chemicals.	  The	  production	  of	  IL-­‐
18	  by	  the	  exposed	  cells	  is	  determined	  in	  cell	  lysates	  by	  sandwich	  ELISA,	  and	  is	  corrected	  for	  
total	  protein	  content.	  IL-­‐18	  production	  after	  exposure	  to	  a	  potential	  sensitiser	  is	  compared	  
to	  a	  positive	  control	  (PPD	  60	  μg/ml)	  and	  to	  the	  vehicle	  control.	  The	  performance	  of	  the	  test	  
is	  good	  when	  the	  relative	  IL-­‐18	  production	  of	  the	  positive	  control	  is	  at	  least	  1.5	  times	  higher	  
than	  that	  of	  the	  vehicle	  control.	  
NCTC2544	   cells	   (obtained	   from	   Institute	   Zooprofilattico	   di	   Brescia,	   Brescia,	   Italy)	   were	  
cultured	  in	  96-­‐	  and	  24-­‐well	  plates	  at	  a	  cell	  density	  of	  1.5–2.5	  ×	  105	  cells/ml,	  to	  a	  confluency	  
of	  80%.	  Cells	  were	  cultured	  in	  0.1	  or	  0.5	  ml,	  respectively	  of	  RPMI-­‐1640	  containing	  2	  mM	  l-­‐
glutamine,	   0.1	  mg/mL	   streptomycin,	   100	  IU/mL	   penicillin,	   supplemented	   with	   10%	   heat-­‐
inactivated	  fetal	  calf	  serum	  (culture	  medium)	  and	  cultured	  at	  37	  °C	  in	  5%	  CO2.	  
Primary	  human	  KC	  were	  obtained	  from	  Invitrogen	  (Carlsbad,	  CA,	  USA).	  Cells	  were	  seeded	  at	  
2.5	  ×	  104/ml	   in	   24-­‐well	   plate.	   Cells	  were	   grown	   in	   serum	   free	   supplemented	   keratinocyte	  
growth	  medium	  (Sigma)	  to	  80–90%	  density	  prior	  to	  treatment.	  Cells	  were	  grown	  at	  37	  °C	  in	  
5%	  CO2.	  Second	  and	  third	  passages	  post-­‐cryopreserved	  seedings	  were	  used	  for	  experiments.	  
To	  study	  the	  impact	  of	  cell	  density	  on	  the	  selective	  production	  of	  IL-­‐18	  by	  contact	  allergens,	  
NTCT	  2544	  cells	  were	  seeded	  in	  24-­‐well	  plate	  at	  different	  density	  (1–10	  ×	  105	  cells/ml).	  After	  
overnight	  adherence,	   cells	  were	   treated	   for	  24	  h	  with	  PPD	   (60	  μg/ml)	  or	  DMSO	  as	  vehicle	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control	   or	   after	   2	  h	   of	   adherence,	   cells	   were	   treated	   for	   24	  h	   with	   PPD	   (60	  μg/ml),	  
cinnamaldehyde	  (30	  μg/ml),	  salicylic	  acid	  (500	  μg/ml)	  or	  DMSO	  as	  vehicle	  control.	  
To	   develop	   a	   high	   throughput	   assay,	   NCTC	   2544	  were	   seeded	   at	   the	   cell	   density	   of	   1.5–
2.5	  ×	  105	  cells/ml	   in	   96-­‐well	   plate	   and	   treated	   after	   overnight	   adherence	   for	   24	  h	   with	  
increasing	   concentration	   of	   contact	   sensitisers	   (DNCB,	   PPD,	   isoeugenol,	   cinnamaldehyde,	  
TMTD,	  resorcinol,	  cinnamic	  alcohol	  and	  eugenol),	  respiratory	  allergens	  (hexachloroplatinate,	  
MDI	  and	  TMA)	  and	  irritants	  (phenol,	  SDS,	  lactic	  acid	  and	  salicylic	  acid).	  
For	   experiments	   using	   HPK	   II	   kindly	   provided	   by	   Prof	   Fusening	   (Heidelberg	   University,	  
Germany),	  and	  HaCaT	  cells	  lines	  (ATCC,	  LCG	  Standards,	  Sesto	  San	  Giovanni,	  Italy),	  cells	  were	  
cultured	  in	  24-­‐well	  plate	  at	  a	  cell	  density	  of	  1.5	  ×	  105	  cells/ml.	  NCTC	  2544,	  HPK	  II	  and	  HaCaT	  
cell	  lines	  were	  treated	  for	  24	  h	  with	  PPD	  (60	  μg/ml)	  or	  DMSO	  as	  vehicle	  control.	  
To	   investigate	   the	   signal	   transduction	   pathway	   involved	   in	   PPD-­‐induced	   IL-­‐18	   production,	  
NCTC	  2544	  were	   treated	  with	   several	   inhibitors,	  namely,	   the	  selective	   inhibitor	  of	  protein	  
kinase	   C	   α	   and	   β1	   isoforms	   GF109203X	   (5	  μM),	   the	   inhibitor	   of	   NF-­‐κB	   and	   anti-­‐oxidant	  
pyrrolidine	  dithiocarbamate	   (PDTC	  100	  μM),	   the	   irreversible	   inhibitor	  of	   I-­‐κB	  Bay	  11-­‐70-­‐85	  
(1	  μM),	  and	  the	  inhibitor	  of	  p38	  MAPK	  SB203580	  (100	  nM),	  for	  1	  h,	  and	  then	  PPD	  (60	  μg/ml)	  
or	   DMSO	   as	   vehicle	   control	   were	   added	   for	   24	  h.	   p38	  MAPK	   and	   NF-­‐κB	   activation	   were	  
assessed	  by	  Western	  blot	  analysis	  as	  described	  below.	  
NCTC2544	  cells	  were	  treated	  with	  several	  inhibitors,	  namely	  Z-­‐VAD-­‐FMK	  (10	  μM),	  anti-­‐TLR4	  
antibody	   (1	   μg/well),	   glycirrizic	   acid	   (100	   μM),	   DPI	   (0.5	   μM),	   rotenone	   (20	   μM),	   and	  
allopurinol	  (10	  μM)	  for	  different	  durations	  (30	  minutes	  for	  anti-­‐TLR4	  antibody	  and	  1	  hour	  for	  
all	  the	  other	  inhibitors),	  and	  then	  PPD	  (30	  μg/ml),	  DNCB	  (2	  μg/ml)	  and	  citral	  (30	  μg/ml)	  or	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DMSO	  as	  vehicle	  control	  were	  added	  for	  24	  hours.	  
The	  chemical	  concentration	  that	  resulted	  in	  a	  CV80	  was	  the	  start	  concentration	  during	  the	  
IL-­‐18	  experiments.	  When	  no	  CV80	  could	  be	  determined,	  the	  maximum	  solubility	  is	  used	  as	  
the	  starting	  concentration.	  
	  
2.2.2	  Human	  epidermal	  equivalent	  	  
epiCS®	   previously	   known	   as	   EST1000 ™ 	   (Epidermal	   Skin	   Test-­‐1000)	   (CellSystems,	  
Biotechnology	   GmbH,	   Troisdorf,	   Germany);	   SkinEthic ™ 	   RHE	   (Reconstructed	   Human	  
Epidermis)	   (SkinEthic	  Laboratories,	  Lyon,	  France);	  EpiDerm™	   (MatTek	  Corp.,	  Ashland,	  USA	  
and	  Bratislava,	  Slovakia)	  and	  VU	  University	  in	  house	  EE	  (VUMC-­‐EE)	  were	  used	  in	  this	  study.	  
EE	   were	   maintained	   according	   to	   the	   suppliers'	   instructions	   at	   37	  °C,	   5%	   CO2	   and	   95%	  
relative	  humidity.	  After	  24	  h	  (1–24	  h	  for	  EpiDerm™)	  of	  equilibration	  time,	  EE	  were	  exposed	  
to	   chemicals	   as	   described	   below	   and	   as	   described	   in	   detail	   previously	   (dos	   Santos	   et	   al.,	  
2011	  and	  Teunis	   et	   al.,	   2013).	   All	   reconstructed	   epidermal	   models	   were	   derived	   from	  
normal	   human	   keratinocytes.	   For	   VUMC-­‐EE,	   human	   foreskin	   was	   obtained	   from	   healthy	  
donors	  with	  informed	  consent.	  The	  VU	  University	  Medical	  Centre	  approved	  the	  experiments	  
described	   in	   this	   paper.	   The	   study	   was	   conducted	   according	   to	   Declaration	   of	   Helsinki	  
Principles.	  
	  A	   total	  of	  17	   contact	   sensitisers	   and	  10	  non-­‐sensitisers	  were	   studied	   (Table	  1).	  At	  DiSFeB	  
and	   VUMC,	   the	   13	   sensitisers,	   marked	   with	   an	   asterisk	   in	   Table	  1,	   were	   tested	   coded	   in	  
order	  to	  further	  challenge	  the	  EE	  potency	  assay	  using	  the	  epiCS®	  model.	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At	  DiSFeB	  and	  VUMC	  where	  epiCS®	  was	  used	  (and	  VUMC-­‐EE	  for	  limited	  experiments):	  (1)	  EE	  
were	   allowed	   to	   equilibrate	   for	   24	  h	   at	   37	  °C,	   5%	   CO2	   and	   then;	   (2)	   chemicals	   were	  
dissolved	  in	  either	  acetone	  olive	  oil	  (AOO	  4:1)	  or	  1%	  DMSO	  in	  culture	  medium.	  At	  VUMC	  and	  
DiSFeB	   the	  vehicles	  and	   chemicals	  were	  purchased	   from	   the	   same	   supplier:	   acetone	   (Cat.	  
No.	  20066.321)	   from	  VWR	  (Radnor,	  Pennsylvania	  (VS);	  olive	  oil	   (cat	  no.	  01514)	  and	  DMSO	  
(Cat.	   No.	   154938)	   from	   Sigma-­‐Aldrich	   (St.	   Louis,	   MO,	   USA).	   With	   the	   exception	   of	   2-­‐
mercaptobenzothiazol	   which	   was	   purchased	   from	   Fisher-­‐Scientific	   (ACROS	   Organics;	  
Loughborough,	  UK),	  all	  chemicals	  were	  purchased	  from	  Sigma-­‐Aldrich	  (Sigma,	  Aldrich,	  SAFC;	  
St	   Louis,	  Missouri,	  USA).	   Chemicals	  were	   >	  95%	  pure	  with	   the	   exception	  of	   formaldehyde	  
which	  was	  36.5%–38%	  in	  H2O.	  Isoeugenol	  was	  a	  98%	  mixture	  of	  the	  cis	  and	  trans	  form	  and	  
oxazolone	  was	  purified	  by	  recrystallization.	  For	  experiments,	  Finn	  Chamber	  filter	  paper	  discs	  
7.5	  (for	  epiCS®)	  or	  11	  mm	  (for	  VUMC-­‐EE)	  (Epitest	  LTD	  Oy,	  Finland)	  were	  impregnated	  with	  
chemicals	  or	  vehicle	  controls	  and	  applied	  topically	  to	  the	  EE	  stratum	  corneum;	  (3)	  cultures	  
were	  incubated	  with	  chemicals	  for	  24	  h;	  (4)	  after	  chemical	  exposure,	  filter	  paper	  discs	  were	  
removed	   and;	   (5)	   metabolic	   activity	   was	   determined	   immediately	   by	   the	  MTT	   assay	   and	  
culture	   supernatants	   were	   harvested	   and	   stored	   at	   −	  20	  °C	   for	   IL-­‐18	   analysis	   by	   ELISA.	  
Chemical	  exposure	  and	  dose	   finding	  was	  performed	  as	  described	   in	  detail	  previously	   (dos	  
Santos	  et	  al.,	  2011	  and	  Teunis	  et	  al.,	  2013).	  
	  
In	  parallel,	  at	  MatTek	  and	  MB	  Research	  Labs	  where	  EpiDerm	  ™	  was	  used,	  a	  protocol	  was	  
developed	   in	   which	   12	   chemicals	   were	   tested:	   (1)	   Epiderm	   tissues	   were	   allowed	   to	  
equilibrate	  for	  1–24	  h	  at	  37	  °C,	  5%	  CO2	  and	  then;	  (2)	  test	  chemicals	  were	  directly	  pipetted	  
to	  the	  EE	  surface,	  dissolved	  in	  either	  ethanol	  (25	  μl)	  for	  lipid	  soluble	  compounds	  or	  distilled	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water	   (100	  μl)	   for	   water-­‐soluble	   compounds	   (Deng	   et	   al.,	   2011).	   The	   only	   exception	   was	  
ethanol:	  DMSO	  4:1	  (25	  μl)	  which	  was	  used	  as	  vehicle	  for	  10%	  MBT	  exposure	  of	  EpiDerm™	  
(Table	  1).	   For	  MB	   Research	   Labs	   and	  MatTek	   Corp.,	   absolute	   ethanol	   (200	   proof),	   sterile	  
tissue	  culture	  water	  (ultrapure)	  and	  all	  other	  chemicals	  were	  at	  least	  98%	  pure	  ACS	  grade,	  
and	  were	   purchased	   from	   Sigma-­‐Aldrich	   (St.	   Louis,	  MO,	  USA).	   Sterile	  DMEM-­‐based	   tissue	  
culture	  medium	  was	  supplied	  by	  MatTek	   (Ashland,	  MA,	  USA);	   (3)	  cultures	  were	   incubated	  
with	   chemicals	   for	   24	  h;	   (4)	   after	   chemical	   exposure,	   the	   epidermal	   surface	   was	   washed	  
with	  PBS	   to	   remove	  chemicals	  and;	   (5)	  metabolic	  activity	  was	  determined	   immediately	  by	  
the	  MTT	   assay	   and	   culture	   supernatants	   were	   harvested	   and	   stored	   at	  −	  20	  °C	   for	   IL-­‐18	  
analysis	  by	  ELISA.	  
In	  addition,	  a	  comparison	  of	  the	  effects	  of	  different	  vehicles	  (AOO,	  ethanol,	  water)	  on	  0.15%	  
DNCB,	  0.3%	  citral	  and	  1.0%	  eugenol	  induced	  IL-­‐18	  release	  and	  cell	  viability	  was	  conducted.	  
This	   experiment	   was	   performed	   at	   MB	   Research	   in	   SkinEthic™ 	   RHE	   EE	   model,	   n	  =	  2	  
replicates	  from	  a	  single	  experiment.	  
	  
2.3	  CELL	  VIABILITY	  
The	  MTT	  assay	  measures	  mitochondrial	  activity,	  which	  is	  representative	  for	  cell	  viability,	  by	  
quantifying	  dehydrogenase	  activity	   in	   the	  mitochondria	   (Gerlier	  and	  Thomasset,	  1986).	  To	  
make	  sure	  no,	  or	  very	  little,	  cytotoxic	  effects	  occur	  during	  the	  NCTC2544	  IL-­‐18	  experiments,	  
cytotoxicity	  was	  assessed	  by	  MTT	  assay.	  Hundred	  microliter	  of	  cells	  (1.5–2.5	  ×	  105/ml)	  were	  
seeded	   in	   a	   96-­‐well	   plate,	   up	   to	   a	   confluency	   of	   80%,	   and	   exposed	   to	   decreasing	  
concentrations	   (using	   CV80	   as	   highest	   concentrations)	   of	   test	   chemicals,	   vehicle	   control	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(0.2%	  DMSO	  or	  culture	  medium)	  and	  positive	  control	  (PPD,	  60	  μg/ml	  in	  0.2%	  DMSO).	  
After	  an	  incubation	  period	  of	  24	  h,	  medium	  was	  aspirated	  and	  100	  μl/well	  of	  MTT	  solution	  
(0.75	  mg/ml	  in	  culture	  medium)	  was	  added.	  Cells	  were	  incubated	  for	  3	  h	  at	  37	  °C,	  medium	  
was	  aspirated	  and	  cells	  were	  lysed	  in	  100	  μl/well	  of	  a	  mixture	  of	  HCl	  1N:isopropanol	  (1:24).	  
The	  absorbance	  of	  the	  resulting	  solutions	  was	  read	  at	  a	  wavelength	  of	  595	  nm	  in	  a	  micro-­‐
plate	   reader	   (molecular	   devices	   or	   equivalent).	   Cell	   viability	   was	   calculated	   for	   each	  
chemical	  by	  linear	  regression	  analysis.	  Concentrations	  resulting	  in	  a	  cell	  viability	  lower	  than	  
80%	  were	  discarded	   from	   further	  analysis.	   The	  CV80	  was	   the	  highest	   concentration	   tested	  
for	  IL18	  production.	  
Five	  decreasing	  concentrations	  (2	  step	  dilutions),	  starting	  with	  the	  EC60	  concentration,	  of	  the	  
training	  chemicals,	  unexposed,	  vehicle	  control	  (1%	  DMSO	  or	  AOO)	  and	  the	  positive	  control	  
were	  tested	  and	  2	  independent	  experiments	  were	  performed	  by	  each	  laboratory.	  
After	  a	  24	  h	  exposure,	  test	  chemicals	  or	  filter	  paper	  discs	  impregnated	  with	  chemicals	  were	  
removed	  from	  EE	  or	  the	  epidermal	  surface	  and	  then	  washed	  with	  PBS	  to	  remove	  chemicals	  
(the	  MatTek	   protocol).	   The	  MTT	   analysis	   was	   performed	   in	   24-­‐well	   plates.	   Thiazolyl	   blue	  
tetrazolium	   bromide	   (MTT)	   (Sigma)	   solution	   in	   PBS	   (0.5	  mL	   of	   a	   5	  mg/mL	   solution)	   was	  
added	  to	  the	  24-­‐well	  plate,	  EE	  cultures	  were	  placed	  on	  top	  and	  further	  incubated	  for	  2–3	  h	  
under	   standard	  culture	   conditions.	  Cultures	  were	   then	   transferred	   to	  a	  new	  24	  well	  plate	  
containing	  0.3–0.9	  mL	  isopropanol	  to	  dissolve	  the	  formazine	  crystals.	  Plates	  were	  incubated	  
overnight,	   covered	  with	   parafilm	   and	   protected	   from	   the	   light	   at	   room	   temperature.	   The	  
absorbance	  of	  the	  formazan	  dissolved	  in	  isopropanol	  was	  measured	  at	  either	  540	  or	  570	  nm	  
and	  expressed	  as	  a	  percentage	  relative	  to	  the	  absorbance	  value	  of	  control	  vehicle.	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2.4	  CYTOKINE	  PRODUCTION	  
For	   IL-­‐18	   production,	   cells	   were	   incubated	   (24	   well	   plates)	   for	   24	  h	   with	   four	   decreasing	  
concentrations	   of	   the	   training	   chemicals	   (starting	   with	   the	   CV80	   concentration),	   vehicle	  
control	   (0.2%	   DMSO	   or	   culture	   medium)	   and	   the	   positive	   control	   PPD.	   Each	   condition	  
(chemical	   concentration,	   positive	   control	   or	   vehicle)	   was	   tested	   in	   quadruplicate	   per	  
independent	  experiment.	  Each	  lab	  performed	  three	  independent	  experiments.	  
After	  incubation	  with	  chemicals,	  culture	  medium	  was	  aspirated,	  monolayers	  gently	  washed	  
once	  with	  1	  ml	  PBS	  and	  cells	  were	   lysed	   in	  0.25	  ml	  0.5%	  Triton	  X-­‐100	   in	  PBS.	  Plates	  were	  
stored	   at	   −80	  °C	   until	   measurement.	   Intracellular	   IL-­‐18	   content	   was	   assessed	   by	   specific	  
sandwich	   ELISA	   commercially	   available	   (MBL,	   Nagoya,	   Japan).	   IL-­‐18	   coating	   antibody	  was	  
used	   at	   a	   working	   concentration	   of	   1	  μg/ml;	   IL-­‐18	   biotinylated	   antibody	   was	   used	   at	   a	  
working	  concentration	  of	  250	  pg/ml;	  IL-­‐18	  standard	  was	  used	  at	  a	  starting	  concentration	  of	  
1000	  pg/ml.	   All	   ELISA	   components	  were	   dissolved	   in	   PBS,	   containing	   1%	   BSA.	   Results	   are	  
expressed	   in	   pg/mg	   of	   total	   intracellular	   protein	   content.	   The	   protein	   content	   of	   the	   cell	  
lysates	  was	  determined	  by	  the	  BCA	  method	  (for	  details	  see	  supplement	  B:	  ‘NCTC2544	  IL-­‐18	  
SOP’).	  All	   IL-­‐18	   samples	  were	  analysed	  using	  dilutions	   in	  PBS	   supplemented	  with	  1%	  BSA.	  
The	  OD	  of	  the	  samples	  was	  only	  accepted	  when	  the	  OD	  was	  well	  within	  the	  linear	  range	  of	  
the	  standard	  curve.	  
Stimulation	  index	  (SI)	  was	  calculated	  as	  follow:	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The	  following	  preliminary	  prediction	  model	  was	  used:	  if	  the	  fold	  increase	  in	  intracellular	  IL-­‐
18	  is	  over	  1.2	  compared	  to	  vehicle	  the	  chemical	  is	  classified	  as	  contact	  sensitiser	  (labeled	  as	  
R43).	   The	   positive	   and	   negative	   controls	   are	   included	   in	   each	   plate.	   The	   positive	   control	  
meets	  the	  acceptance	  criteria	  if	  the	  fold	  increase	  in	  intracellular	  IL-­‐18	  is	  over	  1.5	  compared	  
to	  vehicle	  treated	  cells.	  For	  a	  given	  chemical,	  the	  same	  classification	  must	  be	  obtained	  in	  at	  
least	  two	  out	  of	  three	  independent	  experiments.	  The	  1.2	  fold	  increase	  should	  be	  at	  least	  at	  
one	  of	  the	  concentrations	  tested.	  
In	   the	   96-­‐well	   plate	   format,	   total	   IL-­‐18	   production	   was	   assessed	   (both	   intracellular	   and	  
released).	  In	  this	  case	  after	  incubation,	  20	  μl	  of	  3%	  Triton	  X-­‐100	  (0.5%	  final	  concentration)	  in	  
PBS	   was	   added	   to	   each	   well.	   Plates	   were	   then	   frozen	   at	   −80	  °C,	   and	   100	  μl	   directly	  
transferred	   from	   the	   96-­‐well	   plate	   to	   the	   ELISA	   plate	   to	   asses	   IL-­‐18	   content.	   In	   this	   case,	  
results	  are	  expressed	  as	  pg/ml.	  
For	   IL-­‐1α	   production,	   EE	   cultures	   were	   incubated	   for	   24	  h	   with	   5	   decreasing	   (2	   step	  
dilutions)	   concentrations	   of	   the	   training	   chemicals	   (starting	  with	   the	   EC60	   concentration),	  
unexposed,	   vehicle	   control	   (1%	   DMSO	   or	   AOO)	   and	   the	   positive	   control	   resorcinol.	   Two	  
independent	  experiments	  were	  performed	  by	  each	  lab.	  
The	   amount	   of	   IL-­‐1alpha	   present	   in	   culture	   supernatants	  was	   determined	   by	   ELISA	   (R&D	  
Systems).	   IL-­‐1alpha	   coating	   antibody	  was	   used	   at	   a	  working	   concentration	   of	   2	  μg/ml;	   IL-­‐
1alpha	  biotinylated	  antibody	  was	  used	  at	  a	  working	  concentration	  of	  12.5	  ng/ml;	  IL-­‐1alpha	  
standard	   was	   used	   at	   a	   starting	   concentration	   of	   500	  pg/ml.	   All	   were	   dissolved	   in	   0.5%	  
BSA/0.005%	  Tween.	  Results	  were	  expressed	  in	  pg/ml	  and	  the	  concentration	  resulting	  in	  IL-­‐
1α2×	  value	  can	  be	  measured	  by	  correlating	  to	  the	  vehicle	  control.	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2.5	  WESTERN	  BLOTTING	  
For	  Western	  blot	  analysis	  of	  p38	  MAPK	  activation	  and	  I-­‐κB	  degradation,	  as	  measure	  of	  NF-­‐κB	  
activation,	  NCTC	  2544	  cells	  were	  seeded	  in	  6-­‐well	  plate	  at	  a	  cell	  density	  of	  2.5	  ×	  105	  cells/ml	  
(2	  ml/well).	   After	   24	  h	   of	   adherence,	   cells	  were	   treated	  with	   PPD	   (60	  μg/ml)	   or	   DMSO	   as	  
vehicle	   control	   for	   different	   times	   (5–60	  min).	   After	   incubation,	   culture	   medium	   was	  
discarded,	   1	  ml	   of	   cold	   PBS	   was	   added,	   cells	   were	   collected	   by	   scraping,	   transferred	   in	  
Eppendorf	   tubes	   and	   centrifuge	   for	   5	  min	   at	   1200	  rpm	   at	   5	  °C.	   The	   supernatant	   was	  
discarded	   and	   cells	   lysed	   in	   100	  μl	   of	   homogenization	   buffer	   (50	  mM	   Tris,	   150	  mM	  NaCl,	  
5	  mM	  EDTA	  pH	  7.5,	  0.5%	  Triton	  X-­‐100,	  50	  μM	  PMSF,	  2	  μg/mL	  aprotinin,	  1	  μg/mL	  pepstatin	  
and	  1	  μg/mL	  leupeptin)	  and	  denatured	  for	  10	  min	  at	  100	  °C.	  The	  protein	  content	  of	  the	  cell	  
lysate	  was	  measured	  using	  a	  commercial	  kit	  (Bio-­‐Rad,	  Segrate,	   Italy).	  For	  the	  Western	  blot	  
analysis,	  15	  μg	  of	  extracted	  proteins	  were	  electrophoresed	  into	  a	  15%	  SDS–polyacrylamide	  
gel	   under	   reducing	   conditions.	   The	   proteins	   were	   then	   transferred	   to	   PVDF	   membrane	  
(Amersham,	  Little	  Chalfont,	  UK).	  The	  different	  proteins	  were	  visualized	  using	  activated	  p38	  
(1:1000),	   non-­‐activated	   p38	   (1:500)	   I-­‐κB	   (1:1000)	   as	   primary	   antibodies	   (Sigma),	   and	  
developed	   using	   enhanced	   chemioluminescence	   (Sigma).	   The	   image	   of	   the	   blot	   was	  
acquired	  with	  the	  Molecular	  Imager	  Gel	  Doc	  XR	  (Bio-­‐Rad).	  The	  optical	  density	  of	  the	  bands	  
was	   calculated	   and	   analyzed	   by	   means	   of	   the	   Image	   1.47	   program	   for	   digital	   image	  
processing	  (Wayne	  Rasband,	  Research	  Service	  Branch,	  NIMH,	  NIH,	  Bethesda,	  MD,	  USA).	  
	  
2.6	  PERFORMANCE	  CRITERIA	  –	  EE	  POTENCY	  ASSAY	  
For	  the	  positive	  control:	  Exposure	  to	  60	  mg/ml	  (475	  mM)	  resorcinol	  should	  result	  in	  25–75%	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(preferably	   50%)	   decrease	   in	   cell	   viability	   compared	   to	   vehicle	   control	   (1%	   DMSO	   or	   4:1	  
AOO).	   If	   the	   value	   obtained	   is	   outside	   this	   range	   the	   EE	   batch	   did	   not	   fulfill	   the	   Quality	  
Criteria	  required	  for	  the	  assay	  and	  the	  experiment	  is	  considered	  as	  invalid.	  For	  the	  negative	  
control:	   Vehicle	   exposure	   should	   not	   result	   in	   more	   than	   30%	   decrease	   in	   cell	   viability	  
compared	   to	  unexposed	   cultures.	   If	   the	   vehicle	   value	  obtained	   is	   higher	   than	  30%	   the	  EE	  
batch	   did	   not	   fulfill	   the	  Quality	   Criteria	   required	   for	   the	   assay.	   If	   a	   chemical	   then	   fails	   to	  
result	   in	   >60%	   cytotoxicity,	   this	   chemical	   is	   excluded	   from	   the	   assay.	   Chemical	  
concentrations	   found	   to	   result	   in	   an	   EC50	   or	   IL-­‐1α2×	   can	   be	   used	   to	   rank	   according	   to	  
potency.	  
	  
2.7	  DATA	  ANALYSIS	  
For	   NCTC2544	   IL-­‐18	   assays,	   all	   experiments	   were	   repeated	   at	   least	   three	   times,	   with	  
representative	   results	   shown.	   Data	   are	   expressed	   as	   mean	  ±	  standard	   deviation	   (SD).	  
Statistical	  analysis	  was	  performed	  using	  InStat	  software	  version	  3.0a	  (GraphPad	  Software,	  La	  
Jolla,	  CA,	  USA).	  Statistical	  differences	  were	  determined	  using	  ANOVA	  followed	  by	  a	  multiple	  
comparison	   test	   (Dunnett’s	  multiple	   comparison	   test	  or	  Tukey’s	   t-­‐test)	  as	   indicated	   in	   the	  
legends.	  Effects	  were	  designated	  significant	  if	  p	  <	  0.05.	  
For	  EE,	  experiments	  were	  performed	  in	  duplicate	  in	  two	  of	  the	  laboratories	  (VUMC,	  DiSFeB)	  
and	  at	   least	  once	  in	  each	  lab	  by	  MB	  Research	  Labs	  and	  MatTek	  Corp.	  Different	  EE	  batches	  
were	   used	   in	   each	   experiment.	   Data	   are	   presented	   as	   an	   average	   of	   the	   2	   independent	  
experiments	  ±	  difference	   (VUMC,	   DiSFeB),	   or	   as	   average	  ±	  difference	   of	   duplicate	   tissues	  
within	  a	  single	  experiment	  (EpiDerm™).	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Sensitiser	   labelling	   by	  means	   of	   assessing	   IL-­‐18	   release:	   different	   prediction	  models	  were	  
developed	  for	  the	  epiCS®	  and	  EpiDerm™	  models.	  Based	  on	  data	  obtained	  testing	  sensitisers	  
and	  non-­‐sensitisers,	  for	  the	  epiCS®	  model	  a	  cut-­‐off	  of	  5-­‐fold	  increase	  of	  IL-­‐18	  release	  above	  
vehicle	   control	   and	  ≤	  40%	  cell	   viability	  was	   found	   to	  be	   the	  best	   for	   the	  discrimination	  of	  
contact	  allergens,	  while	  for	  EpiDerm™	  a	  cut-­‐off	  of	  1.6-­‐fold	  increase	  of	  IL-­‐18	  above	  vehicle	  
control	   and	   between	   5	   and	   50%	   cell	   viability	   (Prediction	   Model	   1.6	  ×)	   was	   found	   to	   be	  
optimal	  to	  identify	  allergens.	  
	  
EE	   potency	   assay:	   the	   EE-­‐EC50	   value	   is	   the	   effective	   chemical	   concentration	   required	   to	  
reduce	  metabolic	  activity	  (corresponding	  to	  cell	  viability)	  to	  50%	  of	  the	  maximum	  value.	  The	  
100%	  value	  for	  cell	  viability	  corresponds	  to	  the	  vehicle	  control	  (1%	  DMSO	  culture	  medium	  or	  
acetone/olive	  oil	  4:	  1).	  EE-­‐EC50	  values	  were	  obtained	  by	  linear	  regression	  analysis	  based	  on	  
changes	   in	  metabolic	   activity	   (MTT).	   Statistical	   significances	  were	  determined	  by	  Kruskal–
Wallis	   (nonparametric,	   one	  way	  ANOVA)	  using	  GraphPad	  Prism	  version	  4.00	   for	  Windows	  
(GraphPad	   Software,	   San	   Diego,	   CA,	   USA).	   Differences	   were	   considered	   significant	   for	  
p	  <	  0.05.	  
IL-­‐18	   potency	   assessment:	   IL-­‐18	   SI-­‐2	   and	   SI-­‐5	  were	   obtained	   by	   linear	   regression	   analysis	  
based	  on	  the	  chemical	  concentration	  resulting	  in	  a	  2	  fold	  or	  5	  fold	  release	  in	  IL-­‐18.	  Statistical	  
significances	   were	   determined	   by	   Kruskal–Wallis	   (nonparametric,	   one	   way	   anova)	   using	  
GraphPad	   Prism	   version	   4.00	   for	   Windows	   (GraphPad	   Software,	   San	   Diego,	   CA,	   USA).	  
Differences	  were	  considered	  significant	  for	  p	  <	  0.05.	  
Correlations	  were	  determined	  by	  nonparametric	  two-­‐tailed	  correlation	  Spearman	  Analyses	  
using	  GraphPad	  Software,	  San	  Diego,	  CA,	  USA.	  




3.1	   USE	   OF	   IL-­‐18	   PRODUCTION	   IN	   A	   HUMAN	   KERATINOCYTE	   CELL	   LINE	   TO	  
DISCRIMINATE	   CONTACT	   SENSITISERS	   FROM	   IRRITANTS	   AND	   LOW	  
MOLECULAR	  WEIGHT	  RESPIRATORY	  ALLERGENS	  
	  
Abstract	  
Assessment	  of	  allergenic	  potential	  of	  chemicals	   is	  performed	  using	  animal	  models,	  such	  as	  
the	  murine	   local	   lymph	   node	   assay,	   which	   does	   not	   distinguish	   between	   respiratory	   and	  
contact	  allergens.	  Progress	  in	  understanding	  the	  mechanisms	  of	  skin	  sensitization,	  provides	  
us	  with	   the	  opportunity	   to	  develop	   in	   vitro	   tests	   as	   an	   alternative	   to	   in	   vivo	   sensitization	  
testing.	  
The	  aim	  of	  the	  present	  study	  was	  to	  evaluate	  the	  possibility	  to	  use	  intracellular	  interleukin-­‐
18	  (IL-­‐18)	  production	  to	  assess	  in	  vitro	  the	  contact	  sensitization	  potential	  of	  low	  molecular	  
weight	  chemicals.	  The	  human	  keratinocyte	  cell	  line	  NCTC2455	  was	  used.	  Cells	  were	  exposed	  
to	   contact	   allergens	   (cinnamaldehyde,	   dinitrochlorobenzene,	   glyoxal,	   isoeugenol,	   p-­‐
phenylediamine,	   resorcinol,	   tetramethylthiuram	   disulfide,	   2-­‐mercaptobenzothiazole,	   4-­‐
nitrobenzylbromide),	   to	   proaptens	   (cinnamyl	   alcohol,	   eugenol),	   to	   respiratory	   allergens	  
(diphenylmethane	  diisocyanate,	  trimellitic	  anhydride,	  ammonium	  hexachloroplatinate)	  and	  
to	   irritants	   (sodium	   lauryl	   sulphate,	   salicylic	   acid,	   phenol).	   Cell	   associated	   IL-­‐18	   were	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evaluated	  24	  later.	  At	  not	  cytotoxic	  concentrations	  (cell	  viability	  higher	  of	  75%,	  as	  assessed	  
by	  MTT	  reduction	  assay),	  all	  contact	  sensitisers,	  including	  proaptens,	  induced	  a	  dose-­‐related	  
increase	   in	   IL-­‐18,	   whereas	   both	   irritants	   and	   respiratory	   failed.	   Similar	   results	   were	   also	  
obtained	  using	  primary	  human	  keratinocytes.	  Results	  were	   reproducible,	   and	   the	  method	  
could	   be	   transferred	   to	   another	   laboratory,	   suggesting	   the	   potential	   use	   of	   the	   test	   in	  
immunotoxicity	  testing	  strategies.	  Overall,	  results	  obtained	  indicated	  that	  cell-­‐associated	  IL-­‐
18	   may	   provide	   an	   in	   vitro	   tool	   for	   identification	   and	   discrimination	   of	   contact	   versus	  
respiratory	  allergens	  and/or	  irritants.	  
	  
Determination	  of	  75%	  cell	  viability	  
The	  concentration	  of	  chemical	  resulting	  in	  75%	  of	  viability	  or	  CV75	  respect	  to	  vehicle	  treated	  
cells	  24	  h	  after	  treatment	  was	  calculated	  for	  all	  chemicals.	  About	  500–1000	  μg/ml	  were	  the	  
highest	  concentration	  tested.	  Results	  are	  presented	  in	  Table	  1.	  For	  the	  majority	  of	  chemicals	  
CV75	  represented	  the	  highest	  concentration	  tested.	  In	  Table	  1	  is	  also	  reported	  the	  category	  
and	  classification	  according	  to	  the	  LLNA	  EC3	  values	  (Basketter	  et	  al.,	  1999	  and	  Gerberick	  et	  





















Table	   1	   -­‐	   Confluent	   cells	   were	   treated	   for	   24	  h	   with	   different	   chemicals	   or	   DMSO	   (0.2%	   final	  
concentration)	  as	  vehicle	  control.	  Results	  are	  expressed	  as	  the	  concentration	  of	  chemical	  resulting	  in	  
75%	  cell	  viability,	  as	  assessed	  by	  MTT	  reduction.	  CV75	  was	  calculated	  by	  linear	  regression	  analysis	  of	  
data.	  
In	   the	   last	   column,	   the	   LLNA	   EC3	   values	   expressed	   as%	   and	   its	   relative	   potency	   classification	   in	  
parenthesis	  are	  reported.	  According	  to	  Basketter	  et	  al.	  (1999),	  potency	  classification	  is	  based	  on	  the	  
mathematical	  estimation	  of	  the	  concentration	  of	  chemical	  necessary	  to	  obtain	  a	  threshold	  positive	  
response	   (SI	  =	  3);	   this	   is	   termed	   the	  EC3	  value.	  Chemicals	  with	  an	  EC3	  value	   (%)	  ⩾	  10	   to	  <100	  are	  
classified	  as	  weak,	  ⩾1	  to	  <10	  moderate,	  ⩾0.1	  to	  <1	  strong,	  <0.1	  extreme.	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Table	  1.	  Concentration	  of	  the	  chemicals	  that	  induced	  75%	  viability	  (CV75)	  and	  their	  
classification.	  
	  
Chemical	   CV75	  
(μg/ml)	  
Category	   LLNA	  EC3	  (%)	  
HClPt	   15	   Respiratory	  
allergen	  
Not	  available	  
MDI	   >500	   Respiratory	  
allergen	  
0.3	  (strong)	  
TMA	   >500	   Respiratory	  
allergen	  
9.2	  (moderate)	  
Cinnamaldehyde	   40	   Contact	  allergen	   2.8	  (moderate)	  
Cinnamyl	  alcohol	   300	   Contact	  allergen	   21	  (weak)	  
DNCB	   5	   Contact	  allergen	   0.05	  (extreme)	  
Eugenol	   225	   Contact	  allergen	   12	  (weak)	  
Glyoxal	   50	   Contact	  allergen	   1.3	  (moderate)	  
Isoeugenol	   225	   Contact	  allergen	   1.2	  (moderate)	  
PPD	   108	   Contact	  allergen	   0.22	  (strong)	  
Resorcinol	   >1000	   Contact	  allergen	   6	  (moderate)	  
TMTD	   32	   Contact	  allergen	   5.6	  (moderate)	  
2-­‐Mercaptobenzothiazole	   125	   Contact	  allergen	   5.8	  (moderate)	  
4-­‐Nitrobenzylbromide	   2.5	   Contact	  allergen	   0.05	  (extreme)	  
Phenol	   70	   Irritant	   Non	  sensitiser	  
Lactic	  acid	   >500	   Irritant	   Non	  sensitiser	  
Salicylic	  acid	   250	   Irritant	   Non	  sensitiser	  
SLS	   30	   Irritant	   14.0	  (weak,	  false	  
positive)	  
Glycerol	   >1000	   Negative	   Non	  sensitiser	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Effect	  of	  the	  selected	  chemicals	  on	  cell-­‐associated	  IL-­‐18	  
Preliminary	   experiments	   were	   carried	   out	   to	   determine	   the	   best	   time,	   cell	   density	   and	  
serum	  concentrations	  to	  measure	  cell-­‐associated	  IL-­‐18.	  In	  time	  course	  experiments,	  cells,	  at	  
80–90%	   density,	   were	   treated	   for	   different	   times	   (5,	   24,	   30	   and	   48	  h)	   with	   salicylic	   acid	  
(250	  μg/ml),	   and	   PPD	   (60	  μg/ml).	   As	   shown	   in	   Fig.	   1	   A,	   statistically	   significant	   increase	   in	  
intracellular	   IL-­‐18	   was	   detected	   in	   cells	   treated	   with	   PPD	   already	   after	   5	  h	   of	   treatment,	  
reaching	  a	  plateau	  after	  24–30	  h,	  while	  no	  changes	  were	  observed	  following	  treatment	  with	  
the	   irritant	   salicylic	   acid.	   Therefore,	   the	   incubation	   time	   of	   24	  h	  was	   chosen	   for	   all	   other	  
investigations.	  
The	   effect	   of	   cell	   density	   on	   the	   response	   to	   the	   contact	   allergen	   PPD	   was	   investigated	  
seeding	   cells	   at	  different	  density	   (1	   to	  10	  ×	  105	   cells/ml	   in	  24-­‐well	   plate).	  After	  over	  night	  
adherence,	  cells	  were	  treated	  for	  24	  h	  with	  PPD	  (60	  μg/ml)	  or	  DMSO	  as	  vehicle	  control.	  As	  
shown	   in	   Fig.	   1	   B,	   1	   to	   2.5	  ×	  105	   cells/ml	   represents	   the	   optimal	   cell	   density,	   higher	   cell	  
density	   (>5	  ×	  105	   cells/ml)	   resulted	   in	   a	   loss	   of	   effect.	   Experiments	   were	   therefore	  
conducted	  using	  1.5	  to	  2.5	  ×	  105	  cells/ml.	  
To	   investigate	   the	  effect	  of	   serum	  concentrations	  on	   contact	   allergen-­‐induced	   increase	   in	  
intracellular	   IL-­‐18,	   cells	   were	   treated	   with	   cinnamaldehyde	   (60	  μg/ml),	   DNCB	   (0.5	  μg/ml)	  
and	   PPD	   (60	  μg/ml)	   or	   DMSO	   as	   vehicle	   control	   in	   the	   presence	   of	   1	   or	   10%	   of	   FCS.	   As	  
shown	  in	  Table	  2,	  similar	  results	  were	  obtained	  under	  the	  two	  experimental	  conditions,	  with	  
the	  exemption	  of	  cinnamaldehyde,	  which	  showed	  a	  higher	  response	  if	  cells	  were	  cultured	  in	  
10%	  FCS.	  Therefore,	  all	  experiments	  were	  conducted	  using	  10%	  FCS.	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Fig.	  1.	  Time	  course	  and	  effect	  of	  cell	  density	  on	  intracellular	  IL-­‐18.	  Panel	  A,	  time	  course.	  NCTC	  2544	  
cells	   were	   treated	   for	   different	   times	   (5,	   24,	   30,	   48	  h)	   with	   PPD	   (60	  μg/ml),	   and	   salicylic	   acid	  
(250	  μg/ml)	   or	   vehicle	   control.	   Results	   are	   expressed	   as	  mean	  ±	  SD,	   n	  =	  4.	   Statistical	   analysis	   was	  
performed	   with	   Dunnett’s	   multiple	   comparison	   test,	   with	   ∗∗p	  <	  0.01	   versus	   vehicle	   treated	   cells.	  
Panel	  B,	  effect	  of	  cell	  densitiy:	  NTCT	  2544	  cells	  were	  seeded	  in	  24-­‐well	  plate	  at	  different	  density	  (1–
10	  ×	  105	   cells/ml)	   and	   treated	   for	   24	  with	  PPD	   (60	  μg/ml)	  or	  DMSO	  as	   vehicle	   control.	   Results	   are	  
expressed	  as	  mean	  ±	  SD,	  n	  =	  4.	  Statistical	  analysis	  was	  performed	  with	  Tukey’s	  multiple	  comparison	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Treatment	   1%	  FCS	  (IL-­‐18%	  of	  
control)	  




584	  ±	  87	   839	  ±	  148§	  
DNCB	  0.5	  μg/ml	   146	  ±	  5	   176	  ±	  29	  
PPD	  60	  μg/ml	   414	  ±	  56	   358	  ±	  54	  
	  
Table	   2.	   Effect	   of	   FCS	   on	   contact	   allergen-­‐induced	   intracellular	   IL-­‐18	   production.	   NTCT	   2544	   cells	  
were	   treated	  with	   three	  different	   contact	  allergens	  or	  DMSO	   (0.2%	   final	   concentration)	  as	   vehicle	  
control.	  Twenty-­‐four	  hours	  later	  intracellular	  IL-­‐18	  was	  evaluated	  as	  described	  in	  Section	  2.	  Results	  
are	   expressed	   as%	   of	   control.	   Each	   value	   represents	   the	  mean	  ±	  SD,	   n	  =	  4.	   Statistical	   analysis	  was	  
performed	  by	  Tukey’s	  multiple	  comparison	  test,	  with	  §p	  <	  0.05	  versus	  cells	  treated	  in	  1%	  FCS.	  
	  
Effect	  of	  contact	  allergens	  on	  cell-­‐associated	  IL-­‐18	  
NCTC	  2544	  cells	  were	   then	   treated	   for	  24	  h	  with	   increasing	   concentrations	  of	   the	  contact	  
allergens	  DNCB,	  TMTD,	  cinnamaldehyde,	  cinnamic	  alcohol,	  eugenol,	  isoeugenol,	  resorcinol,	  
PPD.	  As	  shown	  in	  Fig.	  2,	  all	  contact	  allergens,	  including	  the	  proaptens	  cinnamic	  alcohol	  and	  
eugenol,	  induced	  a	  dose-­‐related	  increase	  in	  intracellular	  IL-­‐18.	  Additional	  contact	  allergens	  
tested,	   not	   reported	   in	   Fig.	   2,	   included	   glyoxal,	   4-­‐nitro	   benzylbromide,	   2-­‐
mercaptobenzothiazole.	   Also	   for	   these	   chemicals	   a	   statistically	   significant	   increase	   was	  
observed.	   In	  particular,	   the	  treatment	  with	  glyoxal	  25	  μg/ml	  the	   intracellular	   level	  of	   IL-­‐18	  
was	   283	  ±	  52∗	   pg/mg,	   with	   50	  μg/ml	   371	  ±	  107∗∗	   (control	   132	  ±	  49);	   with	   4-­‐
nitrobenzylbromide	   1.25	  μg/ml	   was	   368	  ±	  15∗,	   with	   2.5	  μg/ml	   was	   442	  ±	  14∗∗	   (control	  
293	  ±	  13);	  with	  2-­‐mercaptobenzothiazole	  62	  μg/ml	  was	  817	  ±	  57∗∗	  and	  with	  125	  μg/ml	  was	  
960	  ±	  111∗∗	  (control	  594	  ±	  29).	  
	   85	  
	  
	  
Fig.	   2.	  Dose	   response	   effects	   of	   contact	   sensitisers	   on	   cell-­‐associated	   IL-­‐18.	  NCTC	   2544	   cells	  were	  
treated	  for	  24	  h	  with	  increasing	  concentrations	  of	  DNCB,	  TNTD,	  cinnamaldehyde,	  cinnamyl	  alcohol,	  
eugenol,	  isoeugenol,	  resorcinol	  and	  PPD.	  Cells	  incubated	  with	  vehicle	  were	  included	  as	  a	  control	  (0).	  
Results	  are	  expressed	  as	  mean	  ±	  SD,	  n	  =	  4.	  Statistical	  analysis	  was	  performed	  with	  Dunnett’s	  multiple	  
comparison	  test,	  with	  ∗p	  <	  0.05	  and	  ∗∗p	  <	  0.01	  versus	  vehicle	  treated	  cells	  (0).	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Effect	  of	  respiratory	  allergens	  and	  irritants	  on	  cell-­‐associated	  IL-­‐18	  
We	  then	  tested	  the	  effect	  of	  the	  respiratory	  allergens	  MDI,	  TMA,	  HClPt	  and	  the	  irritants	  SDS,	  
salicylic	  acid,	   lactic	  acid,	  and	  phenol.	  None	  of	  them	  was	  able	  to	  increase	  intracellular	   IL-­‐18	  
content	   (Fig.	   3),	   suggesting	   a	   selective	   up-­‐regulation	   by	   contact	   allergens	   only.	   We	  




Fig.	   3.	  Dose	   response	   effects	   of	   irritants	   and	   respiratory	   sensitisers	   on	   cell-­‐associated	   IL-­‐18.	  NCTC	  
2544	   cells	   were	   treated	   for	   24	  h	   with	   increasing	   concentrations	   of	   SDS,	   salicylic	   acid,	   lactic	   acid,	  
phenol,	  MDI,	  hexachloroplatinate,	  TMA.	  Cells	  incubated	  with	  vehicle	  were	  included	  as	  a	  control	  (0).	  




We	   investigated	   the	   reproducibility	   of	   data	   by	   comparing	   the	   results	   obtained	   in	   seven	  
independent	  experiments	  conducted	  over	  a	  three	  months	  period	  treating	  NCTC	  2544	  cells	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with	   PPD	   60	  μg/ml.	   As	   shown	   in	   Fig.	   4,	   in	   all	   experiments	   PPD	   induced	   a	   statistically	  
significant	  increase	  in	  intracellular	  IL-­‐18,	  with	  a	  stimulation	  index	  ranging	  from	  1.8	  to	  3.6.	  
	  
	  	  	  	  	  	  	  	  	  	  	   	  
	  
	  
Fig.	  4.	  Reproducibility	  of	  data.	  Results	  obtained	  in	  seven	  independent	  experiments	  performed	  over	  a	  
three	  months	   period	   are	   reported.	  NCTC	  2544	   cells	  were	   treated	   for	   24	  h	  with	   PPD	   (60	  μg/ml)	   or	  
with	  DMSO	  as	  vehicle	  control.	  Intracellular	  IL-­‐18	  was	  evaluated	  as	  described	  in	  Section	  2.	  Results	  are	  
expressed	   as	   mean	  ±	  SD,	   n	  =	  4.	   Statistical	   analysis	   was	   performed	   with	   Student’s	   t-­‐test,	   in	   all	  
experiments	   PPD	   induced	   a	   statistical	   significant	   increase	   in	   cell-­‐associated	   IL-­‐18.	   The	   numbers	  
reported	  in	  figure	  represent	  the	  stimulation	  index	  of	  the	  individual	  experiment.	  
	  
	  
Effects	  of	  selected	  chemicals	  on	  cell-­‐associated	  IL-­‐18	  in	  primary	  human	  KC	  
We	  then	  asked	  the	  question	  if	  these	  results	  were	  peculiar	  of	  this	  cell	  line	  or	  if	  similar	  results	  
could	   be	   obtained	   using	   other	   keratinocyte	   models.	   We	   could	   demonstrate	   that	   similar	  
results	   were	   obtained	   also	   using	   primary	   human	   KC.	   As	   shown	   in	   Table	   3,	   while	  
cinnamaldehyde	   induced	   a	  dose-­‐related	   increase	   in	   intracellular	   IL-­‐18	   content,	  HClPt,	   SDS	  
and	  phenol	  failed,	  confirming	  the	  results	  obtained	  with	  NCTC	  2544	  cell	   line,	  and	  indicating	  
the	  possibility	  to	  use	  other	  keratinocyte	  models.	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Chemical	  (μg/ml)	   Intracellular	  IL-­‐18	  (pg/mg)	  
Control	   507	  ±	  73	  
HClPt	  25	   617	  ±	  110	  
HClPt	  50	   482	  ±	  224	  
HClPt	  100	   582	  ±	  162	  
Cinnamaldehyde	  12.5	   1455	  ±	  367∗	  
Cinnamaldehyde	  25	   1256	  ±	  218∗	  
Cinnamaldehyde	  50	   889	  ±	  76∗	  
SDS	  15	   450	  ±	  13	  
SDS	  30	   198	  ±	  50	  
Phenol	  40	   527	  ±	  134	  
Phenol	  80	   438	  ±	  24	  
	  
Table	  3.	  Effects	  of	  selected	  chemicals	  on	  IL-­‐18	  production	  in	  primary	  human	  keratinocytes.	  
Primary	   keratinocytes	  were	   treated	  with	   different	   concentrations	   of	   selected	   chemicals	   or	   DMSO	  
(0.2%	  final	  concentration)	  as	  vehicle	  control.	  Twenty-­‐four	  hours	  later	  intracellular	  IL-­‐18	  content	  was	  
evaluated	  as	  described	   in	  Section	  2.	  Results	  are	  expressed	  as	  pg/mg	  of	  total	  protein	  content.	  Each	  
value	   represents	   the	   mean	  ±	  SD,	   n	  =	  3.	   Statistical	   analysis	   was	   performed	   by	   Dunnett’s	   multiple	  
comparison	  test,	  with	  ∗p	  <	  0.05	  versus	  vehicle-­‐treated	  control	  cells.	  
	  
Discussion	  
In	  the	  present	  work,	  intracellular	  IL-­‐18	  was	  investigated	  after	  exposure	  of	  NCTC	  2544	  cells	  to	  
contact	   allergens,	   respiratory	   allergens,	   and	   irritants.	  We	   showed	   that	   exposure	   of	   NCTC	  
2544	   cells	   to	   contact	   allergens	   results	   in	   a	   dose-­‐related	   induction	   of	   intracellular	   IL-­‐18,	  
whereas	   exposure	   to	   respiratory	   allergens	   and	   irritants	   fails	   to	   induce	   IL-­‐18	   production,	  
indicating	  the	  possibility	  to	  use	  IL-­‐18	  it	  to	  identify	  contact	  allergens.	  
We	  had	   focused	  our	   attention	  on	   IL-­‐18	   since	   this	   cytokine	  has	   been	   shown	   to	   play	   a	   key	  
proximal	   role	   in	   the	   induction	   of	   allergic	   contact	   sensitization	   and	   to	   favor	   Th-­‐1	   type	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immune	  response	  by	  enhancing	  the	  secretion	  of	  pro-­‐inflammatory	  mediators	  such	  as	  TNF-­‐α,	  
IL-­‐8	   and	   IFN-­‐γ,	   (Okamura	   et	   al.,	   1995,	   Cumberbatch	   et	   al.,	   2001	  and	  Antonopoulos	   et	   al.,	  
2008).	  IL-­‐18	  has	  not	  apparent	  role	  in	  irritant	  contact	  dermatitis	  (Antonopoulos	  et	  al.,	  2008),	  
indicating	   that	   the	   role	  of	   IL-­‐18	   in	   contact	  hypersensitivity	   is	   not	   simply	  part	   of	   a	   general	  
requirement	   for	   IL-­‐18	   in	   skin	   inflammation.	   Furthermore,	   Hartwig	   et	   al.	   (2008)	  
demonstrated	  using	  IL-­‐18-­‐deficient	  mice	  that	  the	  absence	  of	  IL-­‐18	  does	  not	  affect	  any	  of	  the	  
asthma-­‐specific	  parameters,	  including	  allergen-­‐specific	  IgE,	  histological	  changes	  of	  the	  lungs,	  
infiltrating	  leukocytes,	  serum	  cytokine	  levels	  and	  airway	  hyperresponsiveness.	  
We	   therefore	   investigated	   if	   skin	   sensitisers	   could	   selectively	   up-­‐regulate	   this	   cytokine	   in	  
human	   KC.	   We	   could	   indeed	   demonstrate	   that	   contact	   sensitisers,	   including	   proaptens,	  
increase	   in	   a	   dose-­‐related	  manner	   intracellular	   IL-­‐18.	   In	   contrast,	   irritants	   and	   respiratory	  
allergens	  failed	  to	  up-­‐regulate	  IL-­‐18.	  The	  measure	  of	  the	  release	  of	   IL-­‐18	  did	  not	  offer	  any	  
advantage,	   since	   a	   passive	   release	   of	   this	   constitutively	   expressed	   cytokine	   could	   be	  
observed	  at	  high	  concentrations	  with	  both	  allergens	  and	  irritants,	   likely	  to	  be	  due	  to	  a	  cell	  
damage	   effect	   (data	   not	   shown).	   Also	   the	   evaluation	   of	   IL-­‐18	   mRNA	   expression	   did	   not	  
provide	  additional	  advantage.	  KC	  constitutively	  express	  high	  IL-­‐18	  mRNA	  levels,	  which	  could	  
not	   be	  modulated	   further	   following	   treatment	  with	   contact	   allergens	   as	   assessed	   by	   real	  
time	  PCR	  (data	  not	  shown).	  The	  latest	  finding	  is	  consistent	  with	  data	  obtained	  by	  Naik	  et	  al.	  
(1999)	  in	  primary	  human	  KC	  treated	  with	  DNCB.	  
Cultures	   of	   adult	   human	   KC	   are	   readily	   available,	   even	   commercially,	   but	   differences	   in	  
metabolism	   and	   response	   to	   stimuli	   can	   exist	   between	   cultures	   derived	   from	   different	  
donors	   (Berghard	  et	  al.,	  1990);	   therefore,	  established	   lines	  of	  human	  KC	  represent	  a	  good	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alternative.	   We	   obtained	   similar	   results	   using	   both	   the	   NCTC	   2544	   cell	   line	   and	   primary	  
human	   KC,	   confirming	   the	   relevance	   of	   the	   proposed	   model	   and	   the	   possibility	   to	   use	  
different	  source	  of	  KC.	  
Important	   factors	   including	   compound	   solubility,	   chemical	   reactivity	   and	   metabolic	  
activation,	   which	   may	   mask	   the	   potential	   allergenicity	   of	   some	   chemicals	   must	   be	  
considered	   in	   the	   development	   of	   in	   vitro	   tests.	   This	  may	   be	   the	   case	   of	  MDI	   and	   TMA,	  
highly	   instable	   in	   water.	   TMA	   is	   readily	   hydrolyzed	   in	   water	   to	   trimellitic	   acid	   and	   MDI	  
produces	  inert,	  solid,	  insoluble	  polyurea.	  The	  hydrolysis	  of	  isocyanate	  in	  aqueous	  solution	  is	  
rapid,	  with	  a	  half-­‐life	  of	  less	  of	  20	  s.	  If	  submerged	  cell	  culture	  may	  be	  unfavourable	  for	  many	  
of	  the	  respiratory	  sensitisers,	  due	  to	  chemical	  instability,	  we	  have	  tested	  IL-­‐18	  production	  in	  
reconstituted	   human	   epidermis,	  which	   allows	   application	   in	   organic	   solvent,	   i.e.	   acetone:	  
olive	   oil.	   Preliminary	   results	   obtained	   testing	   DNCB,	   phenol,	   salicylic	   acid,	   TMA	   and	  MDI	  
showed	  an	  increase	  in	  IL-­‐18	  only	  following	  treatment	  with	  DNCB,	  which	  may	  support	  results	  
obtained	  with	  submerged	  keratinocytes.	  
The	  lack	  of	  metabolic	  activation	  may	  be	  a	  relevant	  problem	  in	  case	  of	  proaptens.	  However,	  
NCTC	   2544	   cells	   posses	   both	   phase	   I	   and	   II	   metabolic	   activation	   capacity	   (Gelardi	   et	   al.,	  
2001),	  and	  positive	  results	  were	  indeed	  obtained	  with	  the	  proaptens	  eugenol	  and	  cinnamic	  
alcohol	   (Fig.	  2).	  A	  comparison	  between	   the	  phase	   I	  enzyme	  activities	  expressed	   in	  normal	  
human	   KC	   and	   in	   several	   human	   keratinocyte	   cell	   lines,	   namely	   HaCaT,	   SVK14	   and	   NCTC	  
2544,	  was	  established	  by	  Cotovio	  et	  al.	  (1997).	  From	  that	  study	  it	  appeared	  that	  in	  NCTC	  cell	  
line	   both	   basal	   and	   induced	   levels	   of	   7-­‐ethoxycoumarin	   O-­‐deethylase	   (ECOD)	   activity	  
(mainly	  CYP	  1A-­‐	  and	  CYP	  2B-­‐related),	  are	  higher	  than	  those	  found	  in	  normal.	  The	  NCTC	  2544	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cell	  line	  not	  only	  compares	  well	  with	  other	  in	  vitro	  models	  such	  as	  reconstructed	  epidermis	  
and	  primary	  cultured	  KC,	  but	  have	  even	  better	  metabolic	  properties.	  The	  characterization	  of	  
phase	  I	  and	  phase	  II	  metabolism	  expressed	  in	  these	  cells	  gives	  sustained	  evidence	  for	  their	  
suitability	  to	  in	  vitro	  toxicology	  studies	  (Gelardi	  et	  al.,	  2001).	  
In	  terms	  of	  potency,	  the	  calculation	  of	  concentration	  of	  allergen	  that	  induced	  a	  1.4	  increase	  
in	  cell-­‐associated	  IL-­‐18	  by	  linear	  regression	  analysis	  of	  data	  gave	  the	  following	  values:	  DNCB	  
(0.5	  μg/ml),	   4-­‐bromobenzylbromide	   (2.0	  μg/ml),	   2-­‐mercaptobenzothiazole	   (92	  μg/ml),	  
cinnamaldehyde	   (11.0	  μg/ml),	   cinnamyl	   alcohol	   (103	  μg/ml),	   eugenol	   (344	  μg/ml),	  
isoeugenol	   (12.8	  μg/ml),	   glyoxal	   (9.0	  μg/ml),	   resorcinol	   (206.0	  μg/ml),	   PPD	   (31.7	  μg/ml),	  
TMTD	   (1.04	  μg/ml).	   If	   compared	   with	   the	   available	   in	   vivo	   LLNA	   EC3	   values	   a	   significant	  
correlation	  (R	  =	  0.754,	  p	  =	  0.0098)	  was	  obtained.	  Therefore,	  IL-­‐18	  production	  by	  KC	  may	  also	  
be	  seen	  as	  a	  possible	  tool	  for	  the	  prediction	  of	  sensitizing	  strength	  of	  a	  particular	  chemical.	  
However,	  investigations	  are	  needed	  to	  better	  address	  the	  question	  of	  potency.	  
In	   conclusion,	   IL-­‐18	   production	   by	   NCTC	   2544	   cells,	   or	   primary	   KC,	   may	   represent	   a	  
promising	  in	  vitro	  model	  for	  the	  screening	  of	  potential	  contact	  allergens	  and	  may	  be	  useful	  
for	   ranking	   chemicals	   also	   for	   their	   sensitizing	   potency	   resulting	   in	   a	   reduction	   of	   animal	  
testing.	   The	   test	  may	   also	   be	   complementary	   to	   the	   LLNA,	   allowing	   for	   a	   rapid	   and	   easy	  
discrimination	  of	  contact	  sensitisers	  from	  respiratory	  allergens.	  Our	  results	  warrant	  further	  
analysis	  of	  panels	  of	  potential	  allergens	  and	  irritants.	  It	  is,	  however,	  important	  to	  stress	  that	  
due	  to	  the	  complexity	  of	  hypersensitivity	  reactions	  and	  the	  chemical	  diversity	  of	  allergens,	  a	  
more	   realistic	   approach	   should	   consider	   several	   markers	   of	   activation	   and	   different	   cell	  
types,	  including	  dendritic	  like	  cells.	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3.2	  FURTHER	  DEVELOPMENT	  OF	  THE	  NCTC	  2544	  IL-­‐18	  ASSAY	  TO	  IDENTIFY	  IN	  
VITRO	  CONTACT	  ALLERGENS	  
	  
Abstract	  
Several	   European	  Union	   legislations	   request	   the	   use	   of	   in	   vitro	  methods	   for	   toxicological	  
evaluations,	  including	  sensitization,	  in	  order	  to	  increase	  consumer	  safety	  but	  also	  to	  reduce	  
the	  use	  of	  animals.	  The	  EU	  project	  SENS-­‐IT-­‐IV	  addresses	  the	  need	  of	  developing	  predictive	  in	  
vitro	   tests	   to	  assess	   contact	  and	   respiratory	  hypersensitivity	   reactions.	   In	   this	   context,	  we	  
have	  recently	  reported	  the	  possibility	  to	  use	  IL-­‐18	  production	  in	  the	  human	  keratinocyte	  cell	  
line	  NCTC	  2544	   to	  discriminate	   contact	   sensitiser	   from	   irritants	  and	   low	  molecular	  weight	  
respiratory	  allergens.	  The	  aims	  of	   the	  present	   study	  were	   to	   further	  develop	   this	  assay	   in	  
order	  to	  optimize	  experimental	  conditions;	  to	  develop	  a	  96-­‐well	  plate	  format	  to	  establish	  a	  
high	   throughput	   assay;	   to	   test	   the	   performance	   of	   other	   available	   keratinocyte	   cell	   lines,	  
and	  to	  understand	  the	  signal	  transduction	  pathway	  involved	  in	  p-­‐phenylenediamine	  (PPD)-­‐
induced	  IL-­‐18	  production.	  
If	   cells	   reach	   confluence	   at	   the	   moment	   of	   treatment,	   the	   ability	   to	   identify	   contact	  
allergens	  is	  lost;	  therefore	  a	  careful	  check	  for	  the	  optimal	  cell	  density	  using	  PPD	  as	  reference	  
contact	  allergen	   is	  critical.	   In	  our	  hands,	  a	  cell	  density	  of	  1–2.5	  ×	  105	  cells/ml	  gave	  optimal	  
stimulation.	   In	  order	  to	  develop	  a	  high	  throughput	  test,	  cells	  seeded	  in	  96-­‐well	  plate	  were	  
exposed	   to	   contact	   allergens	   (2,4-­‐dinitrochlorobenzene,	   p-­‐phenylenediamine,	   isoeugenol,	  
cinnamaldehyde,	   tetramethylthiuram	   disulfite,	   resorcinol,	   cinnamic	   alcohol	   and	   eugenol),	  
irritants	   (phenol,	   sodium	   laurel	   sulphate,	   lactic	   acid	   and	   salicylic	   acid)	   and	   respiratory	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allergens	   (hexachloroplatinate,	   diphenylmethane	   diisocyanate,	   trimellitic	   anhydride).	   A	  
selective	  increase	  in	  total	  (intracellular	  plus	  released)	  IL-­‐18	  was	  observed	  24	  h	  later	  in	  cells	  
treated	   with	   contact	   allergens,	   whereas	   no	   changes	   were	   observed	   following	   treatment	  
with	   respiratory	   allergens	   and	   irritants,	   confirming	   previous	   results	   obtained	   in	   a	   24-­‐well	  
format	   assay.	   A	   selective	   induction	   of	   IL-­‐18	   was	   also	   obtained	   testing	   with	   PPD	   other	  
keratinocyte	   cell	   lines,	   namely	   HPKII	   and	   HaCaT,	   with	   the	   HPKII	   showing	   the	   highest	  
stimulation	  index.	  Regarding	  the	  signal	  transduction	  pathway,	  we	  could	  demonstrate	  using	  
selective	   inhibitors	   a	   role	   for	   oxidative	   stress,	   NF-­‐κB	   and	   p38	   MAPK	   activation	   in	   PPD-­‐
induced	  IL-­‐18	  production.	  
In	  conclusion,	  results	  obtained	  suggest	  that	  the	  production	  of	  IL-­‐18	  represents	  a	  promising	  
endpoint	  for	  the	  screening	  of	  potential	  contact	  allergens.	  The	  assay	  can	  be	  performed	  in	  a	  
96-­‐well	  plate	  format,	  different	  keratinocyte	  cell	   lines	  can	  be	  used,	  and	  a	  role	  for	  oxidative	  
stress	  in	  contact	  allergen-­‐induced	  IL-­‐18	  was	  demonstrated.	  
	  
Role	  of	  cell	  density	  and	  adhesion	  time	  on	  contact	  allergen-­‐induced	  intracellular	  IL-­‐18	  
The	  effect	  of	   cell	   density	  and	  adhesion	   time	  on	   the	   response	   to	   the	   contact	  allergen	  PPD	  
was	  investigated	  seeding	  cells	  at	  different	  density	  (1–10	  ×	  105	  cells/ml	  in	  24-­‐well	  plate)	  and	  
treating	  them	  after	  o.n.	  or	  2	  h	  seeding.	  As	  shown	  in	  Fig.	  1A,	  1–2.5	  ×	  105	  cells/ml	  represents	  
the	   optimal	   cell	   density,	   higher	   cell	   density	   (>5	  ×	  105	  cells/ml)	   resulted	   in	   a	   loss	   of	   effect.	  
This	   is	   also	   evident	   comparing	   the	   stimulation	   index:	   the	   higher	   SI	   was	   observed	   at	   cell	  
density	  of	  1–2.5	  ×	  105	  cell/ml.	  A	  critical	  point	  in	  the	  performance	  of	  the	  assay	  is,	  therefore,	  
the	   cell	   density:	   if	   cells	   reach	   confluence	   the	  discriminatory	   capacity	   is	   lost.	   This	   problem	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can	  be	  overcome	  treating	  cells	  2	  h	  after	  seeding,	  time	  sufficient	  to	  allow	  cells	  to	  adhere.	  As	  
shown	  in	  Fig.	  1C,	  a	  statistical	  significant	  upregulation	  of	  intracellular	  IL-­‐18	  was	  observed	  at	  
all	   cell	   densities	   tested,	   including	   5–10	  ×	  105	  cells/ml.	   Furthermore,	   as	   shown	   in	   Fig.	   1B,	  
seeding	   cells	   at	   two	   different	   density	   (1.5–2.5	  ×	  105	  cells/ml),	   and	   treating	   them	   after	   2	  h	  
with	   PPD	   (60	  μg/ml),	   cinnamaldehyde	   (30	  μg/ml),	   salicylic	   acid	   (250	  μg/ml)	   or	   DMSO	   as	  
vehicle	  control	  for	  24	  h,	  only	  the	  contact	  allergens	  induced	  an	  increase	  in	  intracellular	  IL-­‐18,	  
whereas	  salicylic	  acid	  fails,	  indicating	  that	  the	  discriminatory	  capacities	  are	  preserved.	  
	  
Selective	  induction	  of	  total	  IL-­‐18	  by	  contact	  allergens	  
In	  order	  to	  develop	  a	  high	  throughput	  assay,	  a	  96-­‐well	  plate	  format	  assay	  was	  developed.	  
NCTC	   2544	   cells	   were	   seeded	   in	   96-­‐well	   plate	   and	   treated	   for	   24	  h	   with	   representative	  
contact	  allergens,	  respiratory	  allergens	  or	  skin	  irritant.	  The	  highest	  concentration	  tested	  for	  
each	  chemical	  was	  the	  CV80.	  Following	  treatment	  the	  total	   IL-­‐18	  content	   (intracellular	  and	  
released)	  was	  assessed.	  NCTC	  2544	  cells	  were	  treated	  with	  increasing	  concentrations	  of	  the	  
contact	   allergens	   DNCB,	   PPD,	   isoeugenol,	   cinnamaldehyde,	   TMTD,	   resorcinol,	   cinnamic	  
alcohol	   and	   eugenol.	   As	   shown	   in	   Fig.	   2,	   all	   contact	   allergens,	   including	   the	   pro-­‐haptens	  
cinnamic	   alcohol	   and	   eugenol,	   induced	   a	   statistical	   significant	   increase	   in	   total	   IL-­‐18,	  
confirming	  results	  previously	  obtained	  in	  24-­‐well	  format	  assay	  (Corsini	  et	  al.,	  2009).	  
We	   then	   tested	   the	   effect	   of	   the	   respiratory	   allergens	   HClPt,	  MDI,	   TMA	   and	   the	   irritants	  
phenol,	  SDS,	  lactic	  acid	  and	  salicylic	  acid	  on	  total	  IL-­‐18.	  None	  of	  them	  was	  able	  to	  increase	  
total	   IL-­‐18	   (Fig.	   3	  and	  Fig.	   4),	   confirming	   the	   selective	   up-­‐regulation	   of	   IL-­‐18	   by	   contact	  
allergens.	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Fig.	   1.	  Effect	  of	  cell	  density	  and	  adhesion	  time	  on	   intracellular	   IL-­‐18.	  Panel	  A,	  over	  night	  adhesion.	  
NCTC	  2544	  were	   seeded	   in	  24-­‐well	   plate	  at	  different	  density	   (1–10	  ×	  105	  cells/ml).	  After	  overnight	  
adherence,	  cells	  were	   treated	   for	  24	  h	  with	  PPD	  (60	  μg/ml)	  or	  DMSO	  (0.2%	  final	  concentration)	  as	  
vehicle	  control.	  Results	  are	  expressed	  as	  mean	  ±	  SD,	  n	  =	  4.	  Panel	  B,	  2	  h	  adhesion.	  NCTC	  2544	  were	  
seeded	   in	   24-­‐well	   plate	   at	   different	   density	   (1–10	  ×	  105	  cells/ml).	   After	   2	  h	   adherence,	   cells	   were	  
treated	  for	  24	  h	  with	  PPD	  (60	  μg/ml)	  or	  DMSO	  (0.2%	  final	  concentration)	  as	  vehicle	  control.	  Results	  
are	  expressed	  as	  mean	  ±	  SD,	  n	  =	  4.	  Panel	  C,	  2	  h	  adhesion.	  NCTC	  2544	  were	  seeded	  in	  24-­‐well	  plate	  at	  
two	  different	  density:	  1.5–2.5	  ×	  105	  cells/ml.	  After	  2	  h	  of	  adherence,	  cells	  were	  treated	  for	  24	  h	  with	  
PPD	   (60	  μg/ml),	   cinnamaldehyde	   (30	  μg/ml),	   salicylic	   acid	   (200	  μg/ml)	   or	   DMSO	   (0.2%	   final	  
concentration)	  as	  vehicle	  control.	  Results	  are	  expressed	  as	  mean	  ±	  SD,	  n	  =	  4.	  Statistical	  analysis	  was	  
performed	  with	  Student’s	  multiple	  comparison	  test	  for	  panel	  A,	  B	  and	  Dunnet’s	  multiple	  comparison	  
test	  for	  panel	  B,	  with	  ∗∗p	  <	  0.01	  versus	  vehicle	  treated	  cells	  (control).	  SI,	  stimulation	  index.	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Fig.	   2.	  Effects	   of	   contact	   sensitisers	   on	   total	   IL-­‐18	   production.	  NCTC	   2544	   seeded	   in	   96-­‐well	   plate	  
were	   treated	   for	   24	  h	   with	   increasing	   concentration	   of	   DNCB	   (A),	   PPD	   (B),	   isoeugenol	   (C),	  
cinnamaldehyde	  (D),	  TMTD	  (E),	  resorcinol	  (F),	  cinnamic	  alcohol	  (G)	  and	  eugenol	  (H).	  Cells	  incubated	  
with	  vehicle	  were	  included	  as	  control	  (0).	  Results	  are	  expressed	  as	  mean	  ±	  SD.	  Statistical	  analysis	  was	  
performed	   with	   Dunnett’s	   multiple	   comparison	   test,	   with	   ∗p	  <	  0.05	   and	   ∗∗p	  <	  0.01	   versus	   vehicle	  
treated	  cells	  (0).	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Fig.	  3.	  Effects	  of	  respiratory	  allergens	  on	  total	  IL-­‐18	  production.	  NCTC	  2544	  seeded	  in	  96-­‐well	  plate	  
were	  treated	  for	  24	  h	  with	  increasing	  concentration	  of	  hexachloroplatinate	  (A),	  MDI	  (B)	  and	  TMA	  (C).	  
Cells	   incubated	   with	   vehicle	   were	   included	   as	   a	   control	   (0).	   Results	   are	   expressed	   as	   mean	  ±	  SD.	  
Statistical	   analysis	   was	   performed	   with	   Dunnett’s	   multiple	   comparison	   test	   with	   ∗p	  <	  0.05	   and	  
∗∗p	  <	  0.01	  versus	  vehicle	  treated	  cells	  (0).	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Fig.	  4.	  Effects	  of	  irritants	  on	  total	  IL-­‐18	  production.	  NCTC	  2544	  seeded	  in	  96-­‐well	  plate	  were	  treated	  
for	  24	  h	  with	  increasing	  concentration	  of	  phenol	  (A),	  SDS	  (B),	  lactic	  acid	  (C)	  and	  salicylic	  acid	  (D,	  Sal.	  
Ac.).	  Cells	  incubated	  with	  vehicle	  were	  included	  as	  a	  control	  (0).	  Results	  are	  expressed	  as	  mean	  ±	  SD.	  
Statistical	   analysis	   was	   performed	   with	   Dunnett’s	   multiple	   comparison	   test	   with	   ∗p	  <	  0.05	   and	  
∗∗p	  <	  0.01	  versus	  vehicle	  treated	  cells	  (0).	  
	  
	  
Effects	  of	  PPD	  on	  cell-­‐associated	  IL-­‐18	  in	  different	  human	  KC	  
We	  then	  investigated	  if	  these	  results	  were	  peculiar	  of	  this	  cell	  line	  or	  if	  similar	  results	  could	  
be	  obtained	  using	  other	  keratinocyte	  cell	  lines.	  At	  this	  purpose,	  two	  other	  KC	  cell	  lines	  were	  
used,	   namely	   HaCaT	   and	   HPK	   II.	   As	   shown	   in	   Fig.	   5,	   the	   treatment	  with	   PPD	   induced	   an	  
increase	   in	   intracellular	   IL-­‐18	  content	   in	  all	   three	  cell	   lines	   tested,	  with	   the	  HPKII	   showing	  
the	  highest	  stimulation	  index:	  3.4	  ±	  0.7	  vs	  1.6	  ±	  0.3	  in	  NCTC	  2544	  and	  2.1	  ±	  0.3	  in	  HaCaT	  cells	  
(p	  <	  0.05).	  These	  results	  confirm	  the	  possibility	  to	  use	  different	  keratinocyte	  models.	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Fig.	   5.	  Effect	   of	   PPD	   on	   intracellular	   IL-­‐18	   in	   three	   keratinocyte	   cell	   lines.	   NCTC	   2544,	   HPKII	   and	  
HaCaT	  cells	   lines	  were	  treated	  for	  24	  h	  with	  PPD	  (60	  μg/ml)	  or	  DMSO	  (0.2%	  final	  concentration)	  as	  
vehicle	  control.	  Results	  are	  expressed	  as	  mean	  ±	  SD.	  Statistical	  analysis	  was	  performed	  with	  Tukey’s	  
multiple	   comparison	   test,	   with	   ∗∗p	  <	  0.01	   versus	   vehicle	   treated	   cells	   (0).	   SI,	   stimulation	   index.	  
#p	  <	  0.05	  and	  ##p	  <	  0.01	  vs	  NCTC	  2544	  or	  HaCaT	  cells	  treated	  with	  PPD.	  
	  
	  
Signal	  transduction	  pathway	  
Finally,	   we	   wanted	   to	   investigate	   the	   signal	   transduction	   pathway	   involved	   in	   p-­‐
phenylenediamine	   (PPD)-­‐induced	   IL-­‐18	   production.	   For	   this	   purpose,	   several	   selective	  
inhibitors	  were	  used:	  GF109203X	  (5	  μM)	  to	  inhibit	  protein	  kinase	  C,	  PDTC	  (100	  μM)	  and	  Bay	  
11-­‐7085	   (1	  μM)	   to	   inhibit	  NF-­‐κB	  and	  SB203580	   (100	  nM)	   to	   inhibit	  p38	  MAPK.	  As	   show	   in	  
Fig.	   6A,	   PPD	   induced	   intracellular	   IL-­‐18	  was	   not	  modulated	   by	   GF109203X,	   excluding	   the	  
involvement	   of	   protein	   kinase	   C.	   On	   the	   contrary,	   PDTC,	   Bay	   11-­‐7085	   and	   SB203580,	  
significantly	  modulated	  PPD-­‐induced	  intracellular	  IL-­‐18,	  indicating	  a	  role	  for	  oxidative	  stress,	  
NF-­‐κB	  and	  p38	  MAPK	  activation.	   (Fig.	  6B–D).	  The	  ability	  of	  PPD	  to	  activate	  p38	  MAPK	  and	  
NF-­‐κB	  was	  confirmed	  by	  Western	  blot	  analysis	  (Fig.	  7).	  Cells	  were	  treated	  with	  PPD	  or	  DMSO	  
	   100	  
as	   vehicle	   control	   for	   5,	   15,	   30	   and	   60	  min.	   As	   shown	   in	   Fig.	   7,	   p38	   MAPK	   was	   clearly	  
activated	  after	  15	  min,	  whereas	  NF-­‐κB	  was	  activated	  at	  later	  time	  points.	  
	  
	  	  	  	  	  	  	  	  	   	  
	  
Fig.	   6.	  Role	   of	   oxidative	   stress,	   p38	  MAPK	   and	   NF-­‐κB	   activation	   in	   PPD-­‐induced	   IL-­‐18	   production.	  
NCTC	  2544	  were	  treated	  with	  GF109203X	  (5	  μM),	  PDTC	  (100	  μM),	  Bay	  11-­‐7085	  (1	  μM)	  and	  SB203580	  
(100	  nM)	  for	  1	  h	  and	  after	  with	  PPD	  (60	  μg/ml)	  or	  DMSO	  (0.2%	  final	  concentration)	  as	  vehicle	  control	  
for	   24	  h.	   Results	   are	   expressed	   as	   mean	  ±	  SD.	   Statistical	   analysis	   was	   performed	   with	   Tukey’s	  
multiple	  comparison	  test,	  with	  ∗∗p	  <	  0.01	  versus	  vehicle	   treated	  cells	   (0).	   ##p	  <	  0.01	  vs	  cells	   treated	  
with	  PPD	  alone.	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Fig.	  7.	  PPD	  activated	  p38	  MAPK	  and	  NF-­‐B	  in	  NCTC	  2544	  cells.	  Cells	  were	  seeded	  in	  6-­‐well	  plate	  at	  a	  
cell	   density	   of	   2.5	  ×	  105	  cells/ml	   (2	  ml/well).	   After	   24	  h	   of	   adherence,	   cells	  were	   treated	  with	   PPD	  
(60	  μg/ml)	   or	   DMSO	   as	   vehicle	   control	   for	   different	   times	   (5–60	  min).	   Panel	   A,	   representative	  





In	  the	  present	  manuscript,	  the	  ‘NCTC	  2544	  IL-­‐18	  assay’	  developed	  to	  identify	  in	  vitro	  contact	  
allergens,	  was	  further	  characterized.	  The	  experimental	  conditions	  were	  optimized	  to	  clarify	  
the	   cell	   density	   issue,	   a	   high	   throughput	   assay	  was	   developed,	   the	   performance	   of	   other	  
available	  keratinocyte	  cell	  lines	  was	  tested,	  and	  the	  signal	  transduction	  pathways	  involved	  in	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PPD-­‐induced	  IL-­‐18	  production	  were	  characterized.	  
In	  our	  previous	  manuscript	  (Corsini	  et	  al.,	  2009),	  and	  also	  during	  technology	  transfer	  of	  the	  
assay	   to	  other	   laboratories,	  a	   critical	  point	  was	   identified	   in	   the	  cell	  density.	   If	   cells	   reach	  
confluence	  at	  the	  moment	  of	  treatment,	  the	  ability	  to	  discriminate	  contact	  allergens	  from	  
skin	  irritants	  and	  respiratory	  sensitiser	  is	  lost.	  Due	  to	  the	  use	  of	  different	  foetal	  calf	  serum,	  a	  
different	  cellular	  doubling	  time	  can	  be	  expected	  in	  the	  different	  laboratories.	  Therefore,	  as	  
the	  cells	  number	  deeply	  influences	  the	  outcome,	  each	  laboratory	  should	  carefully	  check	  for	  
the	  optimal	  cell	  density,	  using	  the	  positive	  control	  PPD	  as	  a	  reference	  compound.	  We	  found	  
that	  a	  possible	  alternative	   is	   to	  treat	  the	  cells	   the	  same	  day	  of	  seeding	  after	  two	  hours	  of	  
adherence.	  Under	  this	  condition,	  the	  selective	  upregulation	  of	  intracellular	  IL-­‐18	  by	  contact	  
allergens	  is	  maintained	  and	  the	  cell	  density	  issue	  is	  overcome.	  
Next,	  in	  order	  to	  further	  develop	  the	  assay	  and	  to	  increase	  its	  screening	  capacity,	  a	  96-­‐well	  
format	  assay	  was	  developed.	  To	  speed	  up	  the	  assay	  and	  reduce	  cell	  manipulation	   (no	  cell	  
washing	   steps	   and	   no	   protein	   determination),	   after	   the	   treatment,	   cells	   were	   lysed	   in	  
culture	  medium	  directly	  adding	  Triton	  X-­‐100	  (final	  concentration	  0.5%).	  In	  this	  case	  the	  total	  
IL-­‐18	   (intracellular	   plus	   released)	  was	   assessed.	   Also	   under	   this	   experimental	   condition,	   a	  
selective	   increase	   in	   total	   IL-­‐18	   was	   observed	   only	   following	   treatment	   with	   contact	  
allergens,	  whereas	  both	  irritants	  and	  respiratory	  allergens	  failed,	  indicating	  the	  possibility	  to	  
use	  total	   IL-­‐18	  to	   identify	  contact	  allergens.	  A	  total	  of	  eight	  contact	  allergens,	  namely	  2,4-­‐
dinitrochlorobenzene,	   p-­‐phenylenediamine,	   isoeugenol,	   cinnamaldehyde,	  
tetramethylthiuram	   disulfite,	   resorcinol,	   cinnamic	   alcohol	   and	   eugenol	   were	   tested.	   All,	  
including	   pre-­‐	   (i.e.	   PPD)	   and	   pro-­‐haptens	   (i.e.	   cinnamic	   alcohol	   and	   eugenol),	   induced	   a	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statistically	   significant	   increase	   in	   total	   IL-­‐18.	   Whereas	   the	   respiratory	   allergens,	   namely	  
hexachloroplatinate,	   diphenylmethane	   diisocyanate,	   trimellitic	   anhydride,	   as	   well	   as	   the	  
irritants	  phenol,	  sodium	  laurel	  sulphate,	  lactic	  acid	  and	  salicylic	  acid	  did	  not	  affect	  the	  total	  
IL-­‐18	  content.	  The	  main	  limitation	  of	  assessing	  total	  versus	  intracellular	  IL-­‐18	  is	  the	  lost,	   in	  
many	   cases,	   of	   a	   dose–response	   curve,	   which	   may	   hamper	   the	   possibility	   to	   use	   the	  
induction	   of	   IL-­‐18	   for	   potency	   classification.	   Indeed,	   as	   previously	   shown	   (Corsini	   et	   al.,	  
2009),	   contact	   allergens	   induced	   a	   dose-­‐related	   increase	   in	   intracellular	   IL-­‐18	   and	   by	  
calculation	  of	  the	  concentration	  of	  allergen	  that	  induced	  a	  1.4	  increase	  in	  cell-­‐associated	  IL-­‐
18	   a	   significant	   correlation	   with	   the	   in	   vivo	   LLNA	   EC3	   values	   was	   obtained	   (R	  =	  0.754,	  
p	  =	  0.0098).	   The	   main	   advantage	   of	   the	   96-­‐well	   format	   is,	   of	   course,	   time	   saving,	   less	  
compound	  needed	  and	  high	  throughput,	  which	  allow	  a	  more	  rapid	  screening	  of	  chemicals	  
for	  their	  contact	  sensitization	  potential.	  The	  lack	  of	  a	  clear	  dose–response	  may	  be	  due	  to	  a	  
different	  effect,	  depending	  on	  the	  concentration,	  of	  the	  sensitiser	  on	  the	  release	  of	  IL-­‐18	  vs	  
the	  effect	  on	  the	   intracellular	   IL-­‐18	  content,	  or	  to	  a	  possible	   interference	  of	  the	  chemicals	  
with	  the	  ELISA.	  Indeed,	  by	  adding	  recombinant	  IL-­‐18	  to	  cell	  lysates,	  as	  an	  internal	  standard,	  
a	   20–40%	   reduction	   in	   its	   recovery	   was	   observed	   in	   cells	   treated	   with	   resorcinol	   and	  
eugenol.	  
The	  ability	  of	  NCTC	  2544	  to	   identify	  contact	  allergens	   is	  not	  peculiar	  of	  this	  human	  KC	  cell	  
lines,	   as	   previously	   demonstrated	   (Corsini	   et	   al.,	   2009)	   with	   primary	   human	   KC,	   similar	  
results	  were	   also	   obtained	   using	   other	   human	   KC	   cell	   lines,	   i.e.	   HPKII	   and	  HaCaT,	   further	  
confirming	  the	  relevance	  of	  the	  proposed	  model	  and	  the	  possibility	  to	  use	  different	  source	  
of	  KC.	  Among	  the	  three	  KC	  cell	  lines	  tested,	  at	  least	  for	  PPD,	  a	  higher	  stimulation	  index	  was	  
obtained	   with	   HPKII.	   Further	   chemicals,	   however,	   must	   be	   tested	   to	   prove	   the	   better	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performance	  of	  this	  cell	  line.	  
Finally,	   we	   aimed	   to	   investigate	   the	   signal	   transduction	   pathways	   involved	   in	   contact	  
allergen-­‐induced	   IL-­‐18	   production.	   KC	   form	   an	   interface	   between	   the	   body	   and	   the	  
environment,	   they	   are	   important	   guardians	   for	   the	   detection	   of	   danger	   signals	   and	   the	  
consecutive	  initiation	  of	  an	  inflammatory	  response.	  The	  transduction	  of	  extracellular	  signals	  
into	   cellular	   response	   is	   mediated	   by	   an	   array	   of	   different	   kinases,	   that	   includes	   protein	  
kinase	  C	  and	  mitogen	  activated	  protein	  kinases	  (MAPK).	  Both	  kinases	  have	  been	  involved	  in	  
the	   induction	   of	   allergic	   contact	   dermatitis.	   It	   has	   been	   reported	   in	   a	   mouse	   model	   of	  
contact	  hypersensitivity,	  that	  pretreatment	  with	  SB202190,	  a	  p38	  MAPK	  inhibitor	  abrogated	  
DNFB-­‐induced	  contact	  hypersensitivity,	  indicating	  the	  important	  role	  of	  this	  kinase	  (Lisby	  et	  
al.,	   1995).	   The	   ability	   of	   allergens	   to	   activate	   p38	  MAPK	  has	   been	   also	   demonstrate	   in	   in	  
vitro	  studies	  in	  both	  keratinocyte	  cell	  line	  A431	  (	  Mehrotra	  et	  al.,	  2007)	  and	  dendritic	  cells	  (	  
Aiba	   et	   al.,	   2003,	   Arrighi	   et	   al.,	   2001,	   Boisleve	   et	   al.,	   2005	  and	  Mitjans	   et	   al.,	   2008).	   Also	  
protein	  kinase	  C	  modulation	  has	  been	  associated	  with	  reduction	  in	  both	  irritant	  and	  allergic	  
contact	  dermatitis	  (	  Jacobson	  et	  al.,	  1995).	  Several	  selective	  inhibitors	  were	  therefore	  used	  
together	   with	   PPD,	   as	   reference	   allergen,	   to	   investigate	   the	   role	   of	   protein	   kinase	   C,	  
oxidative	   stress,	   NF-­‐B	   and	   p38	   MAPK	   in	   PPD-­‐induced	   IL-­‐18.	   In	   particular,	   GF109203X	   a	  
selective	   inhibitor	   for	   the	  α	  and	  β1	  protein	  kinase	  C	   isoforms	  was	  used	   to	   investigate	   the	  
role	  of	  protein	  kinase	  C;	  PDTC,	  an	   inhibitor	  of	  NF-­‐B	  and	  an	  anti-­‐oxidant	   to	   investigate	   the	  
role	   of	  NF-­‐B	   activation	   and	   oxidative	   stress;	   Bay	   11-­‐7085	   as	   an	   irreversible	   inhibitor	   IκBα	  
phosphorylation	  to	  assess	  the	  role	  of	  NF-­‐B	  activation,	  and	  finally,	  SB	  203580	  as	  inhibitor	  of	  
p38	  MAPK	  activation	  to	  investigate	  the	  role	  of	  MAPK.	  Results	  obtained	  indicated	  a	  role	  for	  
oxidative	   stress,	   NF-­‐B	   and	   p38	   MAPK	   activation	   in	   PDD-­‐induced	   IL-­‐18	   production.	   No	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modulation	   was	   observed	   inhibiting	   protein	   kinase	   C	   activation,	   suggesting	   that	   its	  
activation	  is	  not	  involved	  in	  IL-­‐18	  production.	  The	  results	  obtained	  with	  the	  inhibitors	  of	  NF-­‐
B	  and	  p38	  MAPK	  are	  consistent	  with	  an	   inhibition	  of	   IL-­‐18	   transcription	  as	   in	  5ʹ′	  upstream	  
region	  of	  the	  human	  IL-­‐18	  gene	  AP-­‐1,	  PU.1,	  NF-­‐B	  and	  SP-­‐1	  transcription	  binding	  sites	  have	  
been	  identified	  (	  Takeuchi	  et	  al.,	  1999).	  
Oxidative	  stress	  may	  be	  the	  starter	  point,	  as	  it	  leads	  to	  the	  activation	  of	  transcription	  factors	  
and	   signalling	   pathways,	   including	   NF-­‐B	   and	   p38	   MAPK,	   which	   leads	   to	   the	   release	   of	  
cytokines	  and	  chemokines	  (Gloire	  et	  al.,	  2006,	  Kim	  and	  Choi,	  2010	  and	  Rahman	  and	  Biswas,	  
2004).	   Reactive	   oxygen	   species	   plays	   also	   an	   important	   role	   in	   the	   activation	   of	   the	  
NLRP3/NALP3	  inflammasome	  (Bryant	  and	  Fitzgerald,	  2009	  and	  Martinon	  et	  al.,	  2009),	  which	  
is	  required	  to	  direct	  the	  proteolytic	  maturation	  of	  inflammatory	  cytokines	  such	  as	  IL-­‐1	  and	  
IL-­‐18	   (Martinon,	   2010).	   The	   ability	   of	   contact	   sensitisers	   to	   induce	   the	   oxidative	   stress	  
pathway	   in	   KC	   has	   been	   recently	   confirmed	   by	   several	   authors	   (Natsch	   and	   Emter,	  
2008	  and	  Vandebriel	  et	  al.,	  2010).	  
In	   conclusion,	   total	   IL-­‐18	   production	   by	   NCTC	   2544,	   the	   induction	   of	   IL-­‐18	   in	   other	  
keratinocyte	  cell	  lines;	  all	  give	  the	  possibility	  to	  identify	  potential	  contact	  allergens	  in	  vitro.	  
The	  proposed	  test	  may	  be	  used	  as	  a	  stand	  alone	  assay	  or	  as	  a	  pre-­‐screen	  before	  the	  LLNA	  
(i.e.	  the	  LLNA	  can	  be	  used	  to	  confirm	  a	  negative	  finding),	  or	  it	  can	  be	  used	  complementary	  
to	  other	  non-­‐animal	   test	   (i.e.	  QSAR,	  peptide	  binding	   assay,	   etc.),	   allowing	   for	   a	   rapid	   and	  
easy	  discrimination	  of	  contact	  sensitisers	  from	  respiratory	  allergens	  and	  skin	   irritants.	  Due	  
to	  the	  complexity	  of	  contact	  sensitization	  and	  the	  limited	  number	  of	  chemicals	  tested	  in	  the	  
NCTC	  2544	  assay	  (only	  the	  SENS-­‐IT-­‐IV	  list	  has	  been	  so	  far	  tested),	  it	  is,	  however,	  likely	  that	  a	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combined	  analysis	  of	  more	  biomarkers	  rather	  than	  analysis	  of	  a	  single	  biomarkers	  will	  give	  
more	   satisfactory	   results.	   The	  NCTC	  2544	   intracellular	   IL-­‐18	  assay	  has	   currently	   entered	  a	  
prevalidation	   stage	   sponsored	   by	   SENSTIV	   and	   the	   Dutch	   Governmental	   association	  
ZonMW.	   It	   is	   hoped	   to	   have	   a	   fully	   validated	   assay	   implemented	   in	   time	   to	   meet	   the	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3.3	  ESTABLISHMENT	  OF	  AN	  IN	  VITRO	  PHOTOALLERGY	  TEST	  USING	  NCTC2544	  
CELLS	  AND	  IL-­‐18	  PRODUCTION	  
	  
Abstract	  
Differentiation	  between	  photoallergenic	  and	  phototoxic	  reactions	  induced	  by	  low	  molecular	  
weight	   compounds	   represents	   a	   current	  problem.	   The	  use	  of	   keratinocytes	   as	   a	  potential	  
tool	   for	   the	   detection	   of	   photoallergens	   as	   opposed	   to	   photoirritants	   is	   considered	   an	  
interesting	  strategy	  for	  developing	  in	  vitro	  methods.	  We	  have	  previously	  demonstrated	  the	  
possibility	   to	   use	   the	   human	   keratinocyte	   cell	   line	   NCTC2455	   and	   the	   production	   of	  
interleukin-­‐18	  (IL-­‐18)	  to	  screen	  low	  molecular	  weight	  sensitisers.	  The	  purpose	  of	  this	  work	  
was	   to	   explore	   the	   possibility	   to	   use	   the	   NCTC2544	   assay	   to	   identify	   photoallergens	   and	  
discriminate	  from	  phototoxic	  chemicals.	  
First,	  we	  identified	  suitable	  condition	  of	  UV-­‐irradiation	  (3.5	  J/cm2)	  by	  investigating	  the	  effect	  
of	  UVA	  irradiation	  on	  intracellular	  IL-­‐18	  on	  untreated	  or	  chloropromazine	  (a	  representative	  
phototoxic	   compound)-­‐treated	   NCTC2544	   cells.	   Then,	   the	   effect	   of	   UVA-­‐irradiation	   over	  
NCTC2544	   cells	   treated	   with	   increasing	   concentrations	   of	   15	   compounds	   including	  
photoallergens	   (benzophenone,	   4-­‐ter-­‐butyl-­‐4-­‐methoxy-­‐dibenzoylmethane,	   2-­‐ethylexyl-­‐p-­‐
methoxycinnamate,	   ketoprofen,	   6-­‐methylcumarin);	   photoirritant	   and	   photoallergen	   (4-­‐
aminobenzoic	   acid,	   chlorpromazine,	   promethazine);	   photoirritants	   (acridine,	   ibuprofen,	   8-­‐
methoxypsoralen,	   retinoic	   acid);	   and	   negative	   compounds	   (lactic	   acid,	   SDS	   and	   p-­‐
phenilendiamine)	   was	   investigated.	   Twenty-­‐four	   hours	   after	   exposure,	   cytotoxicity	   was	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evaluated	   by	   the	   MTT	   assay	   or	   LDH	   leakage,	   while	   ELISA	   was	   used	   to	   measure	   the	  
production	  of	  IL-­‐18.	  At	  the	  maximal	  concentration	  assayed	  with	  non-­‐cytotoxic	  effects	  (CV80	  
under	   irradiated	   condition),	   all	   tested	   photoallergens	   induced	   a	   significant	   and	   a	   dose-­‐
dependent	   increase	  of	   intracellular	   IL-­‐18	   following	  UVA	   irratiation,	  whereas	  photoirritants	  
failed.	   We	   suggest	   that	   this	   system	   may	   be	   useful	   for	   the	   in	   vitro	   evaluation	   of	   the	  
photoallergic	  potential	  of	  chemicals.	  
	  
Establishment	  of	  the	  irradiation	  conditions	  
The	  dose	  of	  UVA	  irradiation	  was	  assessed	  exposing	  cells	  to	  increasing	  UVA	  doses.	  Under	  our	  
experimental	  conditions,	  as	  shown	  in	  Fig.	  1	  A,	  the	  dose	  of	  3.5	  J/cm2	  represents	  the	  optimal	  
UVA	  dose.	  As	  at	  this	  dose,	  no	  effects	  of	  UVA	  alone	  was	  observed,	  while	  UVA	  dose	  of	  7	  J/cm2	  
resulted	   in	   a	   loss	   of	   IL-­‐18	   production	   and	   LDH	   leakage	   (cytotoxicity),	   compared	   to	   not	  
irradiated	  cells.	  
The	   photoallergen/photoirritant	   chloropromazine	  was	   then	   used	   to	   establish	   the	   optimal	  
irradiation	  conditions	  in	  the	  presence	  of	  potential	  phototoxic	  compound.	  Initially,	  as	  highest	  
concentration	  the	  CV80	  calculated	  in	  non-­‐irradiated	  condition	  was	  used	  (Fig.	  1	  B,	  C),	  hoping	  
to	  use	  the	  same	  SOPs	  developed	  for	  the	  NCTC2544	  IL-­‐18	  assay.	  In	  this	  condition,	  however,	  
following	  UVA	  irradiation	  a	  dramatic	  cytotoxicity	  was	  observed	  as	  assessed	  by	  LDH	  leakage,	  
which	  resulted	  in	  the	  impossibility	  to	  assess	  the	  effect	  of	  irradiated	  chloropromazine	  on	  IL-­‐
18	  production.	  Therefore,	  CV80	  was	  assessed	   in	   irradiated	  condition.	  As	  shown	   in	  Fig.	  1D,	  
using	   the	   CV80	   calculated	   in	   irradiated	   condition	   as	   the	   highest	   concentration,	   irradiated	  
chloropromazine	   induced	   a	   dose-­‐related	   increase	   in	   intracellular	   IL-­‐18.	   To	   appreciate	   the	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effect	   of	   the	   combination	   of	   chemical	  +	  UVA,	   the	   ratio	   of	   IL-­‐18	   SI	   in	   irradiated	   vs	   non-­‐
irradiated	  conditions	  is	  reported	  as	  dotted	  line	  (Fig.	  1D).	  
Based	   on	   these	   experiments,	   the	   UVA	   dose	   of	   3.5	  J/cm2	   was	   selected,	   and	   as	   highest	  
concentration	  the	  CV80	  calculated	  in	  irradiated	  condition	  was	  used.	  
	  
Determination	  of	  80%	  cell	  viability	  
The	  concentration	  of	  chemical	  resulting	  in	  80%	  of	  viability	  (CV80)	  respect	  to	  vehicle	  treated	  
cells	  24	  h	  was	  calculated	  for	  all	  chemicals	  in	  both	  non-­‐irradiated	  and	  irradiated	  conditions.	  
Results	   are	   presented	   in	   Table	   1.	   For	   many	   chemicals,	   including	   photoallergens	   and	  




















Fig.	  1.	  Effects	  of	  UVA	  irradiation	  on	  intracellular	  IL-­‐18	  and	  viability	  of	  NCTC2544	  cells.	  (A)	  Cells	  were	  
irradiated	  at	   the	  UVA	  doses	  of	  3.5	  and	  7	  J/cm2.	   Intracellular	   IL-­‐18	  and	  LDH	   leakage	  were	  assessed	  
24	  h	   later.	   Results	   are	   expressed	   as	   mean	  ±	  SD,	   n	  =	  4.	   Statistical	   analysis	   was	   performed	   with	  
Dunnett’s	   multiple	   comparison	   test,	   with	   ∗∗p	  <	  0.01	   vs	   non-­‐irradiated	   cells	   (NI).	   Dose	   response	  
effects	   of	   chloropromazine	   on	   cell	   viability	   (B)	   and	   cell-­‐associated	   IL-­‐18	   (C).	   NCTC2544	   cells	   were	  
irradiated	   (I)	   at	   the	   UVA	   dose	   of	   3.5	  J/cm2	   or	   non-­‐irradiated	   (NI)	   in	   the	   presence	   of	   increasing	  
concentrations	   of	   chloropromazine,	   using	   the	   CV80	   calculated	   under	   non-­‐irradiated	   condition	   as	  
highest	  concentration.	  (D)	  Dose	  response	  effects	  of	  chloropromazine	  on	  cell-­‐associated	  IL-­‐18,	  using	  
the	  CV80	  calculated	  under	  irradiation	  condition	  as	  highest	  concentrations.	  Results	  are	  expressed	  as	  
mean	  ±	  SD,	  n	  =	  4.	  Statistical	  analysis	  was	  performed	  with	  Dunnett’s	  multiple	  comparison	   test,	  with	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Table	   1.	   Concentration	   (μM)	   of	   the	   tested	   chemicals	   that	   induced	   80%	   viability	   (CV80)	   in	   non-­‐
irradiated	  and	  irradiated	  conditions	  (3.5	  J/cm2),	  and	  their	  classification.	  
	  





2-­‐Ethylhexyl-­‐4-­‐methoxycinnamate	   3400	   9.8	   Photoallergen	  
6-­‐Methylcoumarin	   >1000	   10	   Photoallergen	  
Avobenzone	   90	   90	   Photoallergen	  
Benzophenone	   >1000	   31.2	   Photoallergen	  
Ketoprofen	   3000	   4.9	   Photoallergen	  
	   	   	   	  
4-­‐Aminobenzoic	  acid	  (PABA)	   7300	   7300	   Photoallergen/photoirrita
nt	  
Chlorpromazine	   20	   1.25	   Photoallergen/photoirrita
nt	  
Promethazine	   125	   1	   Photoallergen/photoirrita
nt	  
	   	   	   	  
8-­‐Methoxypsoralen	   700	   2	   Photoirritant	  
Acridine	   2116	   0.05	   Photoirritant	  
Ibuprofen	   >1000	   >1000	   Photoirritant	  
Retinoic	  acid	   50	   20	   Photoirritant	  
	   	   	   	  
p-­‐Phenylenediamine	  (PPD)	   55	   27.5	   Allergen	  
Lactic	  acid	   >8300	   >8300	   Irritant	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Selective	  induction	  of	  intracellular	  IL-­‐18	  by	  photoallergens	  
NCTC2544	   cells	   were	   treated	   for	   24	  h	   with	   the	   selected	   photoallergens	   (Fig.	   2),	  
photoallergens/photoirritants	   (Fig.	   3),	   photoirritants	   (Fig.	   4),	   and	   non-­‐phototoxic	  
compounds	  (Fig.	  5).	  Following	  treatment	  and	  UVA	  irradiation,	  the	  intracellular	  IL-­‐18	  content	  
was	  assessed	  as	  described	  in	  the	  Materials	  and	  Methods	  section.	  Results	  are	  reported	  as	  the	  
ratio	  of	  IL-­‐18	  SI	  in	  irradiated	  vs	  non-­‐irradiated	  conditions	  (IL-­‐18	  SI	  (I/NI)).	  
As	   shown	   in	   Fig.	   2	   and	   Fig.	   3,	   all	   irradiated	   photoallergens	   and	  
photoallergens/photoirritants,	  induced	  a	  statistical	  significant	  increase	  in	  intracellular	  IL-­‐18,	  
with	  an	  IL-­‐18	  SI	  (I/NI)	  up	  to	  7	  for	  chloropromazine.	  The	  lowest	  inductions	  were	  observed	  for	  
avobenzone	   and	   benzophenone.	   In	   all	   figures,	   a	   dotted	   line	   was	   set	   at	   a	   SI	   of	   1.3,	   as	  
provisional	   criteria	   for	   identification	   of	   photoallergens	   and	   discriminate	   them	   from	  
photoirritants.	  
We	   then	   tested	   the	   effect	   of	   the	   photoirritants	   ibuprofen,	   acridine,	   retinoic	   acid	   and	   8-­‐
methoxypsoralene	   (Fig.	   5).	   Irradiated	   ibuprofen	   and	   acridine	   failed	   to	   induced	   IL-­‐18	  
production,	  while	  a	  slight	  increase,	  below	  or	  close	  to	  IL-­‐18	  SI	  (I/NI)	  of	  1.3,	  was	  observed	  at	  
the	  highest	  concentration	  of	  8-­‐methoxypsoralene	  and	  retinoic	  acid.	  
Finally,	  we	  assessed	  the	  effects	  of	  not	  phototoxicants,	  namely	  PPD,	   lactic	  acid	  and	  SDS	  on	  
intracellular	  IL-­‐18	  production.	  Following	  UVA	  irradiation,	  none	  of	  them	  was	  able	  to	  increase	  
intracellular	   IL-­‐18	   (Fig.	   5),	   confirming	   the	   selective	   up-­‐regulation	   of	   IL-­‐18	   by	   irradiated	  
photoallergens.	  
	  




Fig.	  2.	  Effects	  of	  the	  selected	  photoallergens	  on	  cell-­‐associated	  IL-­‐18.	  NCTC2544	  cells	  were	  irradiated	  
(I)	  at	  the	  UVA	  dose	  of	  3.5	  J/cm2	  or	  non-­‐irradiated	  (NI)	  in	  the	  presence	  of	  increasing	  concentrations	  of	  
the	   selected	   photoallergens,	   using	   the	   CV80	   calculated	   under	   irradiated	   condition	   as	   highest	  
concentration.	  Results	  are	  expressed	  as	  IL-­‐18	  SI	  (I/NI).	  A	  dotted	  line	  was	  set	  at	  a	  SI	  of	  1.3.	  Each	  data	  
is	  mean	  ±	  SD,	  n	  =	  4.	  Statistical	  analysis	  was	  performed	  with	  Dunnett’s	  multiple	  comparison	  test,	  with	  
∗p	  <	  0.05	  and	  ∗∗p	  <	  0.01	  vs	  vehicle	  treated	  cells.	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Fig.	  3.	  Effects	  of	  the	  selected	  photoallergens/photoirritants	  on	  cell-­‐associated	  IL-­‐18.	  NCTC2544	  cells	  
were	  irradiated	  (I)	  at	  the	  UVA	  dose	  of	  3.5	  J/cm2	  or	  non-­‐irradiated	  (NI)	  in	  the	  presence	  of	  increasing	  
concentrations	   of	   the	   selected	   photoallergens/photoirritants,	   using	   the	   CV80	   calculated	   under	  
irradiated	  condition	  as	  highest	  concentration.	  Results	  are	  expressed	  as	  IL-­‐18	  SI	  (I/NI).	  A	  dotted	  line	  
was	   set	   at	   a	   SI	   of	   1.3.	   Each	   data	   is	   mean	  ±	  SD,	   n	  =	  4.	   Statistical	   analysis	   was	   performed	   with	  
Dunnett’s	  multiple	  comparison	  test,	  with	  ∗p	  <	  0.05	  and	  ∗∗p	  <	  0.01	  vs	  vehicle	  treated	  cells.	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Fig.	  4.	  Effects	  of	  the	  selected	  photoirritants	  on	  cell-­‐associated	  IL-­‐18.	  NCTC2544	  cells	  were	  irradiated	  
(I)	  at	  the	  UVA	  dose	  of	  3.5	  J/cm2	  or	  non-­‐irradiated	  (NI)	  in	  the	  presence	  of	  increasing	  concentrations	  of	  
the	   selected	   photoirritants,	   using	   the	   CV80	   calculated	   under	   irradiated	   condition	   as	   highest	  
concentration.	  Results	  are	  expressed	  as	  IL-­‐18	  SI	  (I/NI).	  A	  dotted	  line	  was	  set	  at	  a	  SI	  of	  1.3.	  Each	  data	  
is	  mean	  ±	  SD,	  n	  =	  4.	  Statistical	  analysis	  was	  performed	  with	  Dunnett’s	  multiple	  comparison	  test,	  with	  
∗p	  <	  0.05	  and	  ∗∗p	  <	  0.01	  vs	  vehicle	  treated	  cells.	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Fig.	   5.	  	  Effects	  of	   the	  selected	  non-­‐phototoxic	  compounds	  on	  cell-­‐associated	   IL-­‐18.	  NCTC2544	  cells	  
were	  irradiated	  (I)	  at	  the	  UVA	  dose	  of	  3.5	  J/cm2	  or	  non-­‐irradiated	  (NI)	  in	  the	  presence	  of	  increasing	  
concentrations	   of	   the	   selected	   non-­‐phototoxic	   compounds,	   using	   the	   CV80	   calculated	   under	  
irradiated	  condition	  as	  highest	  concentration.	  Results	  are	  expressed	  as	  IL-­‐18	  SI	  (I/NI).	  A	  dotted	  line	  
was	   set	   at	   a	   SI	   of	   1.3.	   Each	   data	   is	   mean	  ±	  SD,	   n	  =	  4.	   Statistical	   analysis	   was	   performed	   with	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Reproducibility	  of	  data	  
To	  appreciate	  the	  variability	  among	  independent	  experiments	  performed	  on	  different	  days	  
over	  one	  year	  period,	  we	  reported	  in	  Fig.	  6	  the	  IL-­‐18	  SI	  (I/NI)	  obtained	  for	  chloropromazine	  
1.25	  μM	   (15	   experiments),	   ketoprofen	   2.5	  μM	   (4	   experiments)	   and	   6-­‐methylcoumarin	  
10	  μM	  (5	  experiments).	  The	  reason	  for	  which	  we	  tested	  these	  chemicals	  repeatidly	  was	  to	  
identify	   a	   positive	   control	   to	   be	   used	   routinely	   in	   the	   assay.	   We	   initially	   tought	   to	   use	  
chloropromazine	   1.25	  μM,	   but	   due	   to	   variability	   in	   the	   SI,	   we	   later	   decided	   to	   use	  
ketoprofen	  or	  6-­‐methylcoumarin.	   IL-­‐18	  SI	   (I/NI)	   for	  chloropromazine	  1.25	  μM	  ranged	  from	  
1.25	   to	   7.7	   with	   an	   average	   of	   3.16;	   for	   ketoprofen	   2.5	  μM	   from	   1.28	   to	   1.42	   with	   an	  
average	  of	  1.33,	  and	  for	  6-­‐methylcoumarin	  10	  μM	  from	  1.2	  to	  3.20	  with	  an	  average	  of	  1.76.	  
As	   for	   the	   NCTC2544	   IL-­‐18	   assay	   (Corsini	   et	   al.,	   2009	  and	  Galbiati	   et	   al.,	   2011),	   the	  
differences	  observed	   in	   the	  absolute	  value	  of	   IL-­‐18	  may	  be	  due	   to	  many	   factors	   including	  
the	  number	  of	  cells	  seeded	  and	  adhering	  to	  plate	  wells,	  to	  the	  use	  of	  a	  different	  cell	  batch,	  
the	  performance	  of	   IL-­‐18	  ELISA	  and	  protein	  assay	  as	  well	  as	  to	  differences	   in	  the	  chemical	  
concentration	   (fresh	   solutions	   are	   used)	   and	   slight	   variation	   in	   the	   irradiation	   conditions.	  
Despite	  the	  variability,	  the	  discriminatory	  capacities	  based	  on	  defined	  prediction	  model	  are,	  
however,	  preserved.	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Fig.	  6.	  Reproducibility	  of	  data.	  Results	  obtained	  in	  several	  independent	  experiments	  performed	  over	  
one	   year	   period	   are	   reported.	  NCTC2544	   cells	  were	   irradiated	   (I)	   at	   the	  UVA	  dose	  of	   3.5	  J/cm2	  or	  
non-­‐irradiated	   (NI)	   in	   the	   presence	   of	   chloropromazine	   1.25	  μM	   (15	   experiments),	   ketoprofen	  
2.5	  μM	  (4	  experiments)	  and	  6-­‐methylcoumarin	  10	  μM	  (5	  experiments).	  Results	  are	  expressed	  as	  IL-­‐
18	  SI	   (I/NI).	  A	  dotted	   line	  was	   set	   at	   a	   SI	  of	  1.3.	   Each	  dot	   represents	  an	   independent	  experiment.	  




Given	  that	  there	  is	  no	  in	  vivo	  or	  in	  vitro	  methods	  developed	  which	  regulatory	  authorities	  to	  
assess	   photosensitization	   induced	   by	   chemicals,	   in	   the	   present	   work,	   have	   adopted	   we	  
describe	  the	  possibility	  to	  use	  the	  NCTC2544	  IL-­‐18	  assay	  to	  identify	  in	  vitro	  photoallergens.	  
We	  found	  that	  irradiated	  photoallergens	  induced	  a	  significant	  increase	  in	  intracellular	  IL-­‐18	  
compared	   to	   photoirritants	   or	   not	   photoxic	   compounds.	   As	   provisional	   prediction	  model,	  
based	  of	  the	  tested	  chemicals,	  an	  IL-­‐18	  SI	  (I/NI)	  >	  1.3	  was	  set	  as	  criteria	  for	  identification	  of	  
photoallergens.	  
Due	   to	   their	   anatomical	   location	  and	   critical	   role	   in	   skin	   inflammatory	  and	   immunological	  
reactions,	   the	   use	   of	   keratinocytes	   and	   skin	   organotypic	   culture	   as	   a	   simplified	   in	   vitro	  
model	  to	  evaluate	  the	  potential	  toxicity	  of	  chemicals	  destined	  for	  epicutaneous	  application	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is	  amply	  justified.	  In	  the	  present	  work,	  intracellular	  IL-­‐18	  was	  investigated	  after	  exposure	  of	  
NCTC2544	   cells	   to	   several	   photoallergens,	   and	   photoirritants.	   We	   showed	   that	   UVA	  
irradiation	  of	  NCTC2544	  cells	  treated	  with	  photoallergens	  results	  in	  a	  dose-­‐related	  induction	  
of	   intracellular	   IL-­‐18,	   indicating	   the	   possibility	   to	   use	   IL-­‐18	   to	   specifically	   identify	  
photoallergens	  and	  distinguish	  them	  from	  photoirritants.	  
As	  mentioned	   in	   the	   Introduction,	   IL-­‐18	  was	   chosen,	   as	   this	   cytokine	   is	  mainly	   associated	  
with	  Th-­‐1-­‐mediated	  immune	  responses.	  Interestingly,	  it	  has	  been	  proposed	  that	  UV	  damage	  
can	   be	   considered	   a	   “danger”	   signal.	   Recent	   data	   linking	   IL-­‐1β	   and	   IL-­‐18	   production	   to	  
“inflammasomes”	   supports	   this	   notion.	   IL-­‐1β	   and	   IL-­‐18	   are	   normally	   expressed	   in	   human	  
keratinocytes	  as	  an	  inactive	  precursor.	  Upon	  exposure	  to	  UV	  radiation,	  both	  precursors	  are	  
cleaved	  by	  caspase-­‐1	  to	  yield	  active	  IL-­‐1β	  and	  IL-­‐18.	  Caspase-­‐1	  activation	  is	  dependent	  upon	  
its	   recruitment	   to	   inflammasomes,	   which	   links	   UV-­‐induced	   cytokine	   production	   to	   the	  
innate	   immune	   system.	   Inflammasomes	   are	   composed	   of	   NOD-­‐like	   receptor	   (NLR)-­‐family	  
proteins	  (Feldmeyer	  et	  al.,	  2007).	  These	   intracellular	  proteins	  contain	  a	  nucleotide-­‐binding	  
oligomerization	   domain	   called	   NACHT	   and	   several	   leucine	   rich	   repeat	   domains	   that	   may	  
bind	   to	   microbial	   ligands	   similar	   to	   Toll-­‐like	   receptor	   family	   proteins.	   The	   relationship	  
between	  inflammasomes	  and	  UV-­‐induced	  IL-­‐1β	  and	  IL-­‐18	  production	  demonstrates	  that	  this	  
pathway	   can	   also	   sense	   UV-­‐induced	   tissue	   injury.	   Under	   our	   experimental	   condition,	   the	  
UVA	  dose	  used	  alone	  didn’t	  induce	  IL-­‐18.	  Only	  the	  combination	  chemical	  (photoallergen)	  +	  
UVA	  resulted	  in	  IL-­‐18	  induction.	  However,	  a	  similar	  mechanism	  of	  inflammasome	  activation	  
is	  likely	  to	  be	  triggered	  by	  photoallergens.	  For	  allergens,	  we	  previously	  demonstrated	  a	  role	  
for	   oxidative	   stress,	   NF-­‐κB	   and	   p38	   MAPK	   activation	   in	   PDD-­‐induced	   IL-­‐18	   production	  
(Galbiati	  et	  al.,	  2011),	  consistent	  with	  an	  inhibition	  of	   IL-­‐18	  transcription	  as	   in	  5ʹ′	  upstream	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region	  of	  the	  human	  IL-­‐18	  gene	  AP-­‐1,	  PU.1,	  NF-­‐κB	  and	  SP-­‐1	  transcription	  binding	  sites	  have	  
been	  identified	  (Takeuchi	  et	  al.,	  1999).	  
A	   critical	   initial	   point	   in	   our	   study	   was	   the	   choice	   of	   UVA	   dose	   and	   chemical	   exposure	  
conditions.	   Suitable	   irradiation	   conditions	   for	   the	   test	   were	   determined	   using	  
chloropromazine	   as	   a	   representative	   photoallergen.	   This	   drug	   and	   several	   others	   related	  
phenothiazines	  are	  known	  to	  cause	  both	  phototoxic	  and	  photoallergic	  reaction	   in	  the	  skin	  
and	  eyes	  of	  patients.	  The	  original	  SOP	  developed	   for	   the	  NCTC2544	   IL-­‐18	  assay	  had	   to	  be	  
adapted	   to	   the	   UVA	   irradiation.	   A	   UVA	   dose	   of	   3.5	  J/cm2	   was	   chosen,	   and	   the	   CV80	  
calculated	  in	  irradiated	  condition	  was	  selected	  as	  the	  highest	  concentration.	  
We	   then	   investigated	   if	   commercially	   available	   photosensitisers	   could	   selectively	   up	  
regulate	   IL-­‐18	   in	  human	  keratinocytes	  after	  UVA	  exposure.	  We	  could	   indeed	  demonstrate	  
that	   compounds	   classified	   as	   photosensitisers	   or	   photoallergens/photoirritants	   have	   the	  
ability	  to	  increase	  IL-­‐18	  intracellular	  levels	  in	  a	  dose	  related-­‐manner,	  whereas	  photoirritants	  
failed.	  A	  slight	  increase	  in	  IL-­‐18	  was	  observed	  with	  8-­‐methoxypsoralene	  and	  retinoic	  acid.	  It	  
is	   important	   to	   mention	   that	   both	   chemicals	   are	   reported	   to	   possess	   photoallergenic	  
effects.	   Recent	   literature	   and	   FDA-­‐approved	   package	   for	   all-­‐trans-­‐retinoic	   acid	   products	  
state	  explicitly	  that	  all-­‐trans-­‐retinoic	  acid	  is	  both	  a	  phototoxin	  and	  a	  photosensitiser	  (Fu	  et	  
al.,	   2003,	   Moore,	   2002,	   Tolleson	   et	   al.,	   2005	  and	  Stein	   and	   Scheinfeld,	   2007).	   Even	   if	  
photoallergy	   to	   furocoumarins	   has	   rarely	   been	   reported,	   Bonamonte	   et	   al.	   (2010)	   clearly	  
demonstrated	  photoallergic	  contact	  dermatitis	  to	  8-­‐methoxypsoralen.	  In	  the	  establishment	  
of	   our	   prediction	   model,	   both	   compounds	   were,	   however,	   considered	   as	   photoirritants.	  
Therefore,	  based	  on	  the	  effect	  on	  IL-­‐18	  observed	  for	  these	  two	  chemicals,	  the	  cut	  off	  of	  IL-­‐
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18	   SI	   (I/NI)	   >	   1.3	  was	   set	   to	   identify	   and	  discriminate	   photoallergens	   from	  photoirritants.	  
Based	   on	   human	   classification,	   an	   overall	   accuracy	   of	   100	   %	   of	   the	   proposed	   assay	   was	  
obtained.	  
In	   conclusion,	   we	   propose	   a	   new	   reliable	   in	   vitro	   photosensitization	   assay	   using	   the	  
keratinocyte	  cell	  line	  NCTC2544	  and	  IL-­‐18	  production.	  The	  induction	  of	  IL-­‐18	  following	  UVA	  
irradiation	  may	   represent	   a	   promising	   in	   vitro	  model	   for	   the	   screening	   and	   evaluation	   of	  
potential	  photoallergens,	  reducing	  the	  risk	  of	  photoallergic	  reactions.	  Although	  we	  need	  to	  
further	   confirm	   the	   applicability	   of	   the	   test	   evaluating	   a	   wider	   battery	   of	   chemicals,	   we	  
consider	   that	   this	   assay	   may	   become	   a	   useful	   cell-­‐based	   in	   vitro	   test	   for	   evaluating	   the	  











	   122	  
3.4	  AN	  EPIDERMAL	  EQUIVALENT	  ASSAY	  FOR	  IDENTIFICATION	  AND	  RANKING	  
POTENCY	  OF	  CONTACT	  SENSITISERS	  
	  
Abstract	  
The	   purpose	   of	   this	   study	   was	   to	   explore	   the	   possibility	   of	   combining	   the	   epidermal	  
equivalent	  (EE)	  potency	  assay	  with	  the	  assay	  which	  assesses	  release	  of	  interleukin-­‐18	  (IL-­‐18)	  
to	   provide	   a	   single	   test	   for	   identification	   and	   classification	   of	   skin	   sensitizing	   chemicals,	  
including	   chemicals	   of	   low	   water	   solubility	   or	   stability.	   A	   protocol	   was	   developed	   using	  
different	  3D-­‐epidermal	  models	   including	   in	  house	  VUMC	  model,	  epiCS®	  (previously	  EPICS®	  
™),	   MatTek	   EpiDerm™	   and	   SkinEthic™	   RHE	   and	   also	   the	   impact	   of	   different	   vehicles	  
(acetone:olive	   oil	   4:1,	   1%	   DMSO,	   ethanol,	   water)	   was	   investigated.	   Following	   topical	  
exposure	  for	  24	  h	  to	  17	  contact	  allergens	  and	  13	  non-­‐sensitisers	  a	  robust	   increase	   in	   IL-­‐18	  
release	  was	  observed	  only	  after	  exposure	  to	  contact	  allergens.	  A	  putative	  prediction	  model	  
is	   proposed	   from	  data	   obtained	   from	   two	   laboratories	   yielding	   95%	   accuracy.	   Correlating	  
the	   in	   vitro	   EE	   sensitiser	   potency	   data,	  which	   assesses	   the	   chemical	   concentration	  which	  
results	   in	   50%	   cytotoxicity	   (EE-­‐EC50)	   with	   human	   and	   animal	   data	   showed	   a	   superior	  
correlation	   with	   human	   DSA05	   (μg/cm2)	   data	   (Spearman	   r	  =	  0.8500;	   P	   value	   (two-­‐
tailed)	  =	  0.0061)	   compared	   to	   LLNA	   data	   (Spearman	   r	  =	  0.5968;	   P	   value	   (two-­‐
tailed)	  =	  0.0542).	  DSA05	  =	  induction	  dose	  per	  skin	  area	  that	  produces	  a	  positive	  response	  in	  
5%	  of	  the	  tested	  population	  Also	  a	  good	  correlation	  was	  observed	  for	  release	  of	  IL-­‐18	  (SI-­‐2)	  
into	   culture	   supernatants	   with	   human	   DSA05	   data	   (Spearman	   r	  =	  0.8333;	   P	   value	   (two-­‐
tailed)	  =	  0.0154).	  This	  easily	  transferable	  human	  in	  vitro	  assay	  appears	  to	  be	  very	  promising,	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but	  additional	   testing	  of	   a	   larger	   chemical	   set	  with	   the	  different	  EE	  models	   is	   required	   to	  
fully	  evaluate	  the	  utility	  of	  this	  assay	  and	  to	  establish	  a	  definitive	  prediction	  model.	  
	  
Dose	  dependent	  increase	  in	  IL-­‐18	  release	  by	  sensitisers	  but	  not	  non-­‐sensitisers	  
A	   total	   of	   17	   sensitisers	   ranging	   from	   extreme,	   strong,	  moderate	   and	  weak	   and	   10	   non-­‐
sensitisers	  were	  selected	  for	  this	  study	  and	  tested	  using	  different	  EE	  models	  (Table	  1).	  In	  the	  
first	   series	   of	   experiments,	   Cell	   Systems	   epiCS®	   were	   exposed	   topically	   to	   13	   coded	  
sensitisers	  and	  9	  non-­‐sensitisers	   in	  a	  dose	  dependent	  manner	  for	  24	  h	  according	  to	  the	  EE	  
potency	   assay	   protocol	   in	   two	   laboratories	   (VUMC,	   DiSFeB)	   (Teunis	   et	   al.,	   2013).	  
	  
Table	   1	   Tested	   chemicals	   and	   vehicles.	   a	   The	   vehicles	   used	   in	   this	   study	   for	   dissolving	   chemicals	  
before	  applying	  topically	  to	  EE.	  DMSO	  =	  1%	  DMSO	  in	  culture	  medium;	  AOO	  =	  acetone:	  olive	  oil	  (4:1);	  
EtOH	  =	  ethanol;	  Neat	  =	  100%;	  Water	  =	  distilled	  H2O;	  n.d.	  =	  not	  determined;	  For	  details	  on	  vehicle	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Culture	   viability	   was	   determined	   by	   the	   MTT	   assay	   and	   IL-­‐18	   release	   into	   culture	  
supernatants	  by	   ELISA.	  Of	   the	  13	   sensitisers	   and	  9	  non-­‐sensitisers	   selected	   for	   this	   study,	  
only	  2	  chemicals	  (cobalt	  II	  chloride	  and	  p-­‐phenylenediamine	  (PPD))	  had	  to	  be	  excluded	  due	  
to	  their	  interference	  with	  the	  MTT	  colorimetric	  assay.	  For	  the	  remaining	  11	  sensitisers	  and	  9	  
non-­‐sensitisers,	  an	   increase	   in	   IL-­‐18	  release	  was	  generally	  observed	  only	  after	  exposure	  to	  
sensitisers	  but	  not	  after	  exposure	  to	  non-­‐sensitisers	  in	  both	  VUMC	  and	  DiSFeB	  laboratories	  
(Figs.	   1A	   and	   B).	   Results	   were	   further	   analyzed	   in	   order	   to	   identify	   a	   putative	   prediction	  
model	  for	  identifying	  sensitisers.	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Fig.	  1.	  Dose	  response	  effects	  of	  the	  selected	  sensitisers	  (A)	  and	  non-­‐sensitisers	  (B)	  on	  IL-­‐18	  release	  
and	   cell	   viability	   in	   the	   epiCS®	   EE	   model	   in	   VUMC	   and	   DiSFeB	   laboratories.	   EE	   were	   exposed	   to	  
chemicals	   as	   described	   in	   Materials	   and	   Methods	   and	   Table	   1.	   IL-­‐18	   was	   assessed	   by	   ELISA	   and	  
results	  are	  expressed	  as	  stimulation	  index	  (SI)	  compared	  to	  vehicle	  alone.	  Cell	  viability	  was	  assessed	  
by	  MTT	  reduction	  assay	  and	  is	  expressed	  relative	  to	  vehicle.	  Sensitisers	  were	  tested	  independently	  in	  
duplicate	  in	  both	  laboratories.	  For	  non-­‐sensitisers:	  SDS,	  lactic	  acid	  and	  methyl	  salicylate	  were	  tested	  
at	   the	  VUMC	   laboratory	  whilst	  HBA,	  phenol,	  chlorobenzene,	  octanoic	  acid,	   tween	  20	  and	  salicyclic	  
acid	  were	  tested	  at	  the	  DiSFeB	  laboratory.	  
Filled	   bars	   represent	   the	   IL-­‐18	   release,	   while	   open	   bars	   the	   viability.	   With	   the	   exception	   of	  
isoeugenol	   in	   DiSFeB	   in	   which	   only	   1	   run	   was	   performed,	   results	   are	   expressed	   as	   average	   ±	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For	   epiCS®,	   three	   prediction	   models	   were	   tested	   (Table	  2).	   Prediction	   model	   1	   (≥	  40%	  
viability	   (EC40);	   ≥	   2	   fold	   increase	   in	   IL-­‐18):	   resulted	   in	   VUMC	   correctly	   identifying	   10/11	  
sensitisers	  and	  DiSFeB	  correctly	  identifying	  9/11	  sensitisers.	  Only	  formaldehyde	  (VUMC	  and	  
DiSFeB)	   and	   isoeugenol	   (DiSFeB)	   scored	   as	   a	   false	   negative	   in	   prediction	   model	   1.	   With	  
regards	  to	  the	  non-­‐sensitisers	  VUMC	  correctly	  identified	  2/4	  chemicals	  and	  DiSFeB	  correctly	  
identified	  5/6	  chemicals.	  Since	  it	  was	  noticed	  that	  in	  general	  IL-­‐18	  release	  was	  greater	  after	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Table	  2.	  Prediction	  models	  for	  epiCS®.	  Highest	  SI	  level	  of	  IL-­‐18	  release	  observed	  within	  the	  defined	  
criteria	  for	  the	  different	  prediction	  models	  (see	  also	  Fig.	  1).	  For	  isoegenol,	  DiSFeB	  had	  data	  only	  from	  
1	  run.	  
False	  positives	  and	  negatives	   in	   the	  predictionmodels	  are	  shown	  bold	  underlined.	  Values	  obtained	  
from	   chemicals	   which	   do	   not	   fulfill	   the	   acceptance	   criteria	   of	   the	   predictionmodel	   are	   shown	   in	  
brackets.	  
Predictionmodel	  1:	  IL18	  SI	  2x	  at	  ≥	  EC40,	  VUMChave	  1	  false	  negative	  and	  2	  false	  positives.	  DiSFeB	  has	  
2	   false	   negatives	   and	   1	   false	   positive.	   ThemaximumIL-­‐18	   release	   (mg/ml)	   observed	   in	   the	   dose	  
response	  (see	  Fig.	  1)	  at	  a	  cell	  viability	  ≥	  40%	  relative	  to	  the	  vehicle	  is	  shown.	  Prediction	  model	  2:	  IL-­‐
18	  SI	  5x	  at	  ≥	  EC5,VUMC	  has	  in	  only	  1	  false	  positive.	  DiSFeB	  has	  3	  false	  negatives.	  ThemaximumIL-­‐18	  
release	   (mg/ml)	   observed	   in	   the	   dose	   response	   (see	   Fig.	   1)	   ata	   cell	   viability	   ≥	   5%	   relative	   to	   the	  
vehicle	  is	  shown.	  
Predictionmodel	  3:	   IL-­‐18	  SI	  5	  x	  at	  ≥	  EC5	  and	  ≤	  40,	  VUMChas	  only	  1	  false	  positive	  and	  DiSFeB	  has	  1	  
false	  negative.	  ThemaximumIL-­‐18	  release	  (mg/ml)	  observed	  in	  the	  dose	  response	  (see	  Fig.	  1)	  at	  a	  cell	  
viability	  ≥	  5%	  and	  ≤	  40%	  relative	  to	  the	  vehicle	  is	  shown.	  With	  the	  exception	  of	  isoeugenol	  in	  DiSFeB	  
in	  which	  only	  1	  run	  was	  performed,	  results	  are	  expressed	  as	  average	  ±	  difference,	  n	  =	  2	  independent	  
experiments	  using	  different	  batches	  of	  EE.	  
a	  Viability	  ≥	  90%.	  
b	  Viability	  is	  N	  50%,	  EC5	  and	  EC40	  =	  5%	  and	  40%	  cell	  viability	  respectively.	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Prediction	  model	   2	   (≥	  5%	   viability	   (EC5);	   ≥	  5	   fold	   increase	   in	   IL-­‐18)	   resulted	   in	   the	   VUMC	  
correctly	  identifying	  all	  sensitisers	  and	  DiSFeB	  correctly	  identifying	  8/11	  sensitisers.	  It	  should	  
be	  noted	  though	  that	  the	  2/3	  false	  negatives	  in	  prediction	  model	  2	  in	  DiSFeB	  corresponded	  
to	  dose	  response	  curves	   in	  which	  very	   little	  cytotoxicity	  was	  observed.	  EE	  were	  still	  >	  40%	  
viable	   after	   exposure	   to	   phenylacetone	   aldehyde	   and	   2-­‐mercaptobenzothiazol.	  
Formaldehyde	   was	   the	   third	   false	   negative	   scored	   in	   DiSFeB	   even	   though	   high	   levels	   of	  
cytotoxicity	  were	  reached.	  With	  regards	  to	  the	  non	  sensitisers	  VUMC	  correctly	  identified	  3/4	  
non	  sensitisers	  and	  DiSFeB	  correctly	  identified	  all	  6	  non-­‐sensitisers.	  These	  results	  led	  to	  the	  
testing	   of	   prediction	   model	   3	   in	   which	   the	   greater	   release	   of	   IL-­‐18	   within	   a	   defined	  
cytotoxicity	  range	  was	  tested.	  
Prediction	  model	   3	   (≥	  5%	   and	   ≤	  40%	   viability	   (EC5-­‐40);	   ≥	  5	   fold	   increase	   in	   IL-­‐18	   release:	  
resulted	  in	  exclusion	  of	  the	  2	  false	  negatives	  from	  DiSFeB	  as	  critical	  cytotoxic	  levels	  were	  not	  
reached	   and	   therefore	   all	   sensitisers	  with	   the	   exception	   of	   formaldehyde	   in	   DiSFeB	  were	  
now	   correctly	   identified	   in	   both	   laboratories.	  With	   regards	   to	   non-­‐sensitisers,	   the	   results	  
were	  the	  same	  as	  those	  obtained	   in	  prediction	  model	  2	  namely	  VUMC	  correctly	   identified	  
3/4	   non	   sensitisers	   and	   DiSFeB	   correctly	   identified	   all	   6	   non-­‐sensitisers.	   Therefore	   for	  
chemical	  exposures	  which	  fulfilled	  the	  criteria	  for	  prediction	  model	  3,	  all	  but	  one	  chemical	  in	  
each	  of	  the	  laboratories	  were	  correctly	  identified	  (phenol	  scored	  false	  positive	  in	  VUMC,	  and	  
formaldehyde	  scored	  false	  negative	  in	  DiSFeB).	  
Prediction	   model	   3	   using	   epiCS®	   was	   therefore	   considered	   the	   most	   optimal	   putative	  
prediction	  model	  since	  it	  showed	  95%	  accuracy	  in	  both	  VUMC	  and	  DiSFeB	  laboratories.	  Of	  
note,	  this	  prediction	  model	   is	  dependent	  on	  the	  chemical	  resulting	   in	  high	  cytotoxicity	  (5–
40%	  viability;	  60–95%	  cytotoxicity)	  in	  the	  EE.	  
	   131	  
In	  parallel,	  at	  MB	  Research	  Labs	  and	  MatTek	  Corp,	  9	  contact	  sensitisers	  (DNCB,	  NBB,	  PPD,	  
CA,	  C-­‐OH,	  GXL,	  RES,	  MBT,	  and	  EUG)	  and	  3	  non	  sensitisers	  (PHL,	  LAC,	  and	  GLC)	  were	  tested	  
using	  the	  EpiDerm™	  EE	  model	   (Fig.	  2).	  Test	  chemicals	  were	  dissolved	   in	  a	  vehicle	  of	  either	  
ethanol	  or	  water.	  Ethanol	  alone	  caused	  an	  IL-­‐18	  secretion	  of	  12.5	  and	  15.1	  pg/ml,	  and	  water	  
caused	   secretion	   of	   5.7	   and	   14.1	  pg/ml,	   respectively	   for	   MB	   Research	   Labs	   and	   MatTek	  
Corp.	  In	  support	  of	  the	  above	  data,	  sensitiser	  exposure	  resulted	  in	  a	  measurable	  increase	  of	  
up	   to	   40	   fold	   in	   IL-­‐18	   release	   over	   vehicle	   controls.	   Using	   a	   ‘Prediction	   Model	   1.6x’	  
(optimally	  between	  5%	  and	  50%	  viability	  (EC5-­‐50);	  coupled	  with	  a	  ≥	  1.6	  fold	  increase	  in	  IL-­‐18	  
release	  as	  indicative	  of	  a	  positive	  sensitiser	  response),	  9/9	  sensitisers	  tested	  at	  MB	  Research	  
Labs	  were	  correctly	  identified	  while	  at	  MatTek	  8/9	  sensitisers	  were	  correctly	  identified	  (RES	  
was	  a	  false	  negative).	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Fig.	  2.	  IL-­‐18	  secretion	  and	  tissue	  viability	  using	  EpiDerm™.	  
EE	   were	   exposed	   to	   chemicals	   as	   described	   in	   Materials	   and	   Methods	   and	   Table	  1.	   MatTek	  
Corporation	   and	   MB	   Research	   Labs	   independently	   tested	   IL-­‐18	   secretion	   in	   duplicate	   EpiDerm™	  
tissues.	  Test	  chemicals	  were	  dissolved	  in	  a	  vehicle	  of	  either	  ethanol	  or	  water,	  with	  the	  exception	  of	  
MBT	   which	   was	   dissolved	   in	   25	  ul	   of	   EtOH:DMSO	   4:1.	   After	   24	  h	   topical	   exposure	   to	   chemicals,	  
culture	  supernatant	  was	  analyzed	  by	   IL-­‐18	  ELISA,	  and	  an	  SI	  was	  calculated	  as	  a	   fold	  change	  above	  
vehicle	  control	  (Panel	  A).	  An	  IL-­‐18	  SI	  value	  of	  1.6	  or	  above	  is	  the	  criterion	  for	  a	  positive	  response	  is	  
indicated	   by	   the	   dotted	   line.	   Tissue	   viability	   was	   determined	   by	  MTT	   assay	   (Panel	   B)	   The	   figures	  
depict	  average	  ±	  difference	  of	  duplicate	  EE	  within	  a	  single	  experiment	  in	  each	  laboratory.	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With	  regards	  to	  the	  3	  non-­‐sensitisers,	  at	  the	  single	  chemical	  concentration	  tested	  (LAC	  2%,	  
PHL	  2%	  and	  GLC	  100%),	  no	  chemical	  exposure	  resulted	  in	  a	  ≥	  1.6-­‐fold	  increase	  in	  IL-­‐18,	  and	  
therefore	  all	  non-­‐sensitisers	  at	  these	  concentrations	  were	  correctly	  predicted	  as	  negative.	  
Taken	  together	  our	  results	  highlight	  the	  advantages	  of	  the	  dose	  response	  and	  demonstrate	  
the	   ability	   of	   the	   IL-­‐18	   endpoint	   to	   identify	   sensitisers	   in	   the	   epiCS®	   and	   EpiDerm™	   3D-­‐
epidermal	  models.	  
	  
Epidermal	  equivalent	  EC50	  values	  rank	  sensitiser	  potency	  
Next	  it	  was	  determined	  whether	  the	  EC50	  values	  identified	  from	  the	  11	  coded	  sensitisers	  in	  
the	  dose	  response	  experiments,	  which	  were	  used	  to	  quantify	  IL-­‐18	  release	  in	  the	  VUMC	  and	  
DiSFeB	   laboratories,	   could	   be	   used	   to	   rank	   sensitiser	   potency.	   Table	  3	   shows	   that	   both	  
laboratories	  obtained	  EC50	  values	  of	  similar	  orders	  of	  magnitude.	  Extreme/strong	  sensitisers	  
classified	   according	   to	   LLNA	   generally	   had	   a	   lower	   EC50	   value	   than	  weak	   sensitisers.	   EC50	  
values	   for	   the	   moderate	   sensitisers	   generally	   ranged	   between	   the	   weak	   and	   strong	  
sensitisers	   (Table	  3).	  When	   results	   of	   both	   laboratories	  were	   combined	   and	   a	   correlation	  
was	  performed	  with	  the	  LLNA	  and	  human	  DSA05	  data,	  ranking	  according	  to	  the	  EE	  potency	  
assay	  was	   found	   to	  significantly	  correlate	   to	   the	   ranking	  obtained	  by	   the	  LLNA	   (Spearman	  
r	  =	  0.5968;	  P	  value	  (two-­‐tailed)	  =	  0.0542)	  and	  to	  human	  DSA05	  data	  (Spearman	  r	  =	  0.8500;	  P	  
value	  (two-­‐tailed)	  =	  0.0061)	  (Fig.	  3A;	  Table	  3).	  Of	  note,	  correlation	  between	  the	  EE-­‐EC50	  data	  
and	  human	  DSA05	  data	  was	  clearly	  better	  than	  between	  EE-­‐EC50	  data	  and	  LLNA	  data.	  
Next	  we	  determined	  whether	   the	   IL-­‐18	  SI-­‐2	  and	  SI-­‐5	  could	  also	  be	  used	   to	   rank	  sensitiser	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again	  better	  with	  human	  data	  than	  with	  LLNA	  data.	  Indeed	  the	  correlation	  SI-­‐2	  with	  human	  
DSA05	  data	  was	  Spearman	  r	  =	  0.8333;	  P	  value	  (two-­‐tailed)	  =	  0.0154	  and	  the	  correlation	  SI-­‐5	  
with	  human	  DSA05	   data	  was	   Spearman	   r	  =	  0.6267;	   P	   value	   (two-­‐tailed)	  =	  0.0603	   indicating	  













Fig.	  3.	  	   Correlation	  of	   EE	  assay	  with	   LLNAEC3	   and	  human	  DSA05.	  A)	  Correlation	  of	   EE-­‐EC50	  data	  with	  
LLNAEC3	   and	   human	   DSA05.	   B)	   Correlation	   of	   IL-­‐18	   SI-­‐2	   data	   with	   LLNAEC3	   and	   human	   DSA05.	   C)	  
Correlation	  of	  IL-­‐18	  SI-­‐5	  data	  with	  LLNAEC3	  and	  human	  DSA05.	  
LLNAEC3	  and	  human	  DSA	  data	  is	  extracted	  from	  Table	  3.	  In	  vitro	  data	  is	  obtained	  by	  linear	  regression	  
analysis	   based	   on	   changes	   in	   metabolic	   activity	   (MTT)	   (A)	   or	   IL-­‐18	   fold	   release	   into	   culture	  
supernatant	  (B,	  C).	  Statistical	  significances	  were	  determined	  by	  Kruskal–Wallis	  (nonparametric,	  one	  
way	  ANOVA)	  using	  GraphPad	  Prism	  version	  4.00	   for	  Windows	   (GraphPad	  Software,	  San	  Diego,	  CA,	  
USA).	  Differences	  were	  considered	  significant	  for	  p	  <	  0.05.	  
EE–EC50	  data	  represents	  the	  average	  of	  the	  combined	  data	  for	  epiCS®	  obtained	  from	  2	  laboratories	  
(VUMC	  and	  DiSFeB)	  n	  =	  4	  ±	  SD:	  dotted	  line	  shows	  visual	  line	  of	  equality.	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Table	   3	   comparison	  of	   LLNAEC3,	  human	  DSA05	  and	  EE-­‐EC50	   values	   for	   all	   sensitisers	   tested	   in	   EE	  
potency	  assay	  using	  VUMC-­‐EE	  and	  epiCS®.Table	  3	  shows	  all	  EC50	  data	  obtained	  until	  present	  for	  the	  
EE	  potency	  assay	  derived	  from	  this	  manuscript	  and	  dos	  Santos	  et	  al.	  (2011).	  Human	  DSA05	  (μg/cm2)	  
=	   induction	   dose	   per	   skin	   area	   (DSA)	   that	   produces	   a	   positive	   response	   in	   5%	   of	   the	   tested	  
population.	  
The	   LLNAEC3	   values	   expressed	   as%	   and	   its	   relative	   potency	   classification	   in	   parenthesis	   are	  
reported.	  According	  to	  Basketter	  et	  al.	  (1999),	  potency	  classification	  is	  based	  on	  themathematical	  
estimation	  of	  the	  concentration	  of	  chemical	  necessary	  to	  obtain	  a	  threshold	  positive	  response	  (SI	  =	  
3);	   this	   is	   termed	   the	   EC3	   value.	   Chemicals	  with	   an	   EC3	   value	   (%)	  N	   10	   to	   b	   100	   are	   classified	   as	  
weak,	  N1	  to	  b	  10	  moderate,	  N0.1	  to	  b	  1	  strong,	  b0.1	  extreme.	  For	  LLNA	  and	  human	  data:	  –	  indicates	  
no	   data	   available;	   for	   EE–EC50:	   NR	   =	   indicates	   interference	  with	  MTT	   assay	   therefore	   no	   reliable	  
EC50	  obtained;	  No	  EC50	  =	  due	  to	  lowsolubility	  of	  the	  chemical	  no	  EC50	  was	  obtained	  (dos	  Santos	  et	  
al.,	  2011).	  
Sensitisers	  are	  ranked	  taking	  into	  account	  ranges	  obtained	  from	  both	  LLNA	  and	  human	  DSA05	  data	  
from	  the	  following	  studies:	   (Danneman	  et	  al.,	  1983;	  Friedmann	  et	  al.,	  1983;	  Gerberick	  et	  al.,	  2005;	  
Griem	  et	  al.,	   2003;	   ICCVAM,	  2011a,	  2011b,	  2011c;	   Jordan	  and	  King,	  1977;	  Kligman,	  1966a,	  1966b;	  
Marzulli	  and	  Maibach,	  1976;	  Rees	  et	  al.,	  1989;	  Schneider	  and	  Akkan,	  2004;	  Steltenkamp	  et	  al.,	  1980).	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Transferability	  of	  EE	  potency	  assay	  to	  different	  EE	  models	  and	  effect	  of	  different	  vehicles	  
Transferability	  of	  EE	  potency	  assay	  to	  different	  EE	  models	  
In	  this	  study,	  epiCS®	  was	  extensively	  used	  to	  further	  investigate	  the	  EE	  potency	  assay	  using	  
coded	   sensitisers	   and	   to	   determine	  whether	   this	   assay	   could	   be	   combined	  with	   an	   IL-­‐18	  
readout	  to	  identify	  sensitisers.	  In	  order	  to	  determine	  how	  well	  the	  results	  from	  one	  EE	  type	  
correlate	   to	   the	   results	   obtained	   from	   another	   EE	   type,	   the	   results	   from	   this	   EE	   potency	  
study	  were	   superimposed	   onto	   our	   previously	   described	   results	   using	   the	   VUMC-­‐EE.	   The	  
results	  shown	  in	  Fig.	  4	  indicate	  that	  very	  similar	  LLNA	  correlations	  are	  obtained	  for	  both	  EE	  
derived	   from	   primary	   human	   keratinocytes.	   Oxazolone	   was	   a	   typical	   outlier	   when	   using	  
either	   EE	   model.	   An	   overall	   ranking	   using	   the	   combined	   results	   of	   the	   both	   EE	   and	   16	  
chemicals	  (including	  oxazolone)	  was	  found	  to	  significantly	  correlate	  to	  the	  ranking	  obtained	  
by	   the	   LLNA	   (Spearman	   r	  =	  0.52;	   P	   value	   (two-­‐tailed)	  =	  0.02)	   and	   was	   similar	   to	   that	  
obtained	  by	  either	  EE	  alone	  (epiCS®:	  Spearman	  r	  =	  0.60;	  P	  value	  (two-­‐tailed)	  =	  0.06;	  VUMC-­‐
EE:	  Spearman	  r	  =	  0.58;	  P	  value	  (two-­‐tailed)	  =	  0.08).	  This	  indicates	  not	  only	  that	  the	  assay	  is	  
fully	  transferable	  to	  different	  EE	  models	  but	  that	  the	  results	  obtained	  from	  all	  different	  EE	  
may	   be	   superimposed	   onto	   a	   single	   sensitiser	   ranking	   correlation	   graph	   if	   identical	  
methodology	  is	  used.	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Fig.	  4.	  	  Correlation	  EE–EC50	  from	  VUMC-­‐EE	  and	  epiCS®	  with	  LLNAEC3	  (%).	  
Data	  obtained	  from	  this	  study	  using	  epiCS®	  are	  plotted	  together	  with	  previous	  published	  data	  using	  
VUMC-­‐EE	  (dos	  Santos	  et	  al.,	  2011)	  and	  correlated	  to	  LLNA	  data.	  Five	  chemicals	  are	  indicated	  which	  
were	  tested	  in	  both	  VUMC-­‐EE	  and	  epiCS®.	  
	  
The	  effect	  of	  vehicles	  on	  different	  EE	  viability	  
Next	  we	  compared	  the	  effect	  of	  three	  different	  commonly	  used	  vehicles	  on	  three	  different	  
commercially	  available	  EE	  (epiCS®,	  SkinEthic™	  RHE,	  MatTek	  EpiDerm™)	  and	  one	  in	  house	  EE	  
(VUMC-­‐EE).	  As	  can	  be	  seen	  from	  Fig.	  5A,	  epiCS®	  and	  SkinEthic™	  RHE	  produced	  very	  similar	  
results	  after	  a	  24	  h	  exposure	  to	  AOO	  resulting	  in	  less	  than	  10%	  decrease	  in	  cell	  viability	  and	  
DMSO	  resulting	  in	  approximately	  20%	  decrease	  in	  cell	  viability.	  For	  the	  VUMC-­‐EE	  less	  than	  
10%	  decrease	   in	   cell	   viability	  was	  observed	   after	   a	   24	  h	   topical	   exposure	   to	   either	  water,	  
AOO	   or	   DMSO.	   For	   EpiDerm™	   approximately	   10%	   decrease	   in	   cell	   viability	  was	   observed	  
after	   a	   24	  h	   topical	   exposure	   to	   either	   water	   or	   AOO.	   For	   all	   EE,	   the	   potential	   cytotoxic	  
effect	  of	   the	  vehicles	  was	  within	   the	  acceptance	  criteria	  of	  <	  30%	  previously	  proposed	   for	  
the	  EE	  potency	  assay	  (Teunis	  et	  al.,	  2013)	  again	  supporting	  the	  ease	  of	  technology	  transfer	  
of	  the	  assay.	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Effect	  of	  different	  vehicles	  and	  application	  methods	  on	  sensitiser	  induced	  IL-­‐18	  release	  
Finally	  we	  determined	  whether	  different	   vehicles	   and	  application	  methods	   influenced	   the	  
IL-­‐18	   readout	   of	   the	   assay.	   DNCB	   (150	  μg)	   was	   topically	   applied	   to	   EpiDerm™	   directly	   in	  
25	  μl	  of	  ethanol	  or	  100	  μl	  of	  AOO	  (1:20),	  or	  by	  use	  of	  a	  filter	  disc	  (25	  μl	  in	  AOO	  4:1).	  50	  μg	  of	  
SDS	   (100	  μl	   in	  water	   or	   25	  μl	   on	   a	   filter	   paper	   in	  water)	  was	   applied	   as	   reference	   irritant	  
(Fig.	  5B).	  EpiDerm™	  were	  then	  incubated	  for	  24	  h.	  At	  similar	  cytotoxicity	  (empty	  columns),	  
DNCB	   induced	  a	  higher	   release	  of	   IL-­‐18	   compared	   to	   tissues	   treated	  with	   SDS	   (SI	  >	  15)	   as	  
expected	   independent	   of	   the	   method	   used	   for	   application.	   However	   the	   IL-­‐18	   release	  
induced	  by	  DNCB	  was	  higher	  if	  AOO	  (either	  directly	  applied	  on	  EE	  or	  on	  filters)	  was	  used	  as	  
vehicle	  when	  compared	  to	  EtOH.	  This	  was	   later	  further	   investigated	  by	  MB	  research	  using	  
SkinEthic™	  RHE	  with	   three	  different	   sensitisers	   (DNCB,	   citral	   and	  eugenol)	   and	  3	  different	  
vehicles	   (EtOH,	   AOO	   and	   DMF)	   (Fig.	  5C).	   In	   SkinEthic™	   RHE,	   release	   of	   IL-­‐18	   was	   similar	  
when	  either	  EtOH	  or	  AOO	  was	  used	  for	  vehicle	  for	  a	  given	  sensitiser.	  However	  when	  DMF	  
was	  used	  as	  vehicle,	   IL-­‐18	  secretion	  was	  clearly	   less.	  This	  observation	  was	   independent	  of	  
the	  degree	  of	  cytotoxicity	  since	  EtOH	  and	  DMF	  exhibited	  similar	  cytotoxicity	  for	  each	  of	  the	  
sensitisers.	  AOO	  appeared	  to	  have	  the	  least	  cytotoxic	  effect	  on	  EE	  when	  used	  as	  vehicle	  for	  
citral	   and	   eugenol.	   Taken	   together	   these	   results	   indicate	   that	   the	   choice	   of	   vehicle	   may	  
influence	  both	  the	  amount	  of	  IL-­‐18	  secretion	  and	  the	  cytotoxicity	   induced	  by	  the	  chemical	  
together	  with	  a	  vehicle.	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Fig.	  5.	   (p.	  149)	  Effects	  of	  different	  vehicles	  on	  cell	  viability	  and	  IL-­‐18	  release	  in	  different	  EE	  models.	  
(A)	   Effects	   of	   water,	   DMSO	   and	   AOO	   (applied	   in	   filter	   paper	   disc)	   on	   cell	   viability	   after	   24	  h	   of	  
exposure	  in	  different	  EE	  models,	  namely	  VUMC-­‐EE,	  epiCS®,	  SkinEthic™	  RHE	  and	  EpiDerm™.	  (VUMC-­‐
EE:	   Water	   n	  =	  15;	   DMSO	   n	  =	  20;	   AOO	   n	  =	  17;	   epics®:	   DMSO	   n	  =	  14;	   AOO	   n	  =	  19;	   SkinEthic™	   RHE:	  
DMSO	  n	  =	  13;	  AOO	  n	  =	  7;	  mean	  ±	  SEM	  is	  shown).	  (B)	  Comparison	  of	  the	  effects	  of	  different	  vehicles	  
(AOO,	  ethanol,	  water)	  and	  mode	  of	  application	  (with	  or	  without	  filter	  paper	  disc)	  on	  DNCB	  and	  SDS-­‐
induced	   IL-­‐18	   release	   and	   cell	   viability	   in	   EpiDerm™	   EE	   model.	   Results	   are	   expressed	   as	  
average	  ±	  difference,	   n	  =	  2	   independent	   experiments.	   (C)	   Comparison	   of	   the	   effects	   of	   different	  
vehicles	   (AOO,	   ethanol,	  water,	  DMF)	   on	   0.15%	  DNCB,	   0.3%	   citral	   and	   1.0%	  eugenol	   induced	   IL-­‐18	  
release	   and	   cell	   viability	   in	   SkinEthic™	   RHE	   EE	   model	   performed	   at	   MB	   Research.	   Results	   are	  











The	   goal	   of	   this	   study	   was	   to	   determine	   whether	   i)	   IL-­‐18	   released	   into	   the	   culture	  
supernatant	  of	  EE	  models	  could	  be	  used	  to	  distinguish	  sensitisers	  from	  non-­‐sensitisers	  and	  
ii)	   whether	   the	   assay	   protocol	   could	   successfully	   rank	   potency	   of	   sensitisers.	   Results	  
obtained	  in	  this	  study	  indicate	  that	  indeed	  this	  single	  in	  vitro	  human	  assay	  may	  be	  able	  to	  
distinguish	  sensitisers	  from	  non-­‐sensitisers	  as	  well	  as	  rank	  sensitisers	  according	  to	  potency.	  
The	   use	   of	   reconstituted	   epidermis	   overcomes	   the	   limitation	   of	   chemical	   solubility	   and	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stability	  in	  water	  solution,	  which	  are	  the	  major	  limitations	  of	  many	  in	  vitro	  methods	  based	  
on	   the	  use	  of	   submerged	   cultures.	  Remarkably	   consistent	   results	  were	  obtained	  between	  
the	   different	   3D	   models,	   indicating	   the	   assays	   robustness	   and	   ease	   to	   transfer	   to	   other	  
laboratories.	   It	   is	  probable	   that	  minor	  method	  optimization	  may	  be	   required	   for	  different	  
types	  of	  commercially	  available	  EE	  and	  different	  vehicles.	  
Due	   to	   their	   anatomical	   location	  and	   critical	   role	   in	   skin	   inflammatory	  and	   immunological	  
reactions,	  the	  use	  of	  the	  KC	  and	  skin	  organotypic	  cultures	  as	  a	  simplified	  in	  vitro	  model	  to	  
evaluate	  the	  potential	  toxicity	  of	  chemicals	  destined	  for	  epicutaneous	  application	   is	  amply	  
justified.	  The	  proposed	  method	  is	  mechanistically	  anchored,	  as	  IL-­‐18	  has	  been	  shown	  to	  play	  
a	  key	  proximal	   role	   in	   the	   induction	  of	  allergic	  contact	  sensitization	   (	  Antonopoulos	  et	  al.,	  
2008;	  Okamura	  et	  al.,	  1995).	  The	  possibility	  of	  using	   IL-­‐18	   for	   the	   in	  vitro	   identification	  of	  
contact	  allergens	  is	  not	  novel;	  as	  we	  have	  previously	  demonstrated	  in	  a	  human	  keratinocyte	  
cell	   line	   (NCTC2544)	  a	   selective	  up-­‐regulation	  of	   intracellular	   IL-­‐18	  by	   contact	   allergens	  at	  
cell	   viability	  >	  80%,	  whereas	   irritants	  and	   respiratory	  allergens	   failed.	  A	   sensitivity	  of	  87%,	  
specificity	  of	  95%	  and	  an	  accuracy	  of	  90%	  was	  reported	  (	  Corsini	  et	  al.,	  2009,	  Corsini	  et	  al.,	  
2012	  and	  Galbiati	   et	   al.,	   2011).	   In	   addition	   to	   requiring	   the	   analysis	   of	   intracellular	   IL-­‐18	  
production	  rather	  than	  release	  of	  IL-­‐18,	  the	  NCTC2544	  assay	  is	  proving	  difficult	  to	  transfer	  
to	  different	  laboratories	  since	  it	  is	  dependent	  on	  critical	  culture	  conditions	  of	  the	  NCTC	  cells	  
(culture	   time	   after	   thawing,	   seeding	   density,	   degree	   of	   confluency)	   and	   has	   a	   cut-­‐off	   for	  
discriminating	  sensitisers	  from	  non-­‐sensitisers	  at	  only	  1.2	  fold	  increase	  in	  intracellular	  IL-­‐18	  (	  
Corsini	   et	   al.,	   2012).	   This	   indicates	   that	   considerable	   cell	   culture	   know-­‐how	   is	   required	   to	  
perform	   the	   assay	   and	   that	   each	   laboratory	   needs	   to	   optimize	   the	   assay	   independently.	  
Replacing	  NCTC2544	  cell	  line	  with	  a	  standardized	  commercially	  available	  EE	  as	  described	  in	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this	   manuscript	   makes	   the	   assay	   extremely	   transferable	   and	   easy	   to	   perform	   for	   any	  
laboratory	  with	  standard	  cell	  culture	  facilities.	  
In	   all	   EE	   models,	   we	   found	   a	   robust	   release	   of	   IL-­‐18	   only	   after	   treatment	   with	   contact	  
allergens.	  Cytotoxicity	  was	  essential	  to	  observe	  the	  release	  of	  intracellular	  IL-­‐18	  into	  culture	  
supernatants.	   At	   a	   similar	   degree	   of	   cytotoxicity	   only	   contact	   allergens,	   and	   not	   irritants,	  
generally	   induced	   a	   dramatic	   increase	   in	   IL-­‐18	   release.	   This	   is	   consistent	   with	   prior	  
neosynthesis	   and	   intracellular	   accumulation	   only	   after	   sensitiser	   exposure,	   and	   is	   in	   line	  
with	  our	  previous	  findings	  (Corsini	  et	  al.,	  2009).	  Our	  observation	  that	  cytotoxicity	  is	  required	  
indicates	   that	  stored	   intracellular	   IL-­‐18	   is	   released	   into	   the	  supernatant	   rather	   than	  active	  
secretion	  of	  IL-­‐18	  and	  again	  is	  in	  line	  with	  previous	  findings	  that	  it	  is	  intracellular	  production	  
rather	   than	   secretion,	  which	   distinguishes	   sensitisers	   from	   non	   sensitisers.	   Increasing	   the	  
chemical	  concentration	  to	  toxic	  concentrations	  enables	  intracellular	  protein	  to	  be	  released	  
via	  membrane	  porosity	  rather	  having	  to	  introduce	  an	  alternative	  lysis	  method	  as	  is	  done	  in	  
the	  NCTC	  assay.	  
In	  prediction	  model	  2	  a	  number	  of	  false	  negatives	  and	  positives	  were	  observed	  which	  led	  to	  
the	  final	  proposed	  prediction	  model	  3.	   In	  prediction	  model	  2	  (≥	  5%	  viability	  (EC5);	  ≥	  5	  fold	  
increase	   in	   IL-­‐18)	  3	  false	  negatives	  were	  observed	   in	  DiSFeB	  and	  1	  false	  positive	   in	  VUMC.	  
Two	  of	   the	   false	  negatives	   in	  DiSFeB	  corresponded	  to	  dose	  response	  curves	   in	  which	  very	  
little	   cytotoxicity	   was	   observed.	   EE	   were	   still	  >	  40%	   viable	   after	   exposure	   to	   phenyl	  
acetaldehyde	  and	  2-­‐mercaptobenzothiazol.	  Formaldehyde	  scored	  as	  the	  third	  false	  negative	  
in	  DiSFeB	  even	  though	  high	   levels	  of	  cytotoxicity	  were	  reached.	  A	  possible	  explanation	  for	  
this	  may	  be	  that	  too	  much	  cytotoxicity	  may	  have	  resulted	  in	  fixation	  of	  the	  tissue	  preventing	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IL-­‐18	   release,	   or	   in	   diffusion	   of	   formaldehyde	   into	   the	   culture	   supernatant	   resulting	   in	  
denaturation	  of	  proteins	  which	  in	  turn	  may	  have	  affected	  the	  ELISA.	  The	  dose	  range	  in	  the	  
DiSFeB	  dropped	   rapidly	   from	  44.5	  ±	  17.53%	  viability	   to	   7.15	  ±	  1.55%	  viability	   in	  which	   the	  
first	  viability	  value	  may	  have	  been	  too	  high	  and	  the	  next	  viability	  value	  too	  low.	  Noticeably,	  
the	   concentrations	   of	   formaldehyde	  used	  by	  DiSFeB	  were	   considerably	   higher	   than	   those	  
used	   by	   VUMC.	   With	   regards	   to	   the	   non-­‐sensitisers	   VUMC	   correctly	   identified	   3/4	   non-­‐
sensitisers	  and	  DiSFeB	  correctly	  identified	  all	  6	  non-­‐sensitisers.	  The	  false	  positive	  phenol	  in	  
the	   VUMC	  may	   possibly	   be	   due	   to	   extended	   storage	   of	   this	   chemical	   resulting	   in	   partial	  
oxidation.	  These	  results	  taken	  together	  led	  to	  the	  testing	  of	  prediction	  model	  3	  in	  which	  a	  
greater	  release	  of	   IL-­‐18	  within	  a	  defined	  cytotoxicity	  range	  was	  tested.	  Prediction	  model	  3	  
(≥	  5%	  and	  ≤	  40%	  viability	  (EC5-­‐40);	  ≥	  5	  fold	  increase	  in	  IL-­‐18	  release)	  resulted	  in	  exclusion	  of	  
the	  2	  false	  negatives	  from	  DiSFeB	  as	  critical	  cytotoxic	  levels	  were	  not	  reached.	  For	  chemical	  
exposures	  which	  fulfilled	  the	  criteria	  for	  prediction	  model	  3,	  all	  but	  one	  chemical	  in	  each	  of	  
the	   laboratories	   were	   correctly	   identified	   (phenol	   scored	   false	   positive	   in	   VUMC,	   and	  
formaldehyde	  scored	  false	  negative	  in	  DiSFeB)	  resulting	  in	  95%	  accuracy	  in	  both	  VUMC	  and	  
DiSFeB	  laboratories.	  Of	  note,	  this	  prediction	  model	  is	  dependent	  on	  the	  chemical	  resulting	  
in	  high	  cytotoxicity	  (5–40%	  viability;	  60–95%	  cytotoxicity)	  in	  the	  EE.	  
In	   this	   study,	  a	  previously	  defined	  standard	  operating	  procedure	   for	   the	  EE	  potency	  assay	  
was	  used	  (Teunis	  et	  al.,	  2013).	  The	  procedure	  defines	  how	  a	  dose	  finding	  is	  performed	  for	  
any	  unknown	  coded	  chemical	   (of	  unknown	  molecular	  mass)	   in	  order	   to	  obtain	  an	  EE-­‐EC50	  
value.	  Our	  results	  show	  that	  by	  following	  this	  procedure	  not	  always	  similar	  dose	  responses	  
were	   obtained	   between	   the	   two	   laboratories	   and	   when	   difference	   were	   observed	   this	  
generally	   corresponded	  with	   the	   variation	   in	   IL-­‐18	   release	   between	   the	   laboratories	   (e.g.	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formaldehyde	   and	   phenyl	   acetaladehyde).	   Minor	   modifications	   to	   the	   procedure	   will	   be	  
expected	  to	  remedy	  this	  in	  the	  future.	  
Correlation	   of	   the	   EE-­‐EC50	   values	   obtained	   from	   the	   11	   chemicals	   in	   two	   different	  
laboratories	   showed	  very	  good	  and	  statistically	   significant	  correlation	  with	  both	  LLNA	  and	  
human	   DSA05	   data.	   Interestingly	   the	   correlation	   was	   much	   better	   with	   the	   human	   data	  
(Spearman	  r	  =	  0.8500;	  P	  value	  of	  0.0061)	  than	  with	  mouse	  LLNA	  data	  (Spearman	  r	  =	  0.5968;	  
P	   value	   of	   0.0542)	   indicating	   that	   our	   human	   in	   vitro	   EE	   assay	   ranks	   human	   sensitiser	  
potency	  more	  accurately	  than	  the	  mouse	  assay.	  It	  should	  be	  mentioned	  though	  that	  these	  
values	  may	  be	  biased	  slightly	  as	  no	  human	  data	  is	  available	  for	  correlation	  for	  the	  chemical	  
oxazolone	  which	  clearly	  deviates	  in	  the	  LLNA	  correlation.	  However,	  our	  finding	  that	  human	  
in	  vitro	  assays	  may	  prove	  superior	  to	  current	  animal	  LLNA	  in	  predicting	  human	  sensitization	  
is	  further	  supported	  by	  the	  findings	  of	  Schneider	  and	  Akkan	  (2004)	  who	  reported	  that	  when	  
comparing	  human	  and	  animal	  data	  for	  46	  substances	  a	  correlation	  of	  only	  r	  =	  0.77	  (HRPIT	  vs	  
LLNA	  data)	  and	  r	  =	  0.65	  (HMT	  vs	  LLNA	  data)	  was	  obtained	  (	  Schneider	  and	  Akkan,	  2004).	  
With	  regards	  to	  assessment	  of	  sensitiser	  potency	  in	  the	  NCTC2544	  assay,	  there	  is	  a	  general	  
trend	   for	   IL-­‐18	   induction	   at	   lower	   concentrations	   for	   extreme/strong	   sensitisers,	  whereas	  
higher	  concentrations	  are	  required	   in	  the	  case	  of	  weak	  sensitisers	   (Corsini	  et	  al.,	  2012).	   In	  
this	   study	  we	  show	  for	   the	   first	   time	   that	   in	  addition	   to	   the	  EE–EC50,	   release	  of	   IL-­‐18	   into	  
culture	  supernatants	  of	  EE	  may	  possibly	  also	  be	  used	   to	  assess	   sensitiser	  potency.	   Indeed	  
our	   correlation	   results	   of	   IL-­‐18	   SI-­‐2	   and	   SI-­‐5	   with	   human	   data	   strongly	   warrant	   further	  
testing	  with	  extended	  chemical	  panels.	  
Importantly	   the	   EE-­‐potency	   assay	   is	   not	   only	   transferable	   between	   laboratories	   but	   also	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between	  different	  types	  of	  EE.	  Results	  obtained	  from	  the	  LLNAEC3–EE–EC50	  correlation	  in	  this	  
study	  using	  epiCS®	  could	  be	  superimposed	  onto	  the	  correlation	  graph	  obtained	  with	  VUMC-­‐
EE	  (dos	  Santos	  et	  al.,	  2011).	  Even	  the	  combined	  correlation	  showed	  a	  significant	  Spearman	  
r	  =	  0.52;	  P	  value	   (two-­‐tailed)	  =	  0.02	  with	   the	   limited	  number	  of	   chemicals	   tested	   including	  
the	   outlier	   oxazolone.	   Further	   experiments	   are	   required	   to	   determine	   whether	   indeed	   a	  
single	   correlation	  graph	   can	  be	  used	   in	   the	   future	   independent	  of	   the	   type	  of	   EE	  used	   to	  
assess	  sensitiser	  potency.	  However	  it	  is	  possible	  that	  at	  least	  minor	  differences	  in	  exposure	  
times	   and/or	   concentrations	   will	   need	   to	   be	   optimized	   among	   different	   EE	   models.	   For	  
example,	   EpiDerm™	   will	   be	   expected	   to	   perform	   slightly	   differently	   than	   epiCS®	   or	  
SkinEthic™	   RHE	   due	   to	   differences	   in	   the	   properties	   of	   the	   stratum	   corneum	   barrier	  
between	  these	  models.	  This	   is	   illustrated	  in	  the	  OECD	  validated	  skin	   irritation	  assay	  where	  
the	  treatment	  time	  for	  inducing	  irritation	  is	  15	  min	  followed	  by	  42	  h	  post-­‐incubation	  in	  the	  
EpiSkin	   model	   whereas	   the	   protocol	   required	   optimization	   for	   SkinEthic™	   RHE	   (42	  min	  
followed	   by	   a	   42	  h	   post-­‐incubation)	   and	   EpiDerm™	   (60	  min	   followed	   by	   a	   42	  h	   post-­‐
incubation)	  (Alepee	  et	  al.,	  2010,	  Kandarova	  et	  al.,	  2009	  and	  Kidd	  et	  al.,	  2007)	  (see	  also	  OECD	  
TG	  439;	  Adopted:	  22	  July	  2010).	  
In	   addition	   to	   comparing	   different	   EE,	   different	   vehicles	   and	   application	   procedures	  were	  
compared.	  Our	  preliminary	  results	   indicate	  that	  the	  choice	  of	  vehicle	  can	  greatly	   influence	  
the	  result	  obtained.	  A	  lower	  IL18	  secretion	  was	  observed	  when	  the	  vehicle	  ETOH	  was	  used	  
rather	  than	  AOO.	  This	  is	  an	  area	  which	  clearly	  requires	  further	  investigation	  using	  the	  single	  
protocol	   developed	   in	   this	   study	  with	   epiCS®	   and	   is	   also	  mirrored	   in	   the	   results	   reported	  
from	  in	  vivo	  studies.	  The	  broad	  range	  of	  LLNAEC3	  values	  and	  human	  DSA05	  values	  shown	  in	  
Table	  3	  are	  due	   in	  part	   to	   the	  different	   vehicles	  used	   in	   the	  different	   studies.	   The	  vehicle	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effect	  is	  thought	  to	  differ	  due	  to	  the	  following	  two	  reasons:	  1)	  the	  vehicle	  will	  influence	  the	  
ability	  of	  the	  test	  substance	  to	  traverse	  the	  stratum	  corneum	  and	  reach	  the	  viable	  epidermis	  
and	  2)	   the	   vehicle	  will	   influence	   the	  efficiency	  of	   Langerhans	   cell	  migration	   from	   the	   skin	  
(Basketter	  et	  al.,	  2001,	  Lea	  et	  al.,	  1999,	  McGarry,	  2007	  and	  Wright	  et	  al.,	  2001).	  The	  former	  
of	  these	  two	  points	  is	  of	  particular	  relevance	  to	  the	  EE	  assay	  described	  in	  this	  manuscript.	  In	  
contrast,	  the	  means	  by	  which	  the	  chemical	  was	  applied:	  direct	  chemical	  application	  or	  filter	  
paper	  application	  did	  not	  appear	  to	  influence	  the	  result.	  
In	   conclusion,	   using	   a	   single	   standard	  operating	  procedure	  we	  have	  developed	  a	  putative	  
prediction	  model	  in	  two	  different	  laboratories	  (VUMC	  and	  DiSFeB)	  using	  two	  different	  types	  
of	  EE	  (epiCS®	  and	  VUMC-­‐EE).	  Our	  results	  indicate	  that	  only	  minor	  modifications	  in	  the	  assay	  
methodology	   and	   prediction	   model	   are	   required	   to	   optimize	   the	   assay	   read-­‐out	   for	   the	  
different	  commercially	  available	  EE	  (eg.	  SkinEthic™	  RHE,	  EpiDerm™).	  Factors	  which	  may	  vary	  
between	  different	  EE	  are	  the	  optimal	  duration	  and	  method	  of	  chemical	  exposure	  (direct	  vs	  
via	   filter	   paper	   disc),	   the	   type	   of	   vehicle	   used,	   the	   optimal	   cytotoxicity	   margin	   to	   insure	  
maximum	  release	  of	   IL-­‐18	  and	  the	   IL-­‐18	   induction	   factor	   to	  distinguish	  a	  sensitiser	   from	  a	  
non	  sensitiser.	  Our	   first	   results	  do	  show	  that	   this	   simple,	  easily	   transferable	  EE	  assay	  may	  
enable	   sensitisers	   to	   be	   distinguished	   from	   non-­‐sensitisers	   (IL-­‐18	   release:	   ELISA)	   and	   also	  
rank	  sensitisers	  according	  to	  potency	  better	  than	  the	  current	  LLNA	  (EC50	  value:	  MTT	  assay;	  
IL-­‐18	  SI-­‐2:	  ELISA).	  The	  assay	  is	  easy	  to	  implement	  in	  any	  laboratory	  with	  standard	  cell	  culture	  
and	  ELISA	  capabilities.	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3.5	   ROLE	   OF	   ROS	   AND	   HMGB1	   IN	   CONTACT	   ALLERGEN–INDUCED	   IL-­‐18	  
PRODUCTION	  IN	  HUMAN	  KERATINOCYTES	  
	  
Abstract	  
Keratinocytes	  have	  a	  key	  role	  in	  all	  phases	  of	  allergic	  contact	  dermatitis.	  We	  have	  recently	  
identified	   the	   possibility	   to	   use	   IL-­‐18	   production	   for	   the	   in	   vitro	   identification	   of	   contact	  
allergens.	   The	   purpose	   of	   this	   study	   was	   to	   characterize	   the	   molecular	   mechanisms	  
underlying	   allergen-­‐induced	   IL-­‐18	   production,	   in	   order	   to	   identify	   the	   cellular	   source	   of	  
reactive	  oxygen	  species	  (ROS)	  and	  the	  danger	  signals	  involved.	  The	  NCTC2544	  cell	  line	  was	  
exposed	   to	   three	   contact	   allergens,	   namely	   p-­‐phenylenediamine	   (PPD),	   2,4-­‐
dinitrochlorobenzene	   (DNCB),	   and	   citral,	   in	   the	   presence	   or	   absence	   of	   diphenylene	  
iodonium	  (DPI),	  allopurinol,	  and	  rotenone	  to	  identify	  the	  source	  of	  ROS,	  and	  to	  anti-­‐Toll-­‐like	  
receptor	   4	   antibody	   and	   glycirrizic	   acid	   to	   characterize	   the	   danger-­‐associated	   molecular	  
pattern	  molecules.	  In	  the	  case	  of	  PPD,	  the	  induction	  of	  IL-­‐18	  can	  be	  modulated	  by	  rotenone,	  
allopurinol,	  and	  DPI.	  In	  the	  case	  of	  DNCB,	  rotenone	  completely	  prevents	  the	  induction	  of	  IL-­‐
18,	  whereas	  for	  citral,	  DPI	  completely	  prevents	  the	  induction	  of	  IL-­‐18.	  We	  demonstrated	  the	  
ability	   of	   all	   allergens	   tested	   to	   induce	   the	   release	   of	   high-­‐mobility	   group	   protein	   B1	  
(HMGB1).	   Its	   sequester	   by	   glycirrizic	   acid	   significantly	   modulates	   PPD-­‐induced	   IL-­‐18	  
production	   and	   completely	   prevents	   DNCB-­‐	   and	   citral-­‐induced	   IL-­‐18.	   We	   found	   that	  
different	   intracellular	  sources	  of	  ROS	  are	  triggered	  by	  contact	  allergens,	  and	  an	   important	  
role	  for	  HMGB1	  in	  chemical	  allergen-­‐induced	  IL-­‐18	  production	  was	  demonstrated.	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Role	  of	  rotenone	  and	  allopurinol	  in	  allergen-­‐induced	  IL-­‐18	  production	  
	  
As	   reference	   allergens,	   PPD,	   2,4-­‐dinitrochlorobenzene	   (DNCB),	   and	   citral	   were	   used.	   The	  
concentrations	   used	   were	   selected	   from	   previously	   published	   data	   (Corsini	   et	   al.,	   2009;	  
Galbiati	  et	  al.,	  2011;	  Corsini	  et	  al.,	  2013).	  
To	   investigate	  the	   intracellular	  source	  of	  ROS,	  specific	   inhibitors	  of	  the	  three	  main	  cellular	  
sources	  of	  ROS,	  namely	  rotenone	  (mitochondrial	  electron	  transport),	  diphenylene	  iodonium	  
(nicotinamide	   adenine	   dinucleotide	   phosphate	   oxidase	   and	   nitric	   oxide	   synthetase),	   and	  
allopurinol	   (xanthine	   oxidase),	   were	   used.	   The	   list	   of	   inhibitors	   used,	   the	   concentrations	  
used,	   cytotoxicity,	   and	   the	   effect	   on	   IL-­‐18	   are	   reported	   in	   Table	   1.	   At	   the	   concentrations	  
used,	  none	  of	  the	  inhibitors	  were	  cytotoxic	  or	  affected	  IL-­‐18	  content.	  
	  
Abbreviations:	  DPI,	  diphenylene	  iodonium;	  TLR4;	  Toll-­‐like	  receptor	  4.	  
Cells	  were	   treated	   for	  24 hours	  with	   the	   selected	   inhibitors.	  Cell	   viability	  was	  assessed	  by	  
the	   MTT	   reduction	   assay	   and	   intracellular	   IL-­‐18	   by	   ELISA.	   Each	   value	   represents	   the	  
mean±SD,	  n=4.	  
1	  Expressed	  as	  %	  of	  viable	  cells	  versus	  vehicle-­‐treated	  cells	  (100%).	  
2	  Expressed	  as	  SI	  (stimulation	  index).	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As	  shown	  in	  Figure	  1,	  all	  sources	  appear	  to	  be	  involved	  to	  some	  degree	  in	  allergen-­‐induced	  
IL-­‐18,	  as	  all	   inhibitors	  were	  able	  to	  significantly	  modulate	  allergen-­‐induced	  IL-­‐18.	  However,	  
we	  found	  that	  the	  different	  allergens	  tested	  seem	  to	  preferentially	  trigger	  ROS	  production	  
from	  the	  different	  intracellular	  sources.	  In	  particular,	  a	  central	  role	  of	  mitochondria	  could	  be	  
demonstrated	   for	   DNCB	   and	   of	   nicotinamide	   adenine	   dinucleotide	   phosphate	   oxidase	   for	  
citral,	  whereas	  for	  PPD	  a	  main	  source	  of	  ROS	  could	  not	  be	  identified	  as	  all	  inhibitors	  equally	  
















Figure	   1.	   Role	   of	  mitochondria,	   nicotinamide	   adenine	   dinucleotide	   phosphate	   (NADPH)	   oxidase,	  
and	   xanthine	   oxidase	   in	   allergen-­‐induced	   IL-­‐18	   production.	   NCTC2544	   cells	   were	   treated	   with	  
rotenone	  (20 μm),	  allopurinol	  (10 μm),	  and	  diphenylene	  iodonium	  (DPI)	  (5 μm)	  for	  1 hour	  and	  then	  
with	   p-­‐phenylenediamine	   (PPD)	   (30 μg ml−1),	   2,4-­‐dinitrochlorobenzene	   (DNCB)	   (2 μg ml−1),	   citral	  
(20 μg ml−1),	   or	   DMSO	   (0.2%	   final	   concentration)	   as	   vehicle	   control	   for	   24 hours.	   Results	   are	  
expressed	  as	  mean±SD,	  n=4.	  Statistical	  analysis	  was	  performed	  with	  analysis	  of	  variance	  followed	  by	  
Bonferroni	  post-­‐tests,	  with	  **P<0.01	  versus	  vehicle-­‐treated	  cells;	  ##P<0.01	  versus	  cells	  treated	  with	  
inhibitors	  alone.	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Figure	  1	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The	  effects	  of	  different	  sources	  of	  ROS	  
	  
To	  investigate	  the	  direct	  effect	  of	  an	  exogenous	  font	  of	  ROS	  on	  cytokines	  production,	  H2O2	  
was	   used.	   Dose-­‐response	   experiments	   were	   performed	   starting	   from	   H2O2	   1 μm	   as	   the	  
highest	  concentration.	  PPD	  (30 μg ml−1)	  was	  used	  as	  a	  positive	  control.	  We	  determined	  IL-­‐
18,	   IL-­‐1α,	   and	   IL-­‐8	   production.	   Cell	   viability	   was	   evaluated	   in	   parallel	   with	   the	   3-­‐(4,5-­‐
dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐diphenyltetrazolium	  bromide	  (MTT)	  assay.	  
As	   shown	   in	   Figure	   2,	   for	   IL-­‐18	   (panel	   a)	   and	   IL-­‐1α	   (panel	   b)	   only	   at	   the	   two	   highest	  
concentrations	   of	   H2O2	   (1 μm	   and	   0.5 μm)	   a	   statistical	   significant	   increase	   in	   cytokine	  
production	   was	   observed.	   These	   concentrations	   were	   associated	   with	   high	   cytotoxicity	  
(about	  50%	  of	  mortality).	  Otherwise,	  H2O2	  was	  able	  only	  to	  induce	  a	  statistically	  significant	  





Figure	  2.	  Effects	  of	  different	  sources	  of	  reactive	  oxygen	  species	  (ROS).	  NCTC2544	  cells	  were	  treated	  
with	   increasing	   concentrations	   of	   H2O2	   or	   with	   p-­‐phenylenediamine	   (PPD)	   (30 μg ml−1)	   as	   positive	  
control.	  After	  incubation	  for	  24 hours,	  cell	  viability	  was	  assessed	  by	  3-­‐(4,5-­‐dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐
diphenyltetrazolium	  bromide	  (MTT)	  assay,	  whereas	  IL-­‐18	  (a),	  IL-­‐1α	  (b),	  and	  IL-­‐8	  (c)	  were	  assessed	  by	  
ELISAs.	  Results	  are	  expressed	  as	  mean±SD,	  n=3.	  Statistical	  analysis	  was	  performed	  with	  analysis	  of	  
variance,	  followed	  by	  Bonferroni	  post-­‐tests,	  with	  *P<0.05	  and	  **P<0.01	  versus	  vehicle-­‐treated	  cells.	  
In	  panel	  d,	  cells	  were	  treated	  with	  PPD	  30 μg ml−1	  in	  pink,	  2,4-­‐dinitrochlorobenzene	  (DNCB)	  2 μg ml−1	  
in	  green,	  and	  citral	  20 μg ml−1	  in	  orange	  for	  5 minutes.	  The	  purple	  histogram	  represents	  control	  cells.	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The	   results	   obtained	   suggest	   that	   KCs	   react	   differently	   to	   exogenous	   or	   to	   endogenous	  
oxidative	  stresses.	   In	  particular,	  we	  found	  that	  an	  external	   font	  of	  ROS,	  such	  as	  H2O2,	  was	  
able	  to	  induce	  IL-­‐18	  and	  IL-­‐1α	  production	  only	  at	  cytotoxic	  concentrations,	  whereas	  contact	  
allergens	   induced	  a	  dose-­‐related	   IL-­‐18	  production	  at	  noncytotoxic	  concentrations	   (viability	  
>80%).	  
To	  estimate	  the	  expression	  of	  ROS	  (H2O2),	  we	  used	  the	  dichlorofluorescein	  diacetate	  assay.	  
As	  shown	  in	  Figure	  2,	  panel	  d,	  and	  in	  agreement	  with	  literature	  data,	  to	  a	  different	  extent	  all	  
allergens	  tested	  induce	  an	  oxidative	  stress	  in	  KCs.	  
	  
Role	  of	  caspase-­‐1	  and	  TLR4	  in	  allergen-­‐induced	  IL-­‐18	  production	  	  
Z-­‐VAD-­‐FMK,	  a	  cell-­‐permeant	  pan	  caspase	  inhibitor	  that	  irreversibly	  binds	  to	  the	  catalytic	  site	  
of	  caspases,	  and	  a	  neutralizing	  anti-­‐TLR4	  antibody	  were	  used	  to	  investigate	  the	  role	  of	  the	  
inflammasome	  and	  TLR4	  in	  allergen-­‐induced	  IL-­‐18	  production.	  DNCB-­‐	  and	  citral-­‐induced	  IL-­‐
18	  were	  completely	  prevented	  by	  Z-­‐VAD-­‐FMK	  (Figure	  3a)	  and	  by	  anti-­‐TLR4	  antibody	  (Figure	  
3b),	   whereas	   PPD-­‐induced	   IL-­‐18	   was	   significantly	   reduced	   but	   completely	   not	   abrogated,	  
possibly	  indicating	  the	  involvement	  of	  other	  pathways.	  
DAMPs	  	  
We	  focused	  our	  attention	  on	  HMGB1	  as	  possible	  DAMP	  associated	  with	  allergen-­‐induced	  IL-­‐
18.	  By	  measuring	  the	  release	  of	  HMGB1	  (Figure	  4a)	  and	  using	   its	  direct	   inhibitor	  glycirrizic	  
acid	  (Figure	  4c),	  we	  could	  demonstrate	  that	  all	  allergens	  tested	  induced	  HMGB1	  release	  and	  
its	   sequestration	   by	   glycirizzic	   acid	   prevented	   IL-­‐18	   induction,	   demonstrating	   the	   role	   of	  
HMGB1	   in	   allergen-­‐induced	   IL-­‐18.	   In	   addition,	   the	   release	   of	   HMGB1	   can	   be	   significantly	  
reduced	  by	   Z-­‐VAD-­‐FMK	   (Figure	   4b).	   This	   is	   consistent	  with	   published	  data,	  which	   showed	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that	   the	   secretion	   of	   HMGB1	   requires	   inflammasome	   and	   caspase	   activation,	   probably	  
associated	  with	  the	  translocation	  of	  HMGB1	  from	  the	  nucleus	  to	  the	  cytoplasm	  (Apetoh	  et	  
al.,	  2007;	  Yamada	  et	  al.,	  2011;	  Lu	  et	  al.,	  2012).	  
Data	  presented	  show	  the	  involvement	  of	  this	  DAMP	  in	  allergen-­‐induced	  KC	  activation.	  This	  
is	   not	   limited	   to	   the	   NCTC2544	   cell	   line,	   as	   we	   also	   observed	   the	   release	   of	   HMGB1	   in	  
human	  reconstituted	  epidermis	   treated	  with	   increasing	  concentrations	  of	  PPD,	  DNCB,	  and	  
citral	   (Figure	  4d),	  demonstrating	  the	  release	  of	  this	  protein	  not	  only	   in	  the	  KC	  cell	   line	  but	  
also	  in	  a	  more	  complex	  in	  vitro	  system.	  
Finally,	  to	  investigate	  the	  role	  of	  HMGB1	  in	  allergen-­‐induced	  IL-­‐8	  and	  IL-­‐1α	  production,	  cells	  
were	  pretreated	  with	  glycirrizic	  acid	  and	  then	  with	  PPD.	  As	  shown	  in	  Table	  2,	  glycirizzic	  acid	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Figure	   3.	   Role	   of	   the	   inflammasome	   and	   Toll-­‐like	   receptor	   4	   (TLR4)	   in	   allergen-­‐induced	   IL-­‐18	  
production.	   NCTC2544	   cells	   were	   treated	   with	   Z-­‐VAD-­‐FMK	   (10 μm,	   (a)	   in	   purple)	   and	   anti-­‐TLR4	  
(2 μg ml−1,	   (b)	   in	   green)	   for	   1 hour	   and	   then	   with	   p-­‐phenylenediamine	   (PPD)	   (30 μg ml−1),	   2,4-­‐
dinitrochlorobenzene	   (DNCB)	   (2 μg ml−1),	   citral	   (30 μg ml−1),	   or	  DMSO	   (0.2%	   final	   concentration)	   as	  
vehicle	   control	   for	   24 hours.	   Results	   are	   expressed	   as	   mean±SD,	   n=4.	   Statistical	   analysis	   was	  
performed	  with	  analysis	  of	  variance	  followed	  by	  Bonferroni	  post-­‐tests,	  with	  *P<0.05	  and	  **P<0.01	  
versus	  vehicle-­‐treated	  cells;	  #P<0.05	  and	  ##P<0.01	  versus	  cells	  treated	  with	  inhibitors	  alone.	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Figure	  4.	  Role	  of	  high-­‐mobility	  group	  protein	  B1	  (HMGB1)	  in	  allergen-­‐induced	  IL-­‐18.	  (a)	  NCTC2544	  
cells	   were	   treated	   for	   24 hours	   with	   p-­‐phenylenediamine	   (PPD)	   (30 μg ml−1),	   2,4-­‐
dinitrochlorobenzene	  (DNCB)	  (2 μg ml−1),	  citral	  (30 μg ml−1),	  or	  DMSO.	  (b)	  Cells	  were	  treated	  with	  Z-­‐
VAD-­‐FMK	   10 μm,	   and	   then	   selected	   allergens	  were	   added	   for	   24 hours.	   (c)	   Cells	  were	   treated	   for	  
1 hour	  with	  glycirrizic	  acid	  (100 μm)	  and	  then	  contact	  allergens	  were	  added	  for	  24 hours.	  (d)	  HMGB1	  
release	   in	   EPICS®	   	   model.	   After	   topical	   exposure	   to	   chemicals,	   HMGB1	   release	   was	   assessed	   by	  
ELISA.	   Results	   are	   expressed	   as	   mean±SD,	   n=4.	   Statistical	   analysis	   was	   performed	   with	   two-­‐way	  
analysis	   of	   variance	   followed	  by	  Bonferroni	   post-­‐tests,	  with	   *P<0.05	   and	   **P<0.01	   versus	   vehicle-­‐
treated	  cells	  and	  ##P<0.01	  versus	  cells	  treated	  with	  inhibitors	  alone.	  
	  
Cells	   were	   treated	   for	   24 hours	   with	   p-­‐phenylenediamine	   30 μg ml−1.	   Cytokines	   were	   assessed	   by	  
ELISA.	  Each	  value	  represents	  the	  mean±SD,	  n=3.	  1	  Expressed	  as	  pg	  per	  mg.	  2	  Expressed	  as	  pg	  per	  ml.	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Discussion	  
We	  found	  that	  contact	  allergens,	  acting	  as	  danger	  signals,	  stress	  the	  cells	  inducing	  oxidative	  
stress	  and	  DAMP	  release,	  and	  stimulate	  the	  assembly	  of	  the	  inflammasome,	  resulting	  in	  IL-­‐
18	  neosynthesis	  and	  release.	  Different	  intracellular	  sources	  of	  ROS,	  including	  mitochondria,	  
nicotinamide	   adenine	   dinucleotide	   phosphate	   oxidase,	   and	   xanthine	   oxidase,	   seem	   to	   be	  
involved,	   as	   allergen-­‐induced	   IL-­‐18	   can	   be	   modulated	   to	   a	   different	   extent	   by	   different	  
selective	  inhibitors.	  
Danger	   signals	   are	   typically	   divided	   into	   pathogen-­‐associated	   molecular	   patterns	   and	  
DAMPs.	   The	   majority	   of	   contact	   allergens	   have	   the	   ability	   to	   deliver	   both	   antigenic	   and	  
danger	   signals	   (McFadden	  et	   al.	   2013).	   In	   this	   case,	   the	   danger	   signals	   are	   related	   to	   the	  
irritant	   capacity	   of	   the	   chemical	   allergens,	   resulting	   in	   cell	   and	   tissue	   trauma	   and	   the	  
elaboration	   of	   DAMPs,	   which	   are	   the	   key	   events	   for	   successful	   contact	   hypersensitivity.	  
Among	   the	   possible	   DAMPs,	   here,	   we	   demonstrated	   the	   ability	   of	   contact	   allergens	   to	  
induce	  the	  release	  of	  HMGB1,	  which	  via	  TLR4	  induces	  IL-­‐18	  neosynthesis	  in	  KCs.	  HMGB1	  is	  a	  
major	  mediator	  of	  endotoxin	  shock	  (Wang	  et	  al.,	  2002),	  and	  it	  acts	  on	  several	  immune	  cells	  
to	   trigger	   inflammatory	   responses	   as	   DAMPs	   (Scaffidi	   et	   al.,	   2002).	   HMGB1	   can	   induce	  
dendritic	   cell	  maturation	  via	  upregulation	  of	  CD80,	  CD83,	  CD86,	  and	  CD11c;	   it	   can	   induce	  
production	  of	  proinflammatory	  cytokines	  in	  myeloid	  cells	  (i.e.,	  IL-­‐1,	  TNF	  alpha,	  IL-­‐6	  ,and	  IL-­‐
8),	  as	  well	  as	  upregulate	  the	  expression	  of	  cell	  adhesion	  molecules	   (i.e.,	   ICAM-­‐1,	  VCAM-­‐1)	  
on	   endothelial	   cells	   (Ferrari	   et	   al.,	   1996;	   Gardella	   et	   al.,	   2002;	   Scheibner	   et	   al.	   2006).	  
Extracellular	   HMGB1	   can	   bind	   to	   TLR2/4	   and	   RAGE	   on	   effector	   cells	   in	   order	   to	   induce	  
inflammation,	   chemotaxis,	   and	   repair	   responses	   (Vande	   Walle	   et	   al.,	   2011).	   We	   could	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demonstrate	  the	  ability	  of	  contact	  allergens	  to	  induce	  the	  release	  of	  HMGB1	  in	  KCs	  and	  its	  
role	  in	  IL-­‐18	  production.	  
The	   inflammasome	   induces	   the	   activation	   of	   caspase-­‐1,	   an	   enzyme	   that	   is	   central	   to	   the	  
development	   of	   skin	   sensitization	   (Ainscough	   et	   al.,	   2013).	   Using	   the	   caspase	   inhibitor	   Z-­‐
VAD-­‐FMK,	  we	  could	  demonstrate	  the	  involvement	  of	  the	  inflammasome	  in	  allergen-­‐induced	  
IL-­‐18	  production	   in	  KCs.	   It	  has	  been	  demonstrated	   that	  a	  multitude	  of	  diverse	   stimuli	   can	  
activate	   NLRP3,	   including	   adenosine	   triphosphate,	   silica,	   asbestos,	   uric	   acid,	   and	   several	  
bacterial	   products	   (Pedra	   et	   al.,	   2009).	   Among	   the	   processes	   associated	   with	   toxin-­‐	   and	  
crystal-­‐mediated	  NLPR3	  activation	  is	  the	  production	  of	  ROS	  (Dostert	  et	  al.,	  2008).	  Evidence	  
indicates	   that	   allergic	   and	   inflammatory	   skin	   diseases	   are	   mediated	   by	   oxidative	   stress	  
(Okayama,	   2005;	   Byamba	   et	   al.,	   2007).	   The	   disturbance	   of	   the	   antioxidant	   systems,	   both	  
enzymatic	   and	   nonenzymatic,	   can	   lead	   to	   increased	   ROS,	   which	   can	   damage	   cellular	  
macromolecules	   (Byamba	   et	   al.,	   2007).	   Many	   in	   vitro	   studies	   have	   revealed	   that	   ROS	  
production	   is	   induced	  by	   contact	  allergens	   (Corsini	  et	  al.,	   2013).	   The	  majority	  of	   chemical	  
allergens	   bind	   to	   the	   thiol	   group	   of	   cysteine	   (Divkovic	   et	   al.,	   2005),	   which	   may	   lead	   to	  
glutathione	  depletion	  and	  oxidative	  stress,	  tissue	  damage,	  and	  increased	  inflammation.	  We	  
have	  previously	  demonstrated	  that	  PPD-­‐induced	  IL-­‐18	  production	   in	  KCs	  can	  be	  abrogated	  
by	   the	   antioxidant	   and	  NF-­‐κB	   inhibitor	   pyrrolidine	   dithiocarbamate	   (Galbiati	  et	   al.,	   2011),	  
supporting	  the	  important	  role	  of	  ROS	  in	  KC	  activation.	  It	  is	  proposed	  that	  mitochondria	  may	  
have	  a	  central	  role	  in	  NLRP3	  activation	  (Zhou	  et	  al.,	  2010),	  as	  these	  organelles	  are	  believed	  
to	  be	  the	  main	  source	  of	  cellular	  ROS	  (Tait	  and	  Green,	  2012).	  Engagement	  of	  certain	  TLRs	  
(TLR	  1,	  2,	  and	  4)	  leads	  to	  mitochondrial	  translocation	  of	  the	  signaling	  adaptor	  TRAF6.	  At	  the	  
mitochondria,	  TRAF6	  interacts	  with	  ECSIT,	  a	  protein	  implicated	  in	  the	  assembly	  of	  complex	  I,	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leading	  to	  its	  ubiquitylation,	  which	  results	   in	  increased	  ROS	  production.	  Finally,	  among	  the	  
protein	  carbonylated	  by	  contact	  allergens,	  mitochondrial	  adenosine	  triphosphate	  synthase	  
was	   identified	   (Je	  et	  al.,	   2008),	   further	   supporting	   the	   central	   role	  of	  mitochondria	   in	   the	  
pathophysiology	   of	   contact	   allergy.	   Using	   selective	   inhibitors	   of	   the	   main	   intracellular	  
sources	   of	   ROS,	   namely	   mitochondria,	   NAPDH	   oxidase,	   and	   xanthine	   oxidase,	   we	   could	  
demonstrate	   that	   all	   these	   three	   sources	   appear	   to	   be	   involved	   in	   allergen-­‐induced	   IL-­‐18	  
production,	  with	  a	  different	  contribution	  depending	  on	  the	  allergen.	  
Among	   the	   several	   assays	   available	   to	   measure	   the	   levels	   of	   ROS,	   we	   used	   the	  
dichlorofluorescein	  diacetate	  assay.	  This	  assay	  is	  sensitive	  to	  oxidation	  by	  peroxynitrite	  and	  
hydrogen	   peroxide,	   whereas	   it	   is	   not	   suitable	   to	   measure	   nitric	   oxide,	   hypochlorite,	   or	  
superoxide	   in	  biological	   systems	  as	   it	   does	  not	  distinguish	  between	   the	  different	   types	  of	  
ROS	   (Byamba	   et	   al.,	   2007).	   Furthermore,	   during	   our	   experiments,	   we	   had	   noticed	   some	  
“interference	  problem”	  with	   the	  pro-­‐hapten	  PPD.	  PPD	   is	   a	  white	   solid	   that	  becomes	  dark	  
owing	  to	  air	  oxidation,	  and	  we	  suppose	  that	  this	  color	  change	  could	  interfere	  with	  the	  flow	  
cytometry	   laser.	  As	  explained	   in	   the	  Results	  section,	  KCs	  react	  differently	   to	   internal	  or	   to	  
external	  oxidative	  stimuli.	  Taken	  together,	  these	  evidence	  suggest	  that	  external	  sources	  of	  
ROS	  (i.e.,	  H2O2),	  not	  induced	  by	  contact	  allergens,	  are	  not	  able	  to	  modulate	  the	  IL-­‐18	  and	  IL-­‐
1α	  response,	  hence	  indicating	  that	  this	  response	  is	  specific	  to	  contact	  allergens.	  
In	  addition	  to	  the	  NLR,	  other	  pathogen-­‐associated	  molecular	  pattern/DAMP	  receptors	  exist,	  
including	   TLRs,	   c-­‐type	   lectin	   receptors,	   prostanoid	   receptors,	   and	   neuropeptide	   receptors	  
(Trinchieri	  and	  Sher,	  2007),	  many	  of	  which	  have	  been	  implicated	  in	  the	  development	  of	  skin	  
sensitization.	   On	   blocking	   TLR4	   with	   a	   specific	   antibody,	   a	   significant	   reduction	   in	   IL-­‐18	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production	   was	   observed,	   demonstrating	   that	   allergen-­‐induced	   IL-­‐18	   production	   is	  
dependent	  upon	  TLR4	  activation.	  
Among	   the	   DAMPs	   that	   are	   able	   to	   activate	   TLR4,	   we	   demonstrated	   the	   involvement	   of	  
HMGB1	  in	  allergen-­‐induced	  IL-­‐18	  production.	  He	  et	  al.	  (2012)	  speculated	  that	  HMGB1	  could	  
increase	  the	  synthesis	  of	  pro-­‐IL-­‐1β	  and	  pro-­‐IL-­‐18	  in	  THP-­‐1	  cells.	  We	  used	  glycirrizic	  acid,	  as	  it	  
has	   been	   demonstrated	   to	   be	   a	   direct	   inhibitor	   of	   HMGB1	   (Girard,	   2007;	   Mollica	   et	   al.,	  
2007).	   Our	   data	   indicated	   that	   glycirrizic	   acid	   significantly	   reduces	   allergen-­‐induced	   IL-­‐18	  
and	  IL-­‐1α	  production,	  supporting	  the	  involvement	  of	  HMGB1	  in	  the	  induction	  of	  these	  two	  
cytokines.	  Otherwise,	  glycirrizic	  acid	  does	  not	  affect	  the	  IL-­‐8	  levels,	  suggesting	  that	  HMGB1	  
is	  not	  involved	  in	  the	  release	  of	  this	  cytokine	  following	  allergenic	  stimulation.	  
Oxidative	   stress,	   the	   inflammasome,	  and	  TLR4	  activation	  are	   strictly	   cross-­‐linked	  and	   they	  
have	  a	  key	  role	  in	  the	  innate	  immune	  and	  stress	  responses.	  TLR4,	  after	  a	  danger	  signal,	  can	  
activate	  NF-­‐κB	  and	  MAPK	  pathways,	  inducing	  the	  release	  of	  inflammatory	  cytokines	  such	  as	  
IL-­‐1β	  and	  IL-­‐18.	  In	  addition,	  TLR4	  has	  the	  ability	  to	  further	  induce	  ROS,	  which	  have	  a	  triple	  
role:	  (1)	  they	  are	  able	  to	  directly	  stimulate	  inflammatory	  and	  cytotoxic	  responses;	  (2)	  they	  
can	   activate	   the	   NF-­‐κB	   and	   MAPK	   pathways;	   and	   (3)	   they	   can	   interact	   with	   the	  
inflammasome	  leading	  to	  IL-­‐1β	  and	  IL-­‐18	  release.	  
On	  the	  basis	  of	  our	  results,	  the	  following	  scenario	  can	  be	  imagined:	  chemical	  sensitisers	  can	  
induce	   oxidative	   stress	   owing	   to	   their	   electrophilicity,	   which	   in	   turn	   activates	   the	  
inflammasome	  and	  HMGB1	   release	   (and	  possibly	  other	  DAMPs),	  which	   can	  activate	  TLR4.	  
Activation	  of	  TLR4	  will	  result	  in	  NF-­‐κB	  and	  p38	  MAPK	  activation	  and	  in	  the	  neosynthesis	  of	  
IL-­‐18.	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More	   importantly,	  a	  similar	  scenario	  has	  been	  demonstrated	   in	  vivo.	   In	  a	  mouse	  model	  of	  
contact	  hypersensitivity	  the	  ability	  of	  contact	  allergens	  to	   induced	  DAMPs	  and	  stimulation	  
of	   TLR4,	   trigger	   the	   production	   of	   proinflammatory	   cytokines,	  which	   in	   turn	   promote	   the	  
acquisition	   of	   skin	   sensitization,	   and	   subsequently	   the	   elicitation	   of	   allergic	   contact	  
dermatitis	  (Martin	  et	  al.,	  2011).	  
In	  conclusion,	  we	  demonstrated	  a	  role	  of	  oxidative	  stress,	  inflammasome	  activation,	  HMGB1	  
release,	   and	   TLR4	   activation	   in	   contact	   allergen–induced	   IL-­‐18	   production	   in	   human	   KC.
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Chapter	  4	  
CONCLUSIONS	  AND	  FUTURE	  PERSPECTIVES	  
	  
Allergic	  contact	  dermatitis	   is	  a	  complex	  disease,	  and	  a	  relevant	  challenge	  for	  public	  health	  
and	   immunology.	   Workplace	   exposure,	   age,	   sex,	   use	   of	   consumer	   products	   and	   genetic	  
predispositions	  were	  identified	  as	  the	  most	  important	  risk	  factors.	  In	  Europe	  about	  20%	  of	  
the	  general	  population	   suffers	   from	  contact	  allergy	   to	  at	   least	  one	  contact	  allergen.	  Most	  
common	  are	  allergies	  to	  nickel,	  fragrances	  and	  preservatives.	  Allergic	  reactions	  to	  chromate	  
and	   p-­‐phenylenediamine	   (PPD)	   are	   generally	   less	   common	   but	   occur	   frequently	   in	  
occupationally	  exposed	  subgroups	  of	  the	  population	  (Peiser	  at	  al.,	  2011).	   
For	   skin	   sensitisers,	   the	   local	   lymph	   node	   assay	   was	   the	   first	   method	   to	   be	   fully	   and	  
independently	   validated,	   as	   well	   as	   the	   first	   to	   offer	   an	   objective	   end	   point	   with	   a	  
quantitative	  measure	   of	   sensitizing	   potency	   (in	   addition	   to	   hazard	   identification).	   Fifteen	  
years	  later,	  it	  serves	  as	  the	  primary	  standard	  for	  the	  development	  of	  in	  vitro/in	  chemico/in	  
silico	  alternatives.	  (Basketter	  et	  al.,2014).	  
There	  is	  still	  a	  lack	  of	  comparable	   in	  vitro	  methods,	  and	  substantial	  efforts	  have	  been,	  and	  
are	  being,	  made	  world-­‐wide	  to	  develop	  alternative	  assays	  to	  achieve	  a	  full	  replacement	  of	  
animals	   use.	   The	   main	   challenge	   is	   to	   address	   the	   required	   level	   of	   integration	   of	   the	  
molecular	  and	  cellular	  processes	  that	  are	  underlying	  skin	  sensitisation.	  	  
Four	  goals	  have	  been	  identified	  for	  a	  full	  replacement	  of	  skin	  sensitisation	  animal	  data:	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1. Hazard	  identification:	  prediction	  of	  potential	  sensitiser	  (yes/no	  answer)	  
2. Classification	   and	   labelling	   (i.e.	  GHS,	   EU-­‐CLP):	  more	   than	   yes/no	   answer,	   i.e.	   some	  
potency	  determination	  
3. Hazard	  characterization:	  prediction	  of	  sensitiser	  and	   its	  potency,	   i.e.	  non-­‐sensitiser,	  
weak,	  moderate,	  strong,	  extreme	  (dose-­‐response	  information).	  
4. Risk	  assessment:	  accurate	  evaluation	  of	  relative	  skin	  sensitizing	  potency	  to	  support	  
effective	  risk	  assessment	  	  
Several	   European	   Union	   legislations	   request	   the	   use	   of	   in	   vitro	  methods	   for	   toxicological	  
evaluations,	  including	  sensitization,	  in	  order	  to	  increase	  consumer	  safety	  but	  also	  to	  reduce	  
the	  use	  of	  animals.	  	  
In	   this	   context,	   the	   NCTC	   2544	   assay	   (results	   described	   in	   Chapter	   3.1),	   based	   on	   the	  
selective	   induction	   of	   IL-­‐18	   in	   human	   keratinocytes	   by	   contact	   allergens,	   was	   developed	  
within	   the	   SENS-­‐IT-­‐IV	   project	   sponsored	   by	   the	   European	  Union.	   The	   assay	   proved	   to	   be	  
useful	   in	   the	   identification	   and	   discrimination	   of	   contact	   allergens	   from	   respiratory	  
sensitisers	   and	   irritants	   (Corsini	   et	   al.,	   2009).	   Exposure	   of	   NCTC	   2544	   cells	   to	   contact	  
allergens	   results	   in	   a	   dose-­‐related	   induction	   of	   intracellular	   IL-­‐18,	   whereas	   exposure	   to	  
respiratory	  allergens	  and	  irritants	  fails	  to	  induce	  IL-­‐18	  production,	  indicating	  the	  possibility	  
to	  use	  IL-­‐18	  to	  specifically	   identify	  contact	  allergens	  and	  distinguish	  them	  from	  respiratory	  
allergens	  and	  irritants.	  
About	  one	  year	  later	  the	  experimental	  conditions	  were	  optimized	  to	  clarify	  the	  cell	  density	  
issue,	  a	  high	   throughput	  assay	  was	  developed,	   the	  performance	  of	  other	  available	  KC	  cell	  
lines	   was	   tested,	   and	   the	   signal	   transduction	   pathways	   involved	   in	   PPD-­‐induced	   IL-­‐18	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production	  were	   characterized,	   as	   described	   in	   Chapter	   3.2	   (Galbiati	   et	   al.,	   2011).	   Critical	  
points	   identified	   in	   the	  performance	  of	   the	  NCTC	  2544	  assay	   are	   the	   cell	   density	   and	   the	  
time	   cells	   have	   been	   cultured	   before	   use	   in	   experiments.	   If	   cells	   reach	   confluence	   at	   the	  
moment	  of	   treatment,	   the	   ability	   to	   identify	   contact	   allergens	   is	   lost.	   In	  our	  hands,	   a	   cell	  
density	   of	   2.5	  ×	  105	  cells/ml	   gave	   optimal	   stimulation.	   Regarding	   time	   after	   thawing,	   cells	  
should	  be	  used	  between	  3	  weeks	  after	  thawing,	  up	  to	  5	  months	  after.	  
The	  influence	  of	  cell	  density	  on	  the	  discriminatory	  capacity	  of	  the	  NCTC	  2544	  assay	  can	  be	  
attributed	   to	   a	   decrease	   in	   cellular	   reactivity	   once	   cells	   reach	   confluence.	   We	   have	  
demonstrated	  that	  PPD-­‐induced	  IL-­‐18	  production	  is	  dependent	  upon	  oxidative	  stress,	  and	  it	  
has	   been	   demonstrated	   that	   the	   capacity	   of	   KC	   to	   generate	   reactive	   oxygen	   species	  
decrease	   as	   the	   cells	   reached	   confluence	   (Turner	   et	   al.,	   1998),	   which	   offers	   a	   logical	  
explanation	  for	  the	  effect	  observed.	  
During	  my	  thesis	  in	  order	  to	  further	  develop	  the	  assay	  and	  to	  increase	  its	  screening	  capacity,	  
a	  96-­‐well	  format	  assay	  was	  developed.	  The	  purpose	  of	  this	  96-­‐well	  format	  was	  to	  speed	  up	  
the	   assay	   and	   reduce	   cell	   manipulation	   (no	   cell	   washing	   steps	   and	   no	   protein	  
determination).	  In	  this	  case	  the	  total	  IL-­‐18	  (intracellular	  plus	  released)	  was	  assessed	  and	  also	  
under	  these	  experimental	  conditions,	  a	  selective	   increase	   in	  total	   IL-­‐18	  was	  observed	  only	  
following	  treatment	  with	  contact	  allergens,	  whereas	  both	  irritants	  and	  respiratory	  allergens	  
failed	  (Galbiati	  et	  al.,	  2011).	  
	  
Another	   important	   issue	   in	   sensitisations	   field	   is	   the	   differentiation	   between	  
photoallergens	  and	  phototoxic	  reactions	  induced	  by	  low	  molecular	  weight	  compounds.	  The	  
use	   of	   KCs	   as	   a	   potential	   tool	   for	   the	   detection	   of	   photoallergens	   as	   opposed	   to	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photoirritants	  is	  considered	  an	  interesting	  strategy	  for	  developing	  in	  vitro	  methods.	  As	  part	  
of	  my	  thesis	  (see	  Chapter	  3.3	  -­‐	  Galbiati	  et	  al.,	  2013)	  was	  to	  explore	  the	  possibility	  to	  use	  the	  
NCTC2544	   IL-­‐18	   assay	   to	   identify	   photoallergens	   and	   discriminate	   from	   phototoxic	  
chemicals.	   We	   found	   that	   irradiated	   photoallergens	   induced	   a	   significant	   increase	   in	  
intracellular	  IL-­‐18	  compared	  to	  photoirritants	  or	  no	  phototoxic	  compounds.	  	  
	  
In	  addition	  to	  being	  able	  to	  determine	  whether	  or	  not	  a	  chemical	  is	  a	  sensitiser	  (labelling)	  it	  
is	  also	  equally	  important	  to	  determine	  the	  potency	  of	  a	  sensitiser	  (classification)	  in	  order	  to	  
identify	   a	   maximum	   safe	   concentration	   for	   human	   exposure	   (risk	   assessment).	   The	  
assessment	  of	  risk	  is	  the	  deciding	  point	  in	  the	  toxicology	  of	  skin	  sensitization.	  A	  primary	  step	  
in	  the	  risk	  assessment	  process	  is	  determination	  of	  the	  relative	  skin	  sensitizing	  potency	  of	  the	  
contact	  allergens.	   (Basketter	   	   1998).	  As	  part	  of	  my	   thesis	  work	   in	   collaboration	  with	  Prof.	  
Sue	   Gibbs	   of	   VUMC	   (Netherland),	   we	   developed	   	   “An	   Epidermal	   equivalent	   assay	   for	  
identification	  and	  ranking	  potency	  of	  contact	  sensitisers”.	  As	  described	  in	  Chapter	  3.4,	  the	  
possibility	  of	  combining	  the	  epidermal	  equivalent	  (EE)	  potency	  assay	  with	  the	  assay,	  which	  
assesses	  release	  of	  IL-­‐18	  to	  provide	  a	  single	  test	  for	   identification	  and	  classification	  of	  skin	  
sensitizing	  chemicals,	  including	  chemicals	  of	  low	  water	  solubility	  or	  stability	  is	  reported.	  
A	  putative	  prediction	  model	  is	  proposed	  from	  data	  obtained	  from	  two	  laboratories	  yielding	  
95%	  accuracy.	  Results	  obtained	  in	  this	  study	  indicate	  that	  indeed	  the	  single	  in	  vitro	  human	  
assay	  may	  be	  able	  to	  distinguish	  sensitisers	  from	  non-­‐sensitisers	  as	  well	  as	  rank	  sensitisers	  
according	   to	   potency.	   The	   use	   of	   reconstituted	   epidermis	   overcomes	   the	   limitation	   of	  
chemical	  solubility	  and	  stability,	  which	  are	  the	  majors	  limitations	  of	  many	  in	  vitro	  methods	  
based	   on	   the	   use	   of	   traditional	   submerged	   cultures.	   Remarkably	   consistent	   results	   were	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obtained	  between	   the	  different	   3D-­‐models,	   indicating	   that	   assays	   robustness	   and	  easy	   to	  
transfer	  to	  other	  laboratories.	  In	  all	  EE	  models,	  a	  robust	  release	  of	  IL-­‐18	  was	  observed	  only	  
after	   treatment	   with	   contact	   allergens.	   This	   is	   consistent	   with	   prior	   neosynthesis	   and	  
intracellular	   accumulation	   only	   after	   sensitiser	   exposure,	   and	   is	   in	   line	  with	   our	   previous	  
findings	  (Corsini	  et	  al.,	  2009;	  Galbiati	  et	  al.,	  2011).	  
Next	  it	  was	  determined	  whether	  the	  EC50	  values	  identified	  from	  the	  sensitisers	  in	  the	  dose	  
response	  experiments	  could	  be	  used	  to	  rank	  sensitiser	  potency.	  Extreme/strong	  sensitisers	  
classified	   according	   to	   LLNA	   generally	   had	   a	   lower	   EC50	   value	   than	  weak	   sensitisers.	   EC50	  
values	   for	   the	   moderate	   sensitisers	   generally	   ranged	   between	   the	   weak	   and	   strong	  
sensitisers.	   It	   was	   found	   a	   significant	   correlation	   with	   the	   ranking	   obtained	   by	   the	   LLNA	  
(Spearman	   r	  =	  0.5968;	  P	   value	   (two-­‐tailed)	  =	  0.0542)	   and	   to	  human	  DSA05	  data	   (Spearman	  
r	  =	  0.8500;	  P	  value	  (two-­‐tailed)	  =	  0.0061).	  We	  also	  determined	  whether	  the	  IL-­‐18	  SI-­‐2	  and	  SI-­‐
5	  could	  be	  used	  to	  rank	  sensitiser	  potency.	  The	  correlation	  of	  in	  vitro	  human	  data	  suggested	  
that	  IL-­‐18	  release	  might	  supply	  an	  additional	  potency	  parameter	  in	  this	  assay.	  
	  
Finally,	   the	   purpose	   of	   the	   last	   part	   of	   my	   thesis	   was	   to	   characterize	   the	   molecular	  
mechanism	  underlying	  allergen-­‐induced	  IL-­‐18	  production,	  to	  identify	  the	  cellular	  sources	  of	  
reactive	  oxygen	  species	  and	  the	  danger	  signals	  involved.	  
Contact	   allergens	   acting	   as	   danger	   signals,	   stress	   the	   cells	   inducing	   oxidative	   stress	   and	  
DAMP	  release,	  and	  stimulate	  the	  assembly	  of	  inflammasome,	  resulting	  in	  IL-­‐18	  neosynthesis	  
and	  release.	  Different	  intracellular	  sources	  of	  ROS,	  including	  mitochondria,	  NADPH	  oxidase,	  
and	  xanthine	  oxidase,	  seem	  to	  be	  involved,	  as	  allergen-­‐induced	  IL-­‐18	  can	  be	  modulated	  to	  a	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different	   extent	   by	   different	   selective	   inhibitors.	   In	   addition,	   to	   prove	   the	   specificity	   of	  
response	   of	   keratinocytes	   to	   contact	   allergens	   we	   can	   demonstrate	   that	   KCs	   reacts	  
differently	   to	   internal	   or	   external	   oxidative	   stimuli.	   These	  evidences	   suggest	   that	   external	  
sources	  of	  ROS	  (i.e.H2O2),	  not	  induced	  by	  contact	  allergens,	  are	  not	  able	  to	  modulate	  the	  IL-­‐
18	  response,	  hence	  indicating	  that	  this	  response	  is	  specific	  to	  contact	  allergens.	  
Furthermore,	   we	   demonstrated,	   among	   the	   DAMPs	   that	   are	   able	   to	   activate	   TLR4,	   the	  
involvement	   of	   HMBG1	   in	   allergen-­‐induced	   IL-­‐18	   production.	   Glycirrizic	   acid	   was	   used	   as	  
direct	   inhibitor	   of	  HMGB1	  production.	  Our	   data	   indicated	   that	   glycirrizic	   acid	   significantly	  
reduces	  allergen-­‐induced	  IL-­‐18	  and	  IL-­‐1α	  production,	  supporting	  the	  involvement	  of	  HMGB1	  
in	  the	  induction	  of	  these	  two	  cytokines.	  The	  direct	  involvement	  of	  TLR4	  in	  allergen-­‐induced	  
IL-­‐18	   production	   was	   demonstrated	   by	   blocking	   this	   receptor	   with	   a	   specific	   neutralizing	  
antibody.	  
On	   the	   basis	   of	   results	   obtained,	   the	   following	   scenario	   can	   be	   imagined	   (see	   Fig.12):	  
chemicals	   sensitisers	   can	   induce	   oxidative	   stress	   owing	   to	   their	   electrophilicity,	   which	   in	  
turn	   activates	   the	   inflammasome	  and	  HMGB1	   release	   (and	  possible	  other	  DAMPs),	  which	  
can	  activate	  TLR4.	  Activation	  of	  TLR4	  will	  result	  in	  NF-­‐κB	  and	  p38	  MAPK	  activation	  and	  in	  the	  
neosynthesis	  of	  IL-­‐18.	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Fig.	  12	  –	  Signal	  transduction	  pathways	  
	  
In	  conclusion,	  the	  NCTC2544	  IL-­‐18	  assay	  optimized	  and	  characterized	  as	  part	  of	  my	  thesis	  is	  
an	   in	   vitro	   method	   able	   to	   discriminate	   contact	   allergens	   and	   photoallergens	   from	  
irritants/photoirritants	  and	  also	  from	  respiratory	  allergens.	  
The	  combination	  of	   two	   in	  vitro	  methods	   (EE	  and	   IL-­‐18),	  both	  “born”	  within	   the	  SEN-­‐IT-­‐IV	  
project,	   has	   lead	   to	   the	  development	  of	   a	   putative	  prediction	  model	   to	   identify	   and	   rank	  
sensitisers	  potency.	  	  
Finally,	  signal	  transduction	  pathways	  involved	  in	  contact	  allergens-­‐induced	  IL-­‐18	  production	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linked:	  after	  a	  danger	  signal	  released	  following	  allergen-­‐induced	  oxidative	  stress,	  TLR4	  can	  
trigger	   to	   NF-­‐κB	   and	   MAPK	   pathways	   activation,	   necessary	   to	   the	   neosynthesis	   of	  
inflammatory	  cytokines	  such	  as	   IL-­‐1β	  and	  IL-­‐18.	   In	  addition,	  TLR4	  has	  the	  ability	  to	  further	  
induce	  ROS,	  which	  have	  a	   triple	   role:	   (1)	   they	  are	  able	   to	  directly	   stimulate	   inflammatory	  
and	  cytotoxic	  responses;	  (2)	  they	  can	  activate	  the	  NF-­‐κB	  and	  MAPK	  pathways;	  and	  (3)	  they	  
can	  activate	  the	  inflammasome	  leading	  to	  IL-­‐1β	  and	  IL-­‐18	  processing	  and	  release.	  
	  
As	  future	  perspectives	  the	  following	  experiments	  can	  be	  foreseen:	  
-­‐ To	  further	  study	  the	  signal	  transduction	  pathways	  involved	  in	  allergen-­‐induced	  IL-­‐18	  
production,	   the	   role	  played	  by	   the	  purinergic	   receptor	   (P2RX7)	   and	  ATP	   should	  be	  
investigated;	  
-­‐ The	  correlation	  between	  ROS,	  TXNIP	  (Thioredoxin	  interacting	  protein)	  and	  NLRP3	  in	  
allergen-­‐induced	  IL-­‐18	  production	  should	  also	  be	  addressed;	  
-­‐ Finally,	  a	  better	  understanding	  of	   the	  molecular	  mechanisms	  underlying	  potency	   is	  
mandatory	   to	   achieve	   a	   full	   replacement	   of	   animal’s	   models	   in	   contact-­‐
hypersensitivity.	   All	   this	   regards	   the	   opposite	   role	   of	   NLRP12	   and	   Blimp-­‐1	   in	   the	  
activation	   of	   the	   inflammasome	  may	   offer	   the	   possibility	   to	   discriminate	   between	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